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A B S T R A C T
Understanding gene regulation is a central question of molecular biol-
ogy. For decades, gene expression was thought to be controlled by a
complex network of proteins called transcription factors. But ten years
ago, microRNAs (miRNAs), a distinct class of short, evolutionarily-
conserved non-coding RNAs were found to regulate gene expression.
Hundreds of miRNAs have since then been discovered in species rang-
ing from plants to nematodes to mammals, where they regulate di-
verse biological processes such as development, metabolism, immu-
nity, cell cycle. MicroRNAs load into the Argonaute protein of the
RNA-Induced Silencing Complex (RISC) and provide binding speci-
ficity to it. Upon guiding the RISC to a complementary motif in the
3’ untranslated transcribed region (UTR) of a mRNA, miRNAs inhibit
the translation and increase the decay rate of the target mRNA.
While the molecular machinery required for miRNA action is well
characterized, the biological function of the miRNAs identified so far
remains unknown. Neither do we know through what target genes
miRNAs achieve their biological function. The most common approach
to this question consists in identifying genes that are differentially ex-
pressed following the experimental perturbation of the expression of a
given miRNA by means of genetic knock-out or transfection. Perturb-
ing the expression of a single miRNA has important side-effects on
gene expression, but this problem can be partly addressed by crossing
the genes responding to the miRNA perturbation with computational
miRNA target predictions. In this thesis, we first illustrate how such
a combined experimental and computational approach can be used to
understand how the miR-375 miRNA controls glucose homeostasis.
However, in practice, extracting direct, functional miRNA targets
from miRNA perturbation experiments and computational predictions
is a difficult task because state-of-the-art computational predictions
yield large amounts of false-positives. We therefore set to improve the
accuracy of computational predictions by inferring what sequence and
structure properties characterize functional miRNA binding sites in a
large number of miRNA perturbation experiments. We then combined
these properties into an algorithm that is most accurate at miRNA tar-
get prediction. Also, we show that miRNA binding sites carried by
mRNAs that respond to miRNA perturbation share the same prop-
erties as miRNA binding sites that are under evolutionary selective
pressure, suggesting that miRNA binding sites may have been shaped
by evolution to favor mRNA degradation. Further analyses also lead
to the view that the temporal aspects of miRNA regulation may be
far more important to the miRNA target identification problem than
previously thought, especially for experiments measuring the effects
of miRNA perturbation at the protein level, where taking the tempo-
ral aspects of miRNA regulation into account appears necessary both
during experimental design and subsequent data analysis.
While measurements from combined miRNA perturbation experi-
ments and omics assays are crucial to determining what genes are reg-
ulated by a given miRNA, they are contaminated by side-effects and do
not provide information on the precise location of the miRNA binding
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site within the 3’ UTR of the target genes. To address these problems,
we introduce PAR-CLIP, a combination of biochemical and computa-
tional methods to identify miRNA binding sites in high-throughput.
The mRNA-miRNA-Argonaute ternary complex are first cross-linked.
The ternary complex is then immuno-precipitated and the unprotected
RNA eliminated by enzymatic digestion. Finally, ultra high-throughput
sequencing of the remaining RNA and computational processing of
the resulting sequencing libraries reveals the precise mRNA regions
bound by miRNAs. PAR-CLIP does not require miRNA perturbation
and makes it possible to identify thousands of miRNA binding sites in
one experiment, with nucleotide resolution.
In summary, the present thesis establishes methods that make it pos-
sible to map miRNA-mRNA interactions with high accuracy in the
spatial domain, and paves the way for future investigation of miRNA-
mediated gene regulation in the temporal domain. These methods will
be useful in understanding the miRNA-mRNA interactions underlying
the implication of miRNAs in the regulation of biological processes.
Z U S A M M E N FA S S U N G
Die Regulation der Genexpression ist eine zentrale Frage der moleku-
laren Biologie. Während Jahrzehnten wurde angenommen, dass die
Expression der Genen von komplexen Netzwerken kontrolliert wird,
die aus Proteinen, so genannten Transkriptionsfaktoren bestehen. Vor
zehn Jahren wurde entdeckt, dass microRNAs (miRNAs) eine eigene
Klasse kleiner, in der Evolution konservierter, nicht-codierender RNA
bilden, die Genexpression regulieren. Seitdem wurden hunderte von
miRNAs in Organismen, unter ihnen Pflanzen, Nematoden und Säugetieren
entdeckt, wo sie diverse biologische Prozesse wie Entwicklung, Metabolis-
mus, Immunität, Zellzyklus regulieren. MicroRNAs binden an die Arg-
onaute Protein vom RNA-Induced Silencing Complex (RISC) und bes-
timmen so die Bindungsspezifität der Argonaute. MiRNAs führen dann
den RISC zu einem komplementären Motif der 3’ untranslatierten Re-
gion (UTR) einer mRNA, was zur Inhibition der Translation und zur
Erhöhung der Zerfallsrate der gebundenen mRNA führt.
Während die molekularen Mechanismen der Genexpressionsregula-
tion durch miRNAs identifiziert wurden, bleibt die biologische Funk-
tion einer grossen Mehrheit der miRNAs, die so weit entdeckt wur-
den, unbekannt. Es ist zudem unklar, durch welche Gene die miRNA
ihre Funktion ausüben. Die häufigste Herangehensweise, diese Frage
zu beantworten ist die Identifikation von Genen, deren Expression
durch eine gegebene miRNA gestört wird. Genetische Knock-Outs
oder Transfektionen sind experimentelle Mittel um die Expression zu
stören. Die Expression einer einzelnen miRNAs zu stören kann erhe-
bliche sekundäre Effekte auf die Expression von Genen haben. Durch
die Kreuzung von miRNA abhängigen, differentiel exprimierten Genen
mit rechnergeschützten miRNA Bindundungsstellenvorhersagen (rmBV)
kann dieses Problem teilweise gelöst werden. In dieser Dissertation
wurde diese Strategie eingesetzt um zu untersuchen, wie miRNA-375
die Glukosehomeostase kontrolliert.
In der Praxis ist es jedoch eine anspruchsvolle Arbeit, direkte, funk-
tionelle miRNA Zielgene aus miRNA-Störungsexperimenten und rmBV
zu extrahieren da rmBV in der Regel einen hohen Anteil an falsch
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Positiven liefern. Wir verbesserten die Genauigkeit der rmBV indem
wir die Sequenz- und Struktureigenschaften von funktionellen miRNA
Bindungsstellen aus einer grossen Anzahl von miRNA Störungsexper-
imenten charakterisierten. Die identifizierten Eigenschaften wurden
dann mit dem Algorithmus zur Vorhersage der miRNA-Bindungsstellen
kombiniert, der bei der Identifikation von Ziel-miRNA am genauesten
ist. Zudem zeigen wir, dass miRNA Bindungsstellen von miRNA-abhängigen
mRNAs dieselben Eigenschaften aufweisen wie Bindungsstellen, welche
unter evolutionärem Selektionsdruck stehen. Das führt zur Hypothese,
dass miRNA Bindungsstellen durch die Evolution umgeformt wur-
den, um den mRNA Zerfall zu bevorzugen. Weitere Analysen führten
zur Auffassung, dass die zeitlichen Aspekte der miRNA Regulation
viel wichtiger sein könnten als bisher angenommen. Dies speziell für
Experimente, die den Effekt der miRNA Störung auf der Ebene der
Proteine messen. Bei diesen Experimenten scheint es unentbehrlich
zu sein, während der Planung und Datenanalyse Rücksicht auf die
zeitlichen Aspekte der miRNA Regulation zu nehmen.
Messungen aus kombinierten miRNA Störungsexperimenten und
Omics-Versuchen sind ausschlaggebend um festzustellen welche Gene
von einer bestimmten miRNA reguliert werden. Sie leiden jedoch darunter,
dass sie von sekundären Effekten gestört werden und dass sie keine In-
formation über die genaue Lokalisation der miRNA Bindungsstellen
liefern. Um diese Probleme zu lösen wurde die PAR-CLIP Methode
entwickelt. Dies ist eine Kombination aus biochemischen und rechn-
ergestützten Methoden um miRNA Bindungsstellen in hohen Daten-
durchsätzen zu identifizieren. Die ternären mRNA-miRNA-Argonaute
Komplexe werden erst kovalent gebunden, dann immuno-prezipitiert.
Danach wird die ungeschützte RNA in einem enzymatischen Verdau
eliminiert. Schlussendlich wird die verbleibende RNA sequenziert und
durch rechnergestützte Verarbeitung der Sequenzierdaten wird fest-
gestellt, welche spezifischen mRNA Regionen von miRNAs gebunden
werden. PAR-CLIP benötigt keine miRNA Störung und ermöglicht die
Identifizierung tausender miRNA Bindungsstellen Nukleotid-Auflösend
in einem einzigen Versuch.
Zusammengefasst führt diese Dissertation Methoden ein, mit denen
sich miRNA-mRNA Wechselwirkungen mit hoher räumlicher Genauigkeit
kartografisieren lassen. Zudem öffnet sie den Weg für zukünftige Un-
tersuchungen von zeitlichen Domänen in der miRNA vermittelten Gen-
regulation. Diese Methoden werden entscheidend zum Verständnis
der miRNA-mRNA Wechselwirkungen beitragen und den Einfluss der
miRNA in der Regulation biologischer Prozesse betonen.
v
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1I N T R O D U C T I O N
How gene expression is controlled in living cells has probably been
the most central question of molecular biology in the last 50 years. For
instance, the human body is made of 1012 human cells, all of which vir-
tually share an identical genetic material, which is carried by the DNA
and packaged in 23 chromosome pairs. Yet, these cells can be divided
in cell types such as epithelial cells, neurons, myocytes, endocrine cells,
immune cells (macrophages, lymphocytes, etc.), erythrocytes, which
differ widely in morphology and function. The mechanism through
which so much phenotypical diversity can be obtained from identi-
cal genetic material is gene expression control: different cell types ex-
press different genes, which determine the morphology and function
of cells [2].
Gene expression control is also crucial in determining how cells re-
act to a changing environment: a brutal depletion in a certain type of
nutrient may require the production of an enzyme that makes it pos-
sible for the cell to metabolize an alternative type of nutrient. It is in
this context that the first mechanism of gene expression control was
characterized in bacteria [105, 58]. Many pathologies also have a deep
connection with gene expression. For instance, viruses are parasites
that replicate themselves by hijacking the gene expression machinery
of infected cells, tricking the mechanisms of gene expression control
of the host cell into expressing the viral genes. In cancer, cumulating
accidental alterations to the genetic material can lead to defects in the
expression of genes that are key to controlling the most basic cellular
function such as growth, division and death, ultimately resulting in
uncontrolled proliferation, migration and foreign tissue invasion [195].
Gene regulation control is known today to be — at least in part —
the product of the action of proteins called transcription factors which
bind the promoter region of genes to induce or repress the transcrip-
tion of DNA by the RNA polymerase [28, 183]. Transcription factors
bind specific DNA sequences [51] and their expression is itself reg-
ulated by transcription factors, which results in a genetic regulatory
network whose function is to control gene expression in the cell.
The control of transcription was the first mechanism of gene expres-
sion control to be discovered. But it was not long until other mech-
anisms were proposed. Britten and Davidson [25] proposed a theory
in which gene expression is controlled by intermolecular RNA-RNA
pairing. A few years later, Heywood and Kennedy [100] found exper-
imental evidence that a so-called “translation control RNA” (tcRNA)
interacts with the myosin mRNA to inhibit its translation. This was
the first experimental evidence of a non-coding RNA regulating gene
expression at the post-transcriptional level. With a reported molecular
weight of 10000, it is not clear whether the tcRNA of Heywood and
Kennedy [100] may have been the first member of the large family
of small, non-coding RNAs formed by microRNAs, whose molecular
weight is more in the 6800 – 8000 range. In any case, the report did
not gather a lot of attention. The role of RNAs in gene expression re-
mained limited to that of passive, intermediate carriers of the genetic
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information (messenger RNAs – mRNAs), or to essential enzymatic
and co-factor functions in protein translation (transfer RNAs – tRNAs,
ribosomal RNAs – rRNAs).
This view started shifting dramatically with the discovery of microR-
NAs (miRNAs), which are short, non-coding RNAs that repress gene
expression at the post-transcriptional level. The first miRNA, lin-4, was
found by genetic screens by [131, 231] in Caenorhabditis elegans and
plays an important role in the development of the nematode by repress-
ing the lin-14 heterochronic gene at the transition between the first and
second larval stage. To date, hundreds of miRNAs have been discov-
ered in a broad range of species ranging from plants to metazoans. A
substantial fraction of them are conserved over long evolutionary dis-
tances [126]. Even some DNA viruses encode miRNAs [169], that act
to regulate viral life cycle in the host cell as well as the expression of
host genes [206, 159, 185, 79].
MiRNA biogenesis progresses through multiple steps and involves
a collection of enzymes and transport proteins. MiRNAs are processed
by the Drosha enzyme [132] from hairpin structures that occur in
longer coding or non-coding transcripts. The pre-miRNA hairpins are
exported out of the nucleus, further sliced into a double-stranded RNA
by the Dicer enzyme and are loaded into the Argonaute protein of the
RNA-Induced Silencing Complex (RISC) [84, 103, 157]. They confer
target recognition specificity to the Argonaute protein and guide the
RISC to miRNA recognition elements located mostly in the 3’ untrans-
lated regions (3’ UTRs) of mRNAs. The binding of RISC to a mRNA
results in a rapid repression of translation, decapping, deadenylation,
and ultimate degradation of the target mRNA [66, 62]. With each miR-
NAs targeting the mRNAs of a specific set of genes, the view emerged
that miRNAs form a new layer of gene regulatory networks on top
of transcription control. As primary location for miRNA binding, 3’
UTRs of mRNAs are now considered to play the same role in post-
transcriptional regulation as promoters do in transcription control.
Many fundamental biological processes, such as metabolism [170,
123], embryogenesis [78], cell cycle [140], cancer [30, 97], epigenetic
modification [198, 50], and immunity [210, 162] are now known to be
regulated by miRNAs. Given that the functions of many miRNAs that
have been isolated in sequencing studies remain to be characterized,
one can speculate that many more biological processes will be found to
be under miRNA control. Therefore, characterizing miRNA expression
and identification of miRNA targets is an important problem. A variety
of platforms such as microarrays [31, 155], Sanger sequencing of small
RNA libraries [126, 129] or next generation sequencing [89, 164] can be
deployed to identify miRNAs and characterize their expression. These
methods will not be discussed in this thesis. Here we rather focus on
the question of understanding the function of miRNAs. As miRNAs
are regulatory molecules that repress gene expression, understanding
their function requires to understand which genes are repressed by
individual miRNAs.
Many studies addressed the question of how miRNAs find their tar-
gets. While in plants miRNAs bind to nearly perfectly complementary
targets [180], in metazoans it appears that most of the targeting speci-
ficity comes from the 7-8 nucleotides at the 5’ end of the miRNA, also
known as the miRNA “seed” [134, 137, 24]. Because miRNAs are con-
served in evolution and were originally discovered because of their
introduction 3
fundamental role in development, one can make the assumption that
functional, physiologically relevant miRNA binding sites are under
evolutionary selective pressure. Indeed, many miRNA target predic-
tion methods make this assumption, aside from requiring extensive
pairing of the miRNA seed, and/or unusually low free energy of bind-
ing between the miRNA and the mRNA [203, 134, 59, 176]. Under
these constraints, the average number of predicted targets per miRNA
is in the range of hundreds [135, 154]. This number is in striking con-
trast with the number of targets that have been so far validated for any
individual miRNA, in part because experimental validation requires
intense work.
Chapter 2 illustrates how the biological function and the regulatory
mechanism of miRNAs can be elucidated in the context of the regula-
tion of glucose homeostasis by the miR-375 miRNA. The study com-
bines high-throughput measurements of the consequences of perturb-
ing the expression of miR-375 on gene expression. Genes whose ex-
pression was altered in response to perturbing the expression of miR-
375 were computationally screened for potential miRNA binding sites,
which resulted in a list of 381 potential miR-375 target genes through
which miR-375 may regulate glucose homeostasis. A chosen subset of
these potential target genes was further investigated experimentally to
establish the mechanism through which miR-375 may control glucose
homeostasis.
However, selecting a handful of genes for further experimental in-
vestigation out of hundreds of potential targets is a difficult task in
which the role of intuition — not to say a certain amount of luck — is
not negligible. Studies whose aim is to understand the biological func-
tion and regulatory mechanism of miRNAs could greatly benefit from
computational miRNA target prediction that are accurate at identify-
ing genes likely to be efficiently regulated by the miRNA of interest
out of hundred of potential target genes. Chapter 3 revisits the ques-
tion of miRNA target prediction with this goal in mind. From high-
throughput experimental measurement of changes in gene expression
in response to miRNA perturbation experiments, we determine what
additional determinants of miRNA targeting beyond seed pairing and
evolutionary conservation can be taken into account in order to im-
prove miRNA target prediction accuracy. We then explore the predic-
tive power and the limitations of such an approach, and draw conclu-
sions regarding the mechanism of miRNA action and the biological
function of miRNAs.
So far, the datasets we have analyzed mostly studied miRNA target-
ing by means of perturbing miRNA expression — typically by trans-
fecting the miRNA prepackaged in liposomes — and by subsequently
measuring the regulatory consequences at the mRNA or protein lev-
els. Such experiments are quite affordable and practically doable in
cell culture. However, it has been debated whether such transfection
experiments, which may result in strong, non-physiological miRNA
over-expression can actually mimic the effect of miRNAs in vivo. In ad-
dition, such experiments, by their interventionist character, have impor-
tant side-effects on cell biology which makes it difficult to distinguish
genes that are directly affected by the miRNA from genes whose ex-
pression changes because of secondary effects of the miRNA transfec-
tion. Finally, the miRNA expression perturbation approach to miRNA
target identification has a fundamental limitation because it focuses on
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the regulatory effect of miRNAs, which takes place at the mRNA and
protein level. Consequently, miRNA targets can be identified at the
gene level, but determining the precise location of the miRNA bind-
ing site requires tedious additional experimental work. The PAR-CLIP
method introduced in Chapter 4, which enables the identification of
the binding sites of RNA binding proteins at the nucleotide resolution
provides a solution to these problems. The method is applied to several
RNA binding proteins, including the Ago proteins to which miRNAs
provide binding specificity. As a result, genome-wide miRNA-mRNA
association maps with nucleotide resolution are produced, without the
need to perturb the expression of any regulator.
Chapter 5 presents MirZ, a web-based resource that makes it pos-
sible to explore miRNA-mRNA association maps and miRNA expres-
sion profiles across tissues in an integrated fashion. The rational be-
hind MirZ is that, within a given tissue, the miRNAs that are most
strongly expressed have the largest impact on mRNA targets. There-
fore, deciphering the miRNA-dependent post-transcriptional regula-
tory layer in a given tissue or cell type has to start from the miRNA
expression profile of that tissue or cell type. Conversely, it is very com-
mon that one identifies differences in miRNA expression between cells
at various stages of differentiation or between normal and malignant
cells, and the natural question is what mRNAs are most likely to be
affected by the change in miRNA expression. The miRNA-mRNA as-
sociation maps currently used in MirZ stem were obtained by compu-
tational miRNA target predictions. But ongoing software development
projects in the Zavolan lab are generalizing this idea to miRNA-mRNA
association maps experimentally determined by PAR-CLIP.
Finally, while PAR-CLIP provides insight into the “where” of miRNA
regulation, it does not address other equally important aspects such as
the time-scale on which miRNA regulation takes place or the magni-
tude of the regulation which can only be studied by perturbing miRNA
expression. Chapter 6 shows that such kinetic aspects need to be taken
into account when designing and analyzing experiments aimed at char-
acterizing the regulatory function of miRNAs by means of miR per-
turbation and subsequent measurements of the induced changes in
mRNA and protein levels. In addition, a detailed model of miRNA ac-
tion is introduced, which makes it possible to study how different pa-
rameters influence the time-scale and magnitude of miRNA-mediated
gene regulation.
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2.1 introduction
The maintenance of β-cell mass during development and throughout
life is a highly regulated process responsible for normal glucose home-
ostasis. Defects in the development of pancreatic islets lead to changes
in islet composition, and often result in the hyperglycemia that char-
acterizes the diabetic state [54, 85]. The dynamic adaptation of β-cell
mass in adult life is influenced by various metabolic stresses, which
control the balance between proliferation and apoptosis. These pro-
cesses, known to be regulated at the transcriptional level, contribute to
the development and maintenance of many tissues, including the pan-
creatic islet [196, 108]. Recent studies have shown that miRNAs, which
regulate gene expression at a post-transcriptional level, are powerful
regulators of growth, differentiation and organ function [3, 12, 238].
For instance, mutant mice in which miRNAs are collectively silenced
during endocrine pancreas development exhibit defects in all pancre-
atic lineages, including a dramatic reduction of insulin producing β-
cells [144]. It is estimated that most protein coding genes are miRNA
targets [69]. Combining target prediction with experimental analysis of
miRNA expression and production of loss of function mutants are be-
ginning to improve our understanding of the roles that miRNAs play
in normal and disease states [238, 144, 236, 122, 210, 219]. It was pre-
viously reported that miR-375, the highest expressed miRNA in pan-
creatic islets of human and mice, regulates insulin secretion in isolated
pancreatic β-cells [170]. In this chapter, we investigate the effect of ge-
netic ablation of miR-375 on pancreatic islet development and function
and in the etiology of type 2 diabetes.
2.2 results
2.2.1 Development of hyperglycemia in miR-375 null mice
To elucidate the role of miR-375 in the maintenance of glucose home-
ostasis and the development of the pancreatic islet in vivo, we gener-
ated miR-375 null mice (375KO) by targeted deletion and homologous
recombination in ES cells. The miR-375 gene is uniquely located within
an intergenic region on mouse chromosome 1, and the targeting con-
struct was designed to eliminate the entire 64 bp miRNA precursor
sequence (Figure 31A). Heterozygous mice were crossed and the mu-
tants were confirmed by Southern blot analysis (Figure 31B). Offspring
of these intercrosses revealed genotypes of expected Mendelian ratios
(data not shown). An analysis of miR-375 by in situ hybridization con-
firmed its expression in wildtype pancreatic islets and its absence in
375KO islets (Figure 31C). Northern blotting also confirmed loss of
expression in other neuroendocrine tissues in which miR-375 is ex-
pressed at low levels (Figure 31D). MiR-375 null animals are fertile
5
6 mir-375 maintains normal pancreatic α- and β-cell mass
Figure 1: miR-375-null mice develop diabetes. (A) Random-fed blood glu-
cose levels in 375KO (filled squares) and wild-type littermate control
(open circles) male mice. (B and C) Plasma insulin and glucagon lev-
els in 10-week-old 375KO mice (black bars) and wild-type (gray bars)
male mice. (D) Intraperitoneal glucose tolerance test administered
to 10-week-old mice. (E) Plasma insulin levels during i.p. glucose
tolerance test. (F) Insulin secretion of isolated islets in response to
indicated glucose concentrations. (G) Insulin tolerance test of 375KO
and wild-type littermates (n=5).
and exhibit no obvious abnormalities or changes in body mass (Fig-
ure 31E).
We investigated the metabolic consequences of miR-375 ablation
by measuring fed and fasted glucose and islet hormone levels. At 4
weeks, male 375KO mice exhibited random hyperglycemia (Figure 1A)
and developed fasting hyperglycemia by 12 weeks (89.7 mg/dl vs.
74.7 mg/dl, p<0.001, 375KO vs. wildtype, respectively). Female 375KO
mice developed random hyperglycemia by 8 weeks in the fed state
(data not shown). Despite the hyperglycemic state, plasma insulin lev-
els remained unchanged in 375KO mice compared to wildtype litter-
mates (Figure 1B). In contrast, plasma glucagon concentrations were
increased in both fasted and random-fed states (Figure 1C). Mutant
375KO mice exhibit elevated glucose levels compared to wildtype con-
trols following an intraperitoneal glucose challenge (Figure 1D). Un-
der identical conditions the first phase insulin release was diminished
but plasma insulin levels were unchanged between 5 and 120 min-
utes after intraperitoneal glucose administration (Figure 1E). Glucose
stimulation of isolated islets from 375KO and littermate control mice
was similar over a range of concentrations (Figure 1F). Furthermore,
no significant differences in glucose clearance were measured during
an insulin tolerance test indicating the absence of peripheral insulin
resistance (Figure 1G).
We have previously shown that silencing of miR-375 increases glucose-
stimulated insulin secretion in pancreatic β-cell lines and isolated pri-
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mary β-cells [170]. To study the effect of chronic ablation of miR-375
on insulin secretion, we therefore measured exocytosis in single, iso-
latedï β-cells by high-resolution capacitance measurements. Secretion
was evoked by a train of depolarizations from -70 mV to 0 mV (Fig-
ure 32A). In wildtype cells, the exocytotic responses fell from an initial
value of 6 fF/pF to 1.5 fF/pF at the end of the train (Figure 32B). The
total increase in capacitance during the train was 34± 5 fF/pF (n=37)
(Figure 32C). In β-cells lacking miR-375, the exocytotic responses fell
from an initial value of 7.5 fF/pF to 3.2 fF/pF and the total response
evoked by the train amounted to 55± 6 fF/pF (P<0.01 vs. wildtype;
n=46)(Figure 32B,C). An identical analysis was performed on isolated
α-cells, however, no differences were observed between mutant and
wildtype animals (Figure 32D-F). While our earlier observations demon-
strated that miR-375 is a negative regulator of β-cell exocytosis [170],
these results show the hyperglycemia observed in 375KO mice is not
due to a deficiency in insulin secretion.
To further analyze the underlying cause for the metabolic derange-
ments in 375KO mice we investigated the endocrine pancreatic cell
composition of mutant and control animals. Measurement of β-cell
mass of 375KO pancreatic sections revealed a 38% and 31% decrease
compared to wildtype controls at 3 and 10 weeks of age, respectively
(Figure 2A). Quantitative morphometric analysis of 375KO pancreatic
sections from 3-week old mice revealed that the change in mass was
due to a comparable decrease in β-cell number (Figure 2B) and re-
sulted in a 20% decrease in total endocrine cells per pancreatic area
compared to control mice (Figure 2C). A similar decrease was observed
in β-cell number at age 10 weeks in 375KO mice. In addition, these ef-
fects were accompanied by a 1.7-fold increase in α-cell number per
pancreatic area compared to littermate controls (Figure 2D). The num-
ber of δ-cells was not changed in pancreata of 375KO mice compared
to controls at either age (Figure 2E). No changes in total pancreatic
insulin or glucagon content, or pancreatic α- and β-cell number were
found at age P14 (data not shown). The results observed in 3-week old
animals are the earliest detectable changes in phenotype (Figure 2A-D).
The morphological analysis also revealed disrupted islet architecture
with increased presence of alpha cells within the islet core and in the
periphery (Figure 2F).
To investigate if elevated plasma glucagon levels could explain the
hyperglycemia in 375KO mice, we evaluated glucagon secretion and
downstream effects in the liver. In contrast to glucose-stimulated in-
sulin secretion, glucagon secretion was increased in isolated pancreatic
islets of 375KO mice at both low (2.8 mM) and high (25 mM) glucose
concentrations compared to wildtype littermates (data not shown, Fig-
ure 2G). Furthermore, pancreatic glucagon content was increased '3-
fold compared to wildtype littermates (375KO vs. WT: 1.25 ± 0.28 vs.
0.41 ± 0.09 ng/mg tissue, p60.01, n=5). Hepatic glucose production
was analyzed by measuring blood glucose levels following an intraperi-
toneal injection of pyruvate in random-fed mice. Significantly higher
plasma glucose levels at 15 and 30 min post-injection indicated that
375KO mice have an increased ability to convert pyruvate to glucose
compared with wildtype littermates (Figure 2H). In addition, 375KO
mice displayed a 25% increase in the rate conversion of pyruvate-2-
14C into blood glucose following of intraperitoneal injection, thereby
providing further evidence that hepatic glucose production was in-
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Figure 2: Decreased β-cell mass in 375KO pancreatic islets. (A) β-Cell mass in
wild-type (gray bars) and 375KO (black bars) mice is quantified and
reported as mean ± SE. (B-E) Quantification of endocrine cell num-
ber per total pancreatic area,β-cell number (B), total endocrine cell
number per total pancreatic area (insulin, glucagon,andsomatostatin-
positive cells) (C) α-cellnumber (D), and δ-cell number (E) in 375KO
(black bar) and wild-type (gray bar) male mice. (F) Representa-
tive sections of pancreas from 10-week-old 375KO and wild-type
male mice visualized by immunofluorescence after staining with
anti-insulin (green) and anti-glucagon (red) antibodies. (Bar, 50 µm.)
(G) Glucagon secretion measured from islets isolated from 10-week-
old male 375KO (black bars) and wild-type (gray bars) mice cultured
overnight and incubated in fresh medium containing the indicated
glucose concentrations. (H) Intraperitoneal pyruvate tolerance test
was performed on random-fed 6-week-old male mice by administer-
ing a dose of sodium pyruvate (in saline) at 2 g/kg body weight.
(I) [2-14C]Pyruvate was administered by i.p. injection into random-
fed 6-week-old 375KO and wild-type (WT) mice and blood was
drawn after 30 min and deproteinized, and labeled glucose in super-
natant was recovered and radioactivity was measured. (J) Quantifi-
cation of PEPCK and G6Pase mRNA expression by real-time PCR in
liver from random-fed, 10-week-old 375KO (375KO) and wild-type
(WT) mice. n = 5-12 animals per genotype unless otherwise noted.
Data are presented as means ± SE. *, P < 0.05; **, P < 0.01; ***, P <
0.001.
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creased in these mice (Figure 2I). Similar results were obtained in
fasted animals (data not shown), demonstrating increased de novo syn-
thesis of glucose by the liver in both fasted and fed conditions. More-
over, under random-fed conditions, real-time PCR analysis revealed a
significant up-regulation of both phosphoenolpyruvate carboxykinase
(PEPCK) and glucose 6-phosphatase (G6Pase) in the livers of 375KO
compared to control mice, demonstrating that the hyperglucagonemia
contributes to the elevated gluconeogenesis (Figure 2J). Plasma and
tissue levels of other neuroendocrine organs such as pituitary (GH,
CART), adrenal (noradrenaline, adrenaline, dopamine, corticosteroids)
and intestinal (GLP-1, VIP, secretin) peptides were similar in 375KO
mice and littermate controls (data not shown). In addition, challenging
the mice with insulin after fasting and measuring ACTH and corticos-
terone to test the hypothalamic-pituitary-adrenal axis revealed no ab-
normality between mutant and wildtype animals, indicating that loss
of miR-375 expression in the pituitary and adrenal does not contribute
to the phenotype of the mutant mice (data not shown). Taken together,
these results show that the hyperglycemia measured in 375KO mice is
primarily caused by hyperglucagonemia resulting from an increase in
pancreatic α-cell mass.
2.2.2 Expression of miR-375 is required for pancreatic β-cell compensation
in obesity
To further address the role of miR-375 in the maintenance of β-cell
mass, we measured miR-375 expression in pancreatic islets isolated
from ob/ob mice, a model for increased islet mass that is induced
by severe insulin resistance [19]. MiR-375 expression was increased
30% in ob/ob islets compared to wildtype controls (Figure 3A). We
next generated mice deficient in both miR-375 and leptin (375/ob) to
determine whether the increase in β-cell mass observed in ob/ob an-
imals is dependent upon miR-375 expression. Insulin and glucagon
immunostaining from 10-week old 375/ob mice revealed an absence
of islet hypertrophy compared to littermate control ob/ob mice (Fig-
ure 3B). Pancreatic β-cell mass was decreased 71% and a similar re-
duction was measured in total β-cell number and total endocrine cell
number per pancreatic area in 375/ob animals compared to ob/ob lit-
termates (Figure 3C-E). The relative number of pancreatic α-cells per
area pancreas was unchanged in 375/ob compared to 375KO animals
(Figure 3F). Consistent with 375KO mice, an increase in α-cell mass
is reflected in an increase in the α- to β-cell ratio compared to both
wildtype and ob/ob littermates (Figure 3G). In addition, the decrease
in β-cell number in 375/ob mice was accompanied by a decrease in β-
cells with Ki-67 positive nuclei (Figure 3H). No changes were observed
in ob/ob mice in which only one miR-375 allele was deleted (data not
shown). Failure of the islet mass to compensate for the insulin resis-
tance induced by the obesity brought about a dramatic increase in
blood glucose levels starting at age 4 weeks (Figure 3I). Consistent
with decreased β-cell mass, plasma insulin levels were decreased 85%
in 375/ob animals compared to ob/ob mice (Figure 3J) and plasma
glucagon levels were unchanged (129.3 pg/ml ± 7.5 vs. 120.3 pg/ml
± 10.1, 375/ob vs. ob/ob, respectively, n=5-8). Furthermore, hepatic
glucose production in 375/ob mice was elevated 1.8-fold compared
to ob/ob mice (Figure 3K). These results, in addition to the 40% de-
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Figure 3: Impaired β-cell proliferation in miR-375/ob double-knockout mice.
(A) Relative miR-375 expression in lepob/lepob (ob/ob) mice and
wild-type (WT) controlsmeasuredbyreal-timePCRandnormalized
toU6(N1) or miR-107 (N2) expression levels. (B) Representative
8-µmsections of pancreas from 10-week-old 375/ob (miR-375−/−
leptin−/−) and ob/ob mice visualized by immunofluorescence
after staining with insulin (green) and glucagon (red). (Bar, 50µm.)
(C) β-Cell mass in 10-week-old WT (gray bar), 375KO (black bar),
ob/ob (dark gray bar), and 375/ob (open bar) mice is quantified
and reported as mean ± SE. (D-F) Quantification of β-cell number
(insulin-positive cells), total endo- crine cell number (insulin,
glucagon, and somatostatin-positive cells) and α-cell number
(glucagon-positive cells) per total pancreatic area in wild-type (gray
bars), 375KO (black bars), ob/ob (dark gray bars), and 375/ob (open
bars) 10-week-old mice. (G) Ratio of α-cell number to islet cell
number in wild-type (gray bar), 375KO (black bar), ob/ob (dark gray
bar), and 375/ob (open bar) 10-week-old mice. (H) Quantification
of percentage of Ki-67 insulin-positive nuclei within insulin-positive
cells of 10-week-old 375/ob (black bar) and ob/ob (gray bar) mice.
n=30 for each genotype. (I) Random-fed blood glucose levels in
375/ob (open squares), ob/ob (filled circles), 375KO (filled squares),
and wild-type littermate control (WT) (open circles) mice. (J) Plasma
insulin levels in random-fed, 10-week-old 375/ob (black bar) and
ob/ob (gray bar) mice. (K) Hepatic glucose production measured
after sodium [2-14C]pyruvate was administered by i.p. injection into
random-fed, 10-week-old 375/ob (black bar) and ob/ob (gray bar)
mice. Data are presented as means ±SE. n=4-6 animals per genotype
unless otherwise noted. *, P=0.05; **, P=0.01; ***, P=0.001.
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Figure 4: Regulation of gene expression and identification of growth target
genes in 375KO islets. (A) Quantification of percentage of Ki-67-
positive nuclei within insulin-positive cells of 375KO (black bars) and
wild-type (gray bars) male mice. (B) Analysis of gene expression of
putative miR-375 targets by real-time PCR in mutant and wild-type
pancreatic islets. n = 5 animals per genotype. (C) Western blot analy-
sis of protein lysates from pancreatic islets isolated from 375KO and
wild-type (WT) male mice (100 islets per lane). Quantitative mea-
surements made from densitometry are expressed as a ratio of mean
values of 375KO to wild-type mice. (D) Increase in intracellular con-
centration of miR-375 decreases luciferase activity in HEK293 cells
transfected with reporter constructs containing either full-length or
partial 3’UTR sequenceof putative miR-375 target genes (n=6). Values
relative to luciferase activity from cells transfected with a scrambled
control are shown. Data are presented as means ± SE. *, P < 0.05; **,
P < 0.01; ***, P < 0.001.
crease in body mass and measured polydipsia and polyuria (data not
shown), demonstrate severe insulin-deficient diabetes in 375/ob mice
compared to ob/ob animals.
2.2.3 MicroRNA-375 regulates genes in growth promoting pathways
We next addressed whether the observed decrease in β-cell mass of
375KO mice could be reflective of changes in the rate of prolifera-
tion. Quantification of Ki-67-positive β-cells, an index for cell prolif-
eration, revealed a significant decrease in 375KO islets at 3 and 10
weeks of age (Figure 4A). A similar result was obtained measuring
BrdU incorporation in β-cells of 375KO mice (data not shown). To ad-
dress the molecular basis for the decrease in pancreatic β-cell mass
observed in the 375KO animals, we performed gene expression analy-
sis using Affymetrix microarrays comparing tissues from mutant mice
to wildtype littermates. Four tissues expressing different levels of miR-
375 were selected: pancreatic islets, pituitary, adrenal, and colon. Pre-
vious studies have established that miRNAs can negatively regulate
the mRNA level of their direct targets [138], and that miRNA loss-of-
function can result in the up-regulation of hundreds of genes [123].
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To determine the direct impact of loss of miR-375, we selected the
5% most up-regulated and 5% most down-regulated transcripts (see
Supp. Methods). Each dataset thus contained 801 of the 16,301 Refseq
transcripts measured by the array. We then determined the number of
occurrences of the miR-375 recognition motif GAACAAA (correspond-
ing to nucleotides 1-7 from the 5’ end of the miRNA) in the 3’UTRs of
these transcripts. When measuring gene expression from pancreatic
islets of 375KO mice compared to wildtype littermates, we counted
138 occurrences of the miR-375 motif in the dataset of up-regulated
transcripts, and 49 occurrences in the dataset of down-regulated tran-
scripts (Figure 33A). Compared to random motifs with similar fre-
quency across the 3’UTRs of all transcripts monitored by the array
(represented in the graph by a blue box plot), the 138 occurrences repre-
sent a 1.9-fold enrichment (P=0.001), while the 49 occurences represent
a 1.9-fold depletion (P=0.002). These results demonstrate that genetic
ablation of miR-375 in the pancreatic islet resulted in the up-regulation
of direct targets of this miRNA. To further illustrate the impact of miR-
375 on islet mRNA levels, we determined the distribution of expres-
sion changes of transcripts that do include a miR-375 motif in their
3’UTR and transcripts that do not. Transcripts that carry a miR-375 mo-
tif show a significant up-regulation compared to transcripts that do not
(P=2.1x10-24 in Wilcoxon rank-sum test), and the up-regulation is even
stronger for transcripts containing evolutionarily-selected miR-375 mo-
tifs (P=0.005) (Figure 33E). A similar analysis of gene expression in the
pituitary of 375KO mice compared to wildtype littermates revealed a
significant number of up-regulated motif-containing transcripts (Fig-
ure 33C). By contrast, the genes up-regulated in the adrenal and colon
data sets were not enriched for the miR-375 motif (P=0.46 and P = 0.5,
respectively) (Figure 33B,D). There are two possible explanations for
this discrepancy: either the magnitude of the response from direct tar-
gets of miR-375 depends upon the endogenous expression level of the
miRNA, or miR-375 expression is limited to specific subpopulations
of cells in the adrenal and colon. In situ hybridization using a miR-
375 specific probe on pituitary tissue sections revealed miR-375 to be
present in both the anterior and posterior pituitary, while its expres-
sion within the adrenal appears to be limited to the medulla and the
zona glomerulosa of the cortex (Figure 34A,B). It is not known whether
miR-375 is expressed in a specific cell type of the colon as probed tissue
sections revealed no specific signal (data not shown).
Several genes within the set of up-regulated transcripts of miR-375
null islets have been documented to negatively regulate cellular growth
and were thus evaluated for direct regulation by miR-375. Selection of
transcripts that contained a miR-375 recognition motif resulted in 381
putative direct targets of miR-375. Real-time PCR analysis confirmed
ten of these genes, including caveolin1 (Cav1), inhibitor of DNA bind-
ing 3 (Id3), Smarca2, Ras-dexamethasone-induced-1 (Rasd1), regulator
of G-protein signaling 16 (Rgs16), eukaryotic elongation factor 1 ep-
silon 1 (Eef1e1), apoptosis-inducing factor, mitochondrion-associated 1
(Aifm1), cell adhesion molecule 1 (Cadm1), HuD antigen (HuD), and
complement component 1, q subcomponent binding protein (C1qbp)
were up-regulated in 375KO islets (Figure 4F). Increased expression of
three additional genes, including cell adhesion molecule 1 (Cadm1),
gephyrin (Gphn), and myotrophin (Mtpn), a previously validated tar-
get of miR-375 [170] was confirmed in 375KO islets by real-time PCR
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and western blotting (Figure 4G,H). Furthermore, measurement of lu-
ciferase activity from HEK293 cells transfected with plasmid constructs
containing a portion of or the entire 3’ UTR of Aifm1, Rasd1, Eef1e1,
Gphn, HuD, and Cadm1 showed reduced expression of all these con-
structs in the presence of miR-375 (Figure 4I). These results suggest
that Cav1, Id3, Smarca2, Aifm1, Rasd1, Rgs16, Eef1e1, C1qbp, HuD,
and Cadm1, all of which have been shown to participate in signaling
mechanisms that negatively regulate cellular growth and proliferation,
are direct targets of miR-375. Published studies have shown that these
genes play a role in the p53-dependent pathway [27, 72, 167], MAP
kinase signaling [41], induce apoptosis [115, 37, 109], and inhibit nor-
mal developmental growth processes [179, 1] or the proliferation of tu-
mors in mice [125, 216]. Using real-time PCR analysis, we found that
the expression levels of these genes in pancreatic islets either exceed
or are comparable to the levels in tissues where a functional role has
previously been determined (Figure 33). We also confirmed changes
in mRNA expression of several up-regulated genes that do not contain
the miR-375 motif, including tyrosine hydroxylase (Th) and neuronatin
(Nnat) (Figure 4H,I). While the exact role of these genes in the pancre-
atic β-cell is not known, it was shown that increased expression of neu-
ronatin is associated with hyperglycemia-induced apoptosis [21, 107].
Both genes appear to be indirectly regulated by miR-375, as reporter
assays with vectors that harbor their 3’-UTRs downstream of the lu-
ciferase gene did not result in decreased activity when co-expressed
with miR-375 (Figure 4J). Together, these results provide evidence that
many direct, as well as indirect targets of miR-375 contribute to the
regulation of the β-cell composition of islets.
2.3 discussion
Our results illustrate an essential role for miR-375 in the establishment
of normal pancreatic endocrine cell mass in the postnatal period and
the maintenance of glucose homeostasis. The primary consequence
resulting from the loss of miR-375 is chronic hyperglycemia due to
a pancreatic α-cell defect, as evidenced by increased α-cell mass, in-
creased glucagon release from isolated islets, elevated fasted and fed
plasma glucagon levels, and the increase in downstream effects of
glucagon such as expression of genes regulating gluconeogenesis and
hepatic glucose production. Of note, 375KO mice in the fed state ex-
hibit plasma glucagon levels that are comparable to fasted levels in
wildtype mice, further emphasizing the chronic glucagon stimulus in
these animals. The hyperglucagonemia in 375KO mice compared to
control littermates is most likely due to the increase in α-cell num-
ber and a defect in glucose sensing since exocytosis measurements
in isolated α-cells in response to direct depolarization was similar in
wildtype and mutant mice. The second observation of note is that the
hyperglycemic phenotype of 375KO animals is unlikely due to the de-
crease in β-cell mass since this reduction is usually insufficient to cause
insulin deficiency and diabetes [20] and insulin secretion of isolated
pancreatic islets from mutant and wildtype mice in response to vari-
ous concentrations of glucose were similar. Furthermore, insulin levels
in the fasted state and during a glucose challenge in 375KO and wild-
type littermates also not changed, despite a reduced β-cell number in
375KO mice, suggesting that insulin secretion per β-cell is enhanced
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in 375KO mice and that reduction of β-cell mass and increased secre-
tion balance each other in mutant mice. The mechanism by which loss
of miR-375 function leads to a reduced β-cell mass is most likely me-
diated by the cluster of negative growth regulators that are directly
regulated by miR-375 and are markedly upregulated in 375KO ani-
mals. The fact that the phenotype is more profound in mice subjected
to metabolic stress might indicate that miR-375 targets play a crucial
role in β-cell compensation when metabolic demand is increased. The
mechanism by which the α-cell number in 375KO pancreata is in-
creased is currently unknown. Two models can be proposed: miR-375
regulates specific target genes in α-cells that are responsible for in-
creased α-cell mass. Alternatively, the increase in α-cell number could
be the result of a compensatory response to altered β-cell mass and
function or to the chronic hyperglucagonemia, which in some models
is associated with α-cell hyperplasia [168, 35].
Mice bearing a conditional deletion of dicer, an enzyme required for
miRNA processing, during pancreas development exhibit defects in all
pancreatic cell lineages, abnormal islet architecture, and a profound re-
duction in pancreatic β-cells [144]. Mutant 375KO mice only discreetly
mimic this phenotype, suggesting that miR-375 alone is not responsi-
ble for the marked developmental defect in β-cell growth and differ-
entiation and that other miRNAs which are expressed in endocrine
pancreatic precursor cells must be responsible for the observed pheno-
type of the Pdx-Cre/dicer mice.
Lastly, it is interesting that miR-375 plays a significant role in the
hypertrophic growth response of pancreatic islets to metabolic stress.
Expression levels of miR-375 are aberrant in obese mice, indicating that
they contribute to increased β-cell mass in insulin resistance. Loss of
miR-375 expression in obese mice leads to a profound loss of β-cells,
metabolic decompensation and premature death. Under these condi-
tions, α-cell mass is not affected, suggesting that miR-375 has a less
prominent role in α-cells, which are not under particular metabolic or
cellular stress in hyperglycemic/insulin resistant conditions. Increas-
ing evidence implicates miRNAs as an essential component mediating
responses to cellular stress. For instance, tissue-enriched miRNAs in
the heart, such as miR-1, miR-208 and mir-133, have been shown to reg-
ulate the hypertrophic proliferative activity in response to a variety of
stresses, and miR-126 affects survival following induction of a myocar-
dial infarction 7, 12, 33). These observations from miRNA knockout
mice highlight the importance of small RNAs in cellular development,
maintenance, and survival and reveal potential novel therapeutic tar-
gets for the treatment of disease.
2.4 materials and methods
2.4.1 Generation of 375KO and 375/ob mice
The murine miR-375 gene was deleted in Sv129 embryonic stem ES
cells by homologous recombination using a targeting vector in which
the entire pre-miRNA was deleted and replaced by a dsRed cDNA and
Neo selection cassette (Figure 31A). Targeted clones were identified by
BstEII digests of genomic DNA and Southern blotting using the indi-
cated 3’probe. Approximately 10% of clones carried the targeted allele
and two clones were used to generate chimeric animals that passed
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the mutant allele to offspring (Figure 31B). Double miR-375-/-, Lep-/-
(375/ob) mice were generated by crossing double heterozygous mice
and identified by PCR. Mice were housed in pathogen-free facilities in
a 12hr light/dark cycle and were backcrossed for six generations with
C57/BL6 mice before characterization of animals. The dsRed trans-
gene was not expressed. Unless stated, male animals were analyzed at
10 weeks of age.
2.4.2 Analysis of metabolic parameters
Blood glucose, insulin, glucagon, free fatty acids and triglycerides in
plasma were measured as described [123, 124]. Vasoactive intestinal
polypeptide (VIP), cocaine and amphetamine regulated transcript (CART),
and secretin were measured by radioimmunoassay (Phoenix Pharma-
ceuticals). The following hormones were measured by ELISA: GLP-
1 (Linco), cortisol (US Biological), and growth hormone (Diagnostic
Systems). Catecholamines were measured from plasma and tissues by
HPLC. Individual animals were placed in metabolic cages to measure
water consumption and urinary output (Columbus Instruments).
Glucose, insulin and pyruvate tolerance tests, in vivo gluconeoge-
nesis, and HPA stimulation studies Glucose tolerance tests were per-
formed following an overnight fast (16hr) and injected intraperitoneally
with glucose (in saline) at 2g/kg body weight. Plasma glucose levels
were measured from tail blood at 0, 15, 30, 60, and 120 min after in-
fusion. Insulin tolerance tests were performed by injecting insulin i.p.
(0.75 U/kg body weight), and measuring blood glucose before (time=0)
and 15, 30 and 60 minutes after injection. Pyruvate tolerance tests were
also performed in a random-fed state or following an overnight fast
(16hr) and injected intraperitoneally with pyruvate (in saline) at 2g/kg
body weight. Plasma glucose values were measured as above. In vivo
gluconeogenesis studies were performed as previously described [223].
Briefly, random-fed mice were injected with sodium pyruvate-2-14C
(1.5 µCi, 15 mCi/mmol) in addition to pyruvate in saline (2g/kg body
weight) and 0.15 mL blood was collected via orbital sinus at 5 and
30 min. An aliquot of 0.1 mL whole blood was transferred to 0.5 ice
cold water, and 0.2 mL of Ba(OH)2 and 5% ZnSO4 were added in
succession. After centrifugation, deproteinized blood was incubated
by batch method with Amberlite Mixed Bed Exchanger MB150 resin
(Sigma). Supernatants were collected and resin was washed with ad-
ditional 0.2 mL water. Eluants were pooled and counted independent
of separate 0.01 mL aliquots of whole blood counted to estimate the
amount of labeled pyruvate absorbed into circulation. Islet secretion
studies were performed on size-matched islets isolated from 10-week
old animals following collagenase digestion and overnight culture and
performed as described [170]. To test the hypothalamic-pituitary axis,
following an overnight fast (16hr), mice received an intraperitoneal in-
jection of insulin (0.75U/kg) and blood was taken at 0, 10, and 30 min-
utes post-injection. Plasma corticosterone and ACTH were measured
by RIA (Peninsula Laboratories and MP Biomedical, respectively).
2.4.3 Isolated islet secretion and capacitance measurements
In vivo insulin release was measured in mice following an overnight
fast (16hr) and injected intraperitoneally with glucose (in saline) at
16 mir-375 maintains normal pancreatic α- and β-cell mass
2g/kg body weight. Plasma insulin was measure at 0, 2.5, 5, and
15 minutes post-injection. Islet secretion studies were performed on
size-matched islets isolated from 10-week old animals following col-
lagenase digestion and overnight culture and performed as described.
Exocytosis of secretory granules was monitored in single β-cells by
capacitance measurements as described previously [122, 56]. The mea-
surements were performed in the standard whole-cell configuration of
the patch-clamp technique at 32-33◦C and the identity of β-cells was
confirmed after the experiment by immunocytochemistry [23].
2.4.4 Computational analysis
The expression analysis of total RNA extracted from tissues of 10-week
old animals using Trizol reagents (Invitrogen) was performed using
Affymetrix mouse genome 430 2.0 arrays. Analysis of total RNA ex-
tracted from MIN6 cells infected with recombinant adenovirus express-
ing miR-375 as described [170] was performed using the Affymetrix
mouse genome 430A array. Details on generation and analyses of data
are found in Supp. Methods.
2.4.5 Northern blotting, qPCR, immunoblotting and luciferase activity mea-
surements
Northern blotting, western blotting and luciferase assays were per-
formed as previously described [170]. Antibodies for western blotting
were obtained from several different sources: anti-gephyrin (Chemi-
con), anti-igsf4a/cadm (R&D Laboratories), anti-neuronatin (Abcam),
anti-tyrosine hydroxylase (Abcam) and anti-HuD (gift of R. Darnell).
For RT-PCR, total RNA was reverse transcribed using random primers
according to manufacturer’s protocol (Invitrogen). Primer sequences
are available upon request. MiRNA qPCR results were normalized to
U6 levels that were detected by using the ABI miRNA U6 assay kit
(Applied Biosystems).
2.4.6 Immunohistochemistry, islet morphometry, and in situ hybridization
Immunohistochemistry was performed on at least five 8-µm sections
(at least 160 µm apart) prepared from paraffin-embedded pancreata
of 3 and 10 week old animals. Tissue sections were mounted with
Vectashield with DAPI (Vector Laboratories) and analyzed using a
Leica DM5500 microscope and the cross-sectional areas of pancreata
and β-cells (insulin-positive cells) were determined using MetaMorph
(version 7) software. Relative cross-sectional area of β-cells was deter-
mined by quantification of the cross-sectional area occupied by β-cells
divided by the cross-sectional area of total tissue. β-cell mass per pan-
creas was determined by the product of the relative cross-sectional
area of β-cells per total tissue and the pancreatic mass. Measurements
were calculated by analyzing pancreata from at least 3 animals for
each age and genotype. Cell quantification was based on counting
nuclei of either insulin-, glucagon- or somatostatin-positive cells and
data is represented as total cell number per pancreatic area. Ki-67 and
BrdU-positive cells were counted from between 1500 to 2000 insulin-
positive cells per animal. Antibodies for immunofluorescence were
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obtained from several sources: anti-insulin and anti-glucagon (Linco),
anti-somatostatin (Dako), anti-BrdU (Sigma), and anti-Ki-67 (Novocas-
tra). BrdU incorporation and in situ hybridization was performed as
described previously [236]. Specific LNA probes (Exiqon) were labeled
using terminal transferase and DIG-ddUTP (Roche).
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3.1 introduction
Since the prediction of animal miRNA targets was first tackled com-
putationally [203, 134], many approaches, taking into account features
ranging from evolutionary conservation to the position of the putative
target site and the nucleotide composition of its environment, have
been proposed. The constraints that functional miRNA target sites
obey as well as the mechanism of miRNA action are intensely debated.
The initial paradigm that emerged from the study of Caenorhabditis ele-
gans miRNAs lin-4 [231] and let-7 [178] was that miRNAs induce trans-
lational repression. More recent studies challenged this paradigm and
demonstrated that substantial miRNA-induced mRNA degradation oc-
curs under both over-expression [138] as well as under physiological
conditions [9]. This opened the possibility to study the determinants
of miRNA targeting based on transcriptome-wide measurements of
mRNA changes in response to over-expression [140, 83, 110, 191, 8,
130], knock-down [123] and knock-out [238] of miRNAs. But because
the ultimate readout of the miRNA activity is the protein output of the
target transcripts, the natural expectation is that measurements of pro-
tein expression changes will generate the most appropriate data sets
for studying principles of miRNA-target site recognition. Such data be-
came available very recently, when Selbach et al. [191] and Baek et al.
[8] determined the changes that are induced in the proteome profiles
upon miRNA over-expression and depletion by different SILAC (sta-
ble isotope labeling with amino acids in cell culture) approaches.
Extensive previous work revealed that 7-8 nucleotides at the 5’ end
of the miRNA are very important for target recognition [127, 134, 47,
135, 24]. Aside from this, the sequence composition of the 3’ UTRs [182]
or of the immediate environment of the putative target sites [83], the
position of the site in the 3’ UTR [70, 83, 146], the base-pairing pattern
in the 3’ region of the miRNA [83], the structural accessibility of the
target site [182, 141, 117, 207], and the presence of multiple target sites
in close proximity [59, 83] have also been reported to be predictive
for the functionality of miRNA target sites. The relative importance of
these features, and in particular the relative contribution of sequence
versus structural determinants are at this point intensely debated.
In an attempt to identify the features that most generally charac-
terize miRNA targets, we performed a systematic analysis of a num-
ber of large-scale publicly available data sets, each typically involv-
ing multiple miRNAs. The experiments, reported by Krützfeldt et al.
[123], Linsley et al. [140], Grimson et al. [83], Karginov et al. [110], Sel-
bach et al. [191], and Baek et al. [8], covered a variety of conditions,
from miRNA over-expression to miRNA knock-down, in cell lines that
expressed a normal amount of DICER1 as well as in DICER1 hypo-
morphs. The effects of miRNAs in these experiments were measured
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Figure 5: Predictive power of different features of putative miRNA target
sites (rows) in predicting functional sites across the 74 data sets
(columns). The data sets covered transcriptomics and proteomics
measurements after miRNA transfection, transcriptomics measure-
ments after miRNA knock-down, profiling of mRNAs bound to
EIF2C/miRNA complexes, and target prediction based on compara-
tive genomics. The heat-map shows the t-values comparing the distri-
butions of feature values in functional vs non-functional miRNA tar-
get sites. The red color indicates positive predictors of miRNA func-
tionality, while the blue color negative predictors of miRNA func-
tionality. The dendrograms of features and data sets were produced
through hierarchical clustering using Ward linkage on the euclidean
space of t-values. See also Supplementary Figure 37, which also indi-
cates the data set represented in each column.
either at the level of the transcriptome or of the proteome. In order to
clarify the steps at which different features appear to come into play,
we have supplemented these published data sets with our own data on
transcriptome-wide changes and Argonaute/EIF2C-bound mRNAs in
miRNA-transfected cells. Finally, to better understand the nature of
the selection pressure on miRNA target sites, we analyzed the same
set of features for sites that we previously predicted with high and
low probability to be under evolutionary selection [70].
3.2 results
3.2.1 Characterization of target sites inferred in individual studies
The approach was to select, from each experiment, a set of functional
and a set of non-functional sites, and to perform two-sample t-tests for
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the difference of the mean values of various features as described in
the Methods. Some of the features that we wanted to compute depend
on the immediate sequence environment of the miRNA target site and
we therefore only considered cases in which the mRNA-level response
could be attributed with reasonable accuracy to a particular miRNA
target site, for which the environment-dependent features could be
unambiguously computed. Based on previous results [135, 83, 70], we
thus selected the transcripts containing precisely one putative target
site that matched nucleotides 1-8, 2-8, or 1-7 of the miRNA that was ma-
nipulated in the experiment. Because we found the effect of the 3’UTR
sites to be more reproducible (Supplementary Figure 36) compared to
that of CDS sites, we further selected those transcripts in which the pu-
tative target site was located in the 3’UTR. Finally, we only considered
sites that were located at least 100 nucleotides away from the 3’UTR
boundaries in order to be able to compute the environment-dependent
features. The results are shown in Figure 5 (and Supplementary Figure
37), in which each feature that we computed is a row and each individ-
ual experiment is a column. The matrix cells indicate how well individ-
ual features perform in distinguishing functional from non-functional
putative target sites in a particular experiment. Red and blue matrix
cells denote positive and negative t-values respectively, i.e. cases in
which the feature takes significantly higher (red) or lower (blue) val-
ues in functional miRNA target sites compared to non-functional tar-
get sites. For instance, the right-most column of the figure summarizes
the comparison of putative miR-17 sites that have a high with those
that have a low inferred probability of being under evolutionary se-
lection [70]. The third cell from the top of that column, labeled “target
site Eopen”, is dark blue, meaning that the energy required to open the
secondary structure of the putative target site is significantly smaller
for sites with high relative to sites with low probability of being under
evolutionary selection. This in turn suggests that evolutionary selec-
tion favored miR-17-complementary sites that are more accessible at
the level of mRNA secondary structure. The second cell from the top
of this column, labeled “target site Einteraction” is also dark blue, indi-
cating that the energy of interaction between the miRNA and the puta-
tive target site is significantly lower (i.e. the interaction is more stable)
for sites with high relative to sites with low probability of being under
evolutionary selection. In contrast, the third cell from the bottom of the
column, labeled “flanks U content” is dark red. This indicates that the
frequency of U nucleotides is significantly higher in the regions flank-
ing the sites with high relative to sites with low probability of being
under evolutionary selection.
Applying 2D hierarchical clustering with Ward linking on the eu-
clidean space of feature t-values reveals that the target sites inferred
from most transcriptomics and from the comparative genomics data
sets have similar properties. They reside in A- and U-rich sequence
environments, the miRNA target region and its flanks are structurally
accessible, and the binding free energy between the seed region of the
miRNA and the mRNA is low. This indicates that the evolutionarily
selected miRNA target sites support an mRNA degradation response
to miRNAs. Strikingly, the proteomics data sets form an entirely dif-
ferent cluster, together with a few of the associated transcriptomics
and the EIF2C (Argonaute) immunoprecipitation data sets. For this
cluster the above-mentioned features are largely uninformative. This
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is very surprising because the targets that were identified based on
proteomics measurements are enriched in miRNA seed matches, just
as the targets that were previously identified based on transcriptomics
measurements [191].
One possible explanation for the less significant t-values obtained in
the analysis of proteomics data sets is that the number of proteins that
are sampled in the proteomics experiments is considerably lower (by a
factor of 5-6) compared to the number of transcripts whose expression
is measured in a microarray experiment. By scaling down the tran-
scriptomics data sets through resampling such that we analyze similar
numbers of genes from transcriptomics and proteomics experiments
we found that this simple explanation does not hold (Supplementary
Figure 38). On the other hand, we found that although functional sites
identified in these experiments have, as expected, a higher probabil-
ity of being under evolutionary selection compared to non-functional
sites, the difference is less pronounced compared to that inferred from
other types of experiments. This is shown in Figure 5 (feature labeled
“ElMMo”) for all the miRNAs covered by the proteomics experiments,
and in Supplementary Figure 39 for the specific case of miRNAs that
have been studied by multiple groups using a number of different
technologies. This result is not due to the ElMMo algorithm having a
poor ability to quantify specifically the functionality of the target sites
determined through proteomics measurements, because as shown in
Supplementary Figure 40, the accuracy of ElMMo in predicting pro-
teomics data is similar to that of TargetScan context.
Although the features of functional target sites are consistent across
most of the studied miRNAs, a few experimental data sets exhibit a
striking reversal of the sign of the base content features, with the G and
C base contents correlating positively and A and U contents negatively
with site functionality. These data sets correspond to let-7 and miR-30a
transfections, but not to the let-7 sites predicted based on evolutionary
conservation, whose profile is consistent with that of most transcrip-
tomics experiments. We conjecture that these observations are due to
both let-7 and miR-30a inhibiting components of the RNAi pathway.
A number of studies already reported on the negative feedback
that let-7 may exert on the RNAi pathway through targeting DICER1
[67, 212] and Selbach et al. [191] already demonstrated that DICER1
protein level increases strongly (over 4-fold) upon let-7 knockdown.
Similarly, we suggest that miR-30a targets the P-body component and
EIF2C interactor TNRC6A (also known as GW182), which carries four
matches to the miR-30a seed in its 3’ UTR, all of which are conserved
all the way from human to chicken, and whose mRNA level decreases
by 21% upon over-expressing miR-30a [191]. The consequence of over-
expressing these miRNAs may therefore be to antagonize the effects of
endogenously expressed miRNAs. Thus, the transcripts that are identi-
fied as let-7 and miR-30a targets by virtue of their down-regulation in
the transfection experiments are probably transcripts that do not carry
functional seed matches to miRNAs endogenously expressed in the
cell, which would otherwise result in their increased expression in re-
sponse to a general down-regulation of the RNAi pathway. If this were
the case, we would expect the transcripts that are down-regulated in
let-7 and miR-30a transfections to be depleted in functional target sites
for the endogenous miRNAs. This is precisely what we found when
we analyzed the transcriptomics data from Selbach et al. [191]: the
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transcripts that are down-regulated in the let-7 and miR-30a transfec-
tions are significantly depleted of evolutionarily selected sites for the
miRNAs that are abundantly expressed in HeLa cells (Supplementary
Figure 41). One may argue that a similar behavior would be produced
by the saturation/competition effect recently described by Khan et al.
[118]. This effect however would apply to all the transfected miRNAs,
not only to the let-7 and miR-30a, wich is not what we found. We
rather observed that in the miR-1, miR-155 and miR-16 transfection ex-
periments the mRNAs that were most down-regulated following the
miRNA transfection were enriched in evolutionarily selected sites for
the abundant HeLa miRNAs. The competition between the transfected
and the endogenous miRNAs still occurs generally across all transfec-
tion experiments, but it is only observable at the earliest time points
(Supplementary Figure 42).
To further establish that TNRC6A is a target of miR-30a, we cloned
the TNRC6A 3’UTR into a luciferase vector and we transfected this
into HeLa cells with or without simultaneously transfecting the miR-
30a antisense inhibitor. Transfection of the TNRC6A reporter results
in a significant reduction (48%) of the luciferase activity compared to
the transfection of empty vector (Supplementary Figure 43), whereas
simultaneous transfection of the miR-30a antisense inhibitor results in
almost complete relief of repression. This result supports our initial
conjecture that the reversal of the sign of the sequence features in the
miR-30a transfection experiment is due to the negative feedback that
miR-30a exerts on the miRNA pathway.
The experiments that measured the binding of EIF2C2 protein (also
known as Ago2) to mRNAs resulted in the second category of data sets
that exhibited the reversal of sign for the sequence features. In these
data sets, the G and C contents of the transcripts and of the miRNA
target site environment also correlated positively with site functional-
ity (in this case EIF2C2 binding), while the A and U contents were
negative predictors. Compared to the let-7 and miR-30a transfections,
these correlations were however weaker and not significant statistically.
On the other hand, structure features such as the accessibility of the
miRNA binding site and the energy of interaction between the miRNA
and mRNA were good predictors of the functionality of these sites, as
they were for the sites inferred from transcriptomics or comparative ge-
nomics analyses. Section 3.2.2 describes our detailed investigation of
the features that favor EIF2C2 binding and those that favor subsequent
mRNA degradation.
Because the sequence composition of the environment of the miRNA
target site affects the structural accessibility of the site, it is currently
unclear which of these features is primarily undergoing evolutionary
optimization. To address this question, we shuffled the sequence flank-
ing functional miRNA target sites (keeping the miRNA target site
fixed) and we asked whether the energy required to open the struc-
ture of the miRNA target site was higher in the context of the shuffled
sequences compared to the real sequence. We found that for a sub-
set of the data sets this is indeed the case (see Figure 5, row labeled
“flanking sequence optimization”), providing weak but statistically sig-
nificant support to the hypothesis that the sequence surrounding func-
tional miRNA target sites is constrained to increase the accessibility
of the miRNA target site beyond what can be explained from the A,
C, G, U content of the flanking regions (see also Figure 6). The fact
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Figure 6: Upper panel: predictive power of different features across all tran-
scriptomics experiments, excluding the let-7 and miR-30a transfec-
tions. Lower panel: predictive power of different features across all
comparative genomics data sets. The y-axes show the t-values of the
individual features when comparing their distribution in functional
vs non-functional sites, aggregating over all data sets. The dotted
horizontal lines represent the cut-off where the t-values are signifi-
cant with a bilateral type I error of 5% after applying the Bonferroni
multiple testing correction. Pita 12-12 and Pita 3-15 are the scores ac-
cording to the algorithm described in Kertesz et al. [117], using 12-12
or 3-15 nucleotides upstream and downstream of the miRNA target
site for computing target site accessibility.
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that this property does not generally characterize all data sets explains
in part the current controversies concerning the relative importance of
sequence and structure parameters in determining the functionality of
miRNA target sites [83]. We further found that with the exception of
the accessibility of the miRNA flanking regions which correlates with
the G+C content of these regions, the sequence features that we com-
puted do not correlate well with the structure features (Supplementary
Figure 44). This, and the results in section 3.2.2 suggest that sequence
and structure features come into play in a non-redundant manner, at
different steps of the RNAi effector cascade, and that it is probably nec-
essary to take them both into account in order to understand miRNA
targeting specificity.
Finally, comparative genomics-based analyses reported that miRNAs
tend to target transcripts with long 3’ UTRs [204]. Strikingly, we here
found that functional miRNA target sites that are identified experimen-
tally generally reside in transcripts with relatively short 3’UTRs, and
that the transcript length is an even better predictor of functionality
compared to the 3’UTR length. Nonetheless, within the long 3’UTRs
in which evolutionarily selected sites are found, functional sites reside
closer to the 3’UTR boundaries (stop codon or polyA tail) compared
to non-functional sites, as has been previously reported [70, 83, 146].
3.2.2 Structural features direct EIF2C2 binding while sequence features are
associated with mRNA degradation
To gain insight into the origin of the sequence and structure biases dis-
cussed above, we transfected HEK293 cells stably expressing EIF2C2
with either a miRNA (miR-124 and miR-7) or a mock control, and
we measured the mRNA expression in total RNA and in the RNA
from the EIF2C2 immunoprecipitate (IP) with oligonucleotide microar-
rays. The degree of miRNA-specific EIF2C2 association and degrada-
tion of individual mRNAs were quantified by the enrichment of the
respective mRNAs in the EIF2C2-immunoprecipitates and the total
cellular RNA, respectively, of miRNA-transfected compared to mock-
transfected cells (see Supplementary Material in chapter B). We also
analyzed the results of a similar experiment performed with miR-124
by Karginov et al. [110].
Binding to EIF2C2 of transcripts whose 3’UTRs contains precisely
one match to the miRNA seed was very reproducible between the two
biological replicates of each transfected miRNA, with correlation coef-
ficients of 0.85 for miR-124 and 0.70 for miR-7 (Figure 7, upper panels).
Moreover, the degree of EIF2C2 binding was correlated with that of
mRNA degradation (r=-0.70 for miR-124 and r=-0.62 for miR-7, shown
on the the lower panels of Figure 7), with the large majority of EIF2C2-
bound transcripts undergoing some degree of degradation. This cor-
relation between EIF2C2 binding and mRNA degradation was much
higher than the correlations that were reported between changes in the
mRNA and in the protein levels by Selbach et al. [191] and Baek et al.
[8] (see also Supplementary Figure 45). A small number of EIF2C2-
bound mRNAs did not show evidence of degradation, as previously
reported by Karginov et al. [110] and Hendrickson et al. [98]. To exper-
imentally confirm that such transcripts are nonetheless regulated by
miR-124 and miR-7, we generated dual luciferase reporter constructs
containing the 3’UTRs of some of the EIF2C2-bound mRNAs. Cotrans-
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Figure 7: Upper panels: Correlation between the level of EIF2C2 binding in
two replicate experiments of transcripts carrying a single seed match
for miR-124 (left panel) and miR-7 (right panel) in their 3’ UTRs.
The level of EIF2C2 binding was computed as described in the Meth-
ods. The number of transcripts and Pearson correlation coefficients
are shown on the respective panels. Transcripts that were considered
positives for EIF2C2 binding are marked with red, those that were
considered negatives with black, and transcripts that were not used
for feature analysis are shown in gray. Lower panels: Correlation be-
tween EIF2C2 binding and mRNA degradation in one experiment
(miR-124 over-expression in the left panel, miR-7 over-expression in
the right panel). The levels of EIF2C2 binding and mRNA degrada-
tion were computed as described in the Methods. The numbers in
the four quadrants indicate the proportion of all transcripts with a
single seed-complementary 3’ UTR site that fall in each individual
quadrant.
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Figure 8: Contribution of secondary structure (upper panel), sequence and
transcript length-related (lower panel) features to the efficiency of
EIF2C2 binding and mRNA degradation. The y-axis shows the value
of the t-statistic obtained in comparing bound with unbound tran-
scripts (dark gray bars), bound and degraded with bound but not
degraded transcripts (medium gray bars), and degraded with not
degraded transcripts (light gray bars). The dashed lines indicate the
values beyond which the difference in the mean values obtained for
the positive and negative sets is considered significant with a bilat-
eral type I error of 5% after applying the Bonferroni multiple testing
correction. The individual features that we tested are indicated in the
figure and further described in the text.
fections of these luciferase reporters with the respective miRNA re-
sulted in a reduction of luciferase activity compared to control trans-
fections indicating that irrespective of whether they undergo degrada-
tion, EIF2C2-bound transcripts are translationally repressed by miR-
NAs (Supplementary Figure 46).
We returned to the features that we tested on the targets inferred
from all other experiments and asked at what step, mRNA binding
or degradation of bound mRNAs, do these features come into play.
As shown in Figure 8, the t-statistics for the energy necessary to un-
wind the secondary structure of the seed pairing region (labeled “seed
Eopen”) and of the entire target site (labeled “target site Eopen”) were
significantly negative, meaning that they were significantly smaller in
EIF2C2-bound sites compared to unbound sites. That is, we found that
3’UTRs that are specifically bound by EIF2C2 tend to have seed- and
miRNA-binding regions that are structurally more accessible, consis-
tent with the results previously reported by Ameres et al. [4]. The en-
ergy of hybridizing the seed (labeled “seed Eduplex”) makes a major
contribution to EIF2C2 binding. Combining the structural accessibility
of the seed-binding region with the energy of hybridizing the seed to
the target site into a probability of interaction gives the most significant
difference between target sites that are and those that are not bound
by the EIF2C2-containing RISC complex. Note that we found the same
feature to be highly predictive of miRNA sites that are under evolution-
ary selection (Figure 5). The 3’ region of the miRNA on the other hand
does not appear to play a crucial role in EIF2C2 binding to miRNA
seed-complementary sites (the feature labeled “pos. 13-16 Eduplex”),
consistent with the whole miRNA hybridization energy (labeled “tar-
get site Eduplex”) being a weaker determinant of EIF2C2 binding than
28 determinants of risc binding and mrna degradation
the energy of hybridizing the seed (labeled “seed Eduplex”). None of
these features however, was able to distinguish between bound sites that
do and those that do not promote degradation.
In contrast, we found that features describing the sequence compo-
sition of the transcripts harboring miRNA target sites have a dramatic
effect on the degradation of bound transcripts. While at the level of
EIF2C2 binding, the nucleotides composition does not appear to play
a statistically significant role, once transcripts are bound by EIF2C2, it
is the U, and to a smaller extent the A content that are positive pre-
dictors of mRNA degradation (Figure 8, lower panels). The trends in
nucleotide composition of the regions flanking miRNA target sites are
largely a reflection of global biases. Previous studies pointed to the ef-
fect of A/U content on the efficacy of miRNA target sites [182, 106, 83],
though at what step in the miRNA effector cascade this feature plays
a role was so far unknown. Here we found that this feature comes
into play in the degradation of EIF2C2-bound targets. We furthermore
found that the U content is more predictive of functionality than the
A nucleotide. Interestingly, two known examples of modulation of
miRNA activity – the release of miRNA-dependent inhibition of the
SLC7A1 (CAT-1) mRNA by the ELAVL1 (HuR) protein under stress
[17] and the inhibition of miRNA action in primordial germ cells of
zebrafish by DND1 protein [114] – involve interactions of U-rich ele-
ments, and a study of mRNA decay [234] also identified a number of
AU-rich elements that positively correlated with degradation rate.
Consistent with the nucleotide bias, the energy required to open the
secondary structure in the vicinity of miRNA target sites is lower in
the case of functional sites (feature labeled “flanks Eopen”, Figure 5).
Not all transcriptomics data sets however exhibit this property, which
is probably why Grimson et al. [83] reported that secondary structure
prediction was uninformative once the A/U-content of the region was
taken into account. Interestingly, some of the experiments from Grim-
son et al. [83] (e.g. miR-133a and miR-142-3p on Supplementary Figure
37) did not show strong support for structural features, while other
experiments in the same series did (e.g. miR-122 and miR-9 on Supple-
mentary Figure 37).
3.2.3 Implications for target prediction
An immediate question is what features and training sets one should
use in order to develop more accurate target prediction methods. To
address this question, we constructed three groups of data sets:
• the transcriptomics data sets shown on Figure 5, with the ex-
ception of the let-7 and miR-30a transfections, which we left out
because of the negative feedback on the RNAi pathway
• the proteomics data sets from Selbach et al. [191] and Baek et al.
[8], again excluding the let-7 and miR-30a experiments
• the comparative genomics data sets from Gaidatzis et al. [70] that
are shown on Figure 5
Based on a principal component analysis, we selected a set of 14 non-
redundant features (listed in the legend of Figure 9) and we trained
generalized linear models on the transcriptomics, proteomics and the
combination of the two data sets. In the latter case, we weighted the
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Figure 9: Receiver Operating Characteristic (ROC) curves of different miRNA
target prediction algorithms on transcriptomics, proteomics and com-
parative genomics data sets. The numbers that appear in parentheses
in the legends indicate the areas under the curves (AUC). The model
fitted on transcriptomics, proteomics and combining the transcrip-
tomics and comparative genomics data sets (Tr. and Prot.) include
the following features: seed Eopen, target site Eopen, flanks G and
U content, 3’ UTR length, ElMMo, seed Pinteraction, seed Eduplex,
target site Eduplex, flanking sequence optimization, pos. 13–16 Edu-
plex, 3’ region Eduplex, distance to 3’ UTR boundary, and relative
distance to 3’ UTR boundary. Pita 3-15 is the score according to the
algorithm published by Kertesz et al. [117], and TargetScan is the
TargetScan context score from Grimson et al. [83].
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contribution of the points in the two data sets such that the combined
transcriptomics measurements have equal weight in the model as the
combined proteomics measurements. Because the extent of evolution-
ary selection measured by the ElMMo algorithm is a feature in these
models, we did not train a model on the comparative genomics data
only. We then assessed the predictive power of all three models on all
three data sets through receiver operating characteristic (ROC) curves.
We added the sensitivities and specificities of some of the current and
most distinct target prediction methods for comparison. In cases where
models were trained on the same data set, the ROC curve shows the
cross-validation specificities and sensitivities. Finally, to get an impres-
sion of the upper bound in prediction accuracy that can be expected
from a model trained on an experimental data set, we simulated du-
plicated experiments of varying reproducibility through sampling bi-
variate Gaussians with correlation coefficients of 0.4 or 0.8. This covers
the range of reproducibilities found in the studies whose results we
used here, such as the miR-124 transfection of Karginov et al. [110]
(Supplementary Figure 47).
Unsurprisingly, each of the models that we trained performed very
well on the data set on which it was trained. When it comes to predict-
ing transcriptomics data, the model trained on these data performs as
well as a replicate experiment with a relatively low (0.4) correlation
coefficient would perform (Figure 9, left panel). In other words, given
the noise in some experimental data sets, it is not possible to train a
better model from these data, although the situation may change as
more reproducible data sets become available. This is illustrated by
the comparative genomics ROC curves (Figure 9, right panel), where
it is possible to achieve areas of the curve (AUC) of 0.91, while no
model is able to achieve an AUC greater than 0.7 on the transcrip-
tomics or proteomics data sets. On the proteomics data set even the
model trained on proteomics only achieves an AUC of 0.6, suggesting
that either entirely novel features have to be taken into account in or-
der to explain the protein-level changes that are induced by miRNAs,
or that these data sets are too preliminary for studying the determi-
nants of miRNA targeting specificity. Overall, the model trained on
transcriptomics data generalizes very well to comparative genomics
data, though additionally training on the proteomics data still im-
proves slightly the prediction accuracy. Of the previously published
models, TargetScan context has good performance on all data sets,
which is perhaps due to the fact that it uses features that were in-
ferred from both comparative genomics as well as miRNA transfec-
tion and transcriptomics analysis. Interestingly, its performance on the
proteomics data set is better even than the performance of the linear
model that we trained on the proteomics data itself. On the other hand,
the performance of the Pita algorithm [117] suggests that attempting
to predict miRNA targets purely from secondary structure considera-
tions is currently not an optimal strategy.
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3.3 discussion
3.3.1 A model that combines both sequence as well as structural aspects
performs best in miRNA target prediction
The studies of the determinants of miRNA targeting specificity that
have been published so far can be divided into two main classes: those
that emphasize sequence features [182, 83], and those that emphasize
mostly structural aspects [182, 4, 141, 117, 91]. Because different studies
used different systems, looked at different readouts and had different
degrees of precision in the experimental measurements, it has been dif-
ficult to reconcile their conclusions concerning the relative importance
of these feature in the prediction of miRNA target sites. Here we ad-
dressed this problem by applying a uniform battery of tests in order
to determine the relative power of individual features in distinguish-
ing functional from non-functional target sites. The general conclusion
is that a model that combines both sequence as well as structural as-
pects performs best in miRNA target prediction. The features have
nonetheless to be carefully chosen, because the physico-chemistry of
miRNA-target interactions is not well characterized at the moment.
Thus, although the energy of interaction between a miRNA and its tar-
get is generally not a very good predictor, especially when one does
not specifically enforce the hybridization of the miRNA seed, struc-
tural descriptors improve the predictive power of models that are only
based on sequence features. Of the sequence features, we found that
the U and A/U content of the 3’UTRs are the strongest positive and
the C and G content of the 3’UTRs are the strongest negative predic-
tors of miRNA target site functionality (Figure 6). The question arises
of why nucleotide biases computed over regions of the length scale
of 3’UTR lengths are predictive of the functionality of individual sites.
One possible answer is that the entire 3’ UTR contributes to the ac-
cessibility of individual miRNA binding regions. Consistent with this
hypothesis we found that miRNA target site accessibility is one of
the strongest structural predictors of target site functionality. On the
other hand, we found that target site accessibility is only important for
EIF2C2 binding, for which a high A/U content is not predictive. An-
other possible answer is that various selection pressures act to optimize
the nucleotide composition over relatively long regions of the 3’UTR.
This is consistent with the idea that transcripts of certain functional cat-
egories such as transcription factors, are heavily regulated [181, 204],
and as a result their 3’UTR are docking platforms for a multitude of
regulatory factors all of which prefer structurally accessible regions.
An interesting implication of the length scale of nucleotide composi-
tional biases is that functional target sites will more likely emerge in
3’UTRs that already have such sites, accompanied by a specific nu-
cleotide bias that extends over long regions. A final possibility is that
efficiency of mRNA degradation by exonucleases depends on how ex-
tensive the secondary structure of the transcript is. In this scenario,
the A/U content of the transcript and its 3’ UTR is not an indicator of
the functionality of a miRNA site per se, but sites that are located in
A/U-rich transcripts are associated with more efficient target mRNA
degradation.
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3.3.2 miRNA target sites have been selected in evolution on their ability to
trigger mRNA degradation
The original paradigm regarding the mechanism of action of miR-
NAs was that miRNAs cause translational repression of bound mR-
NAs [231, 178]. Further studies have then shown that miRNAs also
trigger the degradation of the targeted mRNAs [138, 9, 123], lead-
ing to the view that miRNAs primarily cause translation repression,
with mRNA degradation occurring as a by-product [61]. Our results
here show that the target sites that are under evolutionary selection
share most features with the target sites that induce mRNA degrada-
tion responses. Thus, we suggest that the translational inhibition only
paradigm is the exception rather than the rule at least for mammalian
miRNAs. This conjecture is also supported by the results of EIF2C2-IP
and miRNA over-expression/proteomics experiments. The degree of
EIF2C2 binding correlates very well with the extent of mRNA degra-
dation (Figure 7) and there are relatively few targets that appear to be
bound by EIF2C2 but not undergo mRNA degradation. Additionally,
the proteomics data sets of Selbach et al. [191] also indicate that there
are relatively few targets that appear to be translationally inhibited yet
the corresponding mRNA levels are unchanged (Supplementary Fig-
ure 45). One important exception may be those mRNAs whose trans-
lation needs to be inhibited only transiently. Bhattacharyya et al. [17]
described for instance the example of the cationic transporter (CAT-1)
message, whose inhibition by miR-122 in the liver is reversible under
stress. Similar situations arise in neurons, in which the translation of
some messages needs to be specifically triggered in response to sig-
nals at the neuronal synapse, but not otherwise. For such cases, the
measurement of protein levels may be essential in target identifica-
tion, and it will be extremely interesting to analyze in more depth
the targets obtained from proteomics and from transcriptomics mea-
surements performed after transfection of the neuron-specific miRNA,
miR-124. Nonetheless, our results indicate that the more common tran-
scriptomics measurements are still very useful for the identification of
miRNA targets.
Finally, we found that a model that was trained on transcriptomics
data performs better in predicting target sites that are under evolution-
ary selection than those that are inferred from transcriptomics exper-
iments and that miRNAs appear to feed back on various steps of the
RNAi pathway. These findings suggest that a more accurate identifica-
tion of miRNA target sites may require a deeper quantitative under-
standing of the miRNA-induced response rather than additional de-
terminants of miRNA targeting specificity. We will elaborate on these
aspects in Chapter 6.
What we have not addressed up to this point are the practical as-
pects of using miRNA target predictions in the framework of a specific
biological question. We have also not elaborated on some of the steps
involved in designing miRNA target prediction algorithms that are
not straightforward and are dependent on aspects of gene regulation
which are presently only partially understood.
In this section, we will address these questions. We will start by ex-
amining issues that arise when using miRNA target predictions for an-
swering specific biological questions in an experimental setting. Then,
we will discuss how some of the uncertainties regarding gene regula-
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tion are reflected in computational miRNA target predictions and to
what extent one can deal with these uncertainties.
3.3.3 Using miRNA target predictions in an experimental setting
A typical setting in which miRNA target predictions are useful is when
the miRNAs that are involved in a specific process have been identified
by miRNA expression profiling or genetic screens, and the question be-
comes what targets respond to these miRNAs. Target predictions are
then necessary to guide target discovery. This approach has been used
in numerous studies aiming to understand, the role of miRNAs in
development [231, 131, 178], insulin secretion [170], cholesterol biosyn-
thesis [123], or pathologies [97, 185], to mention only a few cases.
how accurate are mirna target predictions? If miRNA
target prediction is essential for the identification of miRNA targets,
the immediate question is what target prediction program should an
experimental biologist use. The literature does not provide a clear an-
swer to this question for a number of reasons. First is that it is still
unclear what experimental data is suitable to assess the quality of
miRNA target predictions. Are measurements of mRNA stability suf-
ficient, or does one really need measurements of the protein levels in
order to identify miRNA targets? Second, given that miRNAs appear
to act at multiple levels, it is unclear how we should treat the predic-
tions. Should one require that the response to miRNA perturbations
is predicted quantitatively or would it be sufficient to predict whether
the target responds or not? Another complication in comparing tar-
get prediction methods is that there is no standard set of potential
targets that are always considered. That is, some authors used Refseq
transcripts, others use transcripts from specialized databases (such as
WormBase [92] or FlyBase [213]), even the content of a given database
(such as Refseq) changes in time, and thus one method may have a
prediction that another is missing simply because the transcript was
not even considered. Nonetheless, we attempted to perform such a
comparison on a subset of the available, commonly used, miRNA tar-
get prediction programs and a set of genes and transcripts that were
used in all of these programs. Our results [95] indicated that the there
are a number of miRNA target prediction programs that perform com-
parably well and explain around 20% of the variance in the changes
in gene expression induced in a miRNA perturbation experiment. This
means that 1) there is no clear "best miRNA target prediction method")
and 2) the predictive power of the best miRNA target prediction meth-
ods available today is comparable to that of duplicated experiments
of low reproducibility [95]. One category of targets that is generally
not predicted by the methods that are currently available is that of
the so-called "non-canonical" miRNA binding sites, that is, sites that
cannot extensively pair with the miRNA seed. While such sites were
in fact among the first to be identified [178], attempts to predict them
presently come at the cost of a dramatic loss of specificity [135, 70] and,
on average, their impact on the mRNA stability appears to be limited
in vivo [90].
One thing that we need to keep in mind though is that high-throughput
experiments of miRNA perturbations were frequently done on (cancer)
cell lines. It is likely that in such systems the miRNA effects are more
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easily interpretable compared to in vivo situations, and moreover, that
miRNA transfections usually lead to large changes in miRNA expres-
sion that may not be typical of the in vivo situations. Additional pitfalls
arising from the use of high-throughput datasets for assessing the ac-
curacy of miRNA target predictions are discussed in the second part
of section 3.3.4 below. To circumvent the current limitations of high-
throughput methods, one can focus instead on high-quality, experi-
mentally validated "positives" and "negatives" [166], though the set of
such targets is significantly smaller and perhaps not even representa-
tive for the entire set of miRNA targets.
“which mirna target prediction method should i use?”
Because no method can currently predict miRNA targets very accu-
rately, some authors attempted to obtain high-confidence predictions
by intersecting the results of several prediction methods. While this
idea may sound reasonable in theory, it may not necessarily result in
more accurate predictions in practice, as can be illustrated by a simple
example.
Let us imagine that we are given the list of genes that are predicted
to be targeted by a certain miRNA by two different methods. Let us
further assume that method A is a very accurate prediction method,
while method B simply consists of tossing a coin for each gene in
the human genome, calling the gene a predicted target when the coin
toss returns heads. Intersecting the two lists of "predictions" we obtain
a "random" subset of the targets predicted by method A. The frac-
tion of real targets within this subset (the positive predictive value)
will remain the same as for method A. The fraction of real targets
that will indeed be predicted as targets (the sensitivity) in the inter-
section will be half of that in the list of predictions from method A
alone. Thus, the accuracy of this method that combines prediction lists
is lower than the accuracy a single method (method A). In fact, the
situation may be even worse, when the current best method is not
among those whose prediction lists will be intersected. Thus, in the
context of an experiment-driven project, when the aim is to find what
genes regulated by a given miRNA explain a certain phenotype, one
should rather start by considering the assumptions made by the differ-
ent prediction methods that are available. For instance, if the miRNA
of interest is conserved in evolution we may expect that its targets are
also conserved and we could consider miRNA target prediction meth-
ods that rely on sequence conservation. If the miRNA is itself poorly
conserved, one should rather consider methods that aim to predict
miRNA-complementary sites that induce mRNA destabilization, even
though it is presently unclear whether these methods have higher or
lower accuracy relative to comparative genomics-based methods.
how many targets does mirna x have? One of the main aims
of miRNA target prediction is to generate a list of genes sorted in
descending order of confidence of the gene being a miRNA target.
Depending on the method and on the miRNA, one typically finds that
the number of predicted targets ranges from a dozen to thousands
of genes. Therefore, a natural question arising from such lists is: how
many targets does a miRNA have?
This is again a difficult question to answer in principle, not in the
least because, as we discussed above, it is not entirely clear how to
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define a miRNA target. From the point of view of computational pre-
dictions, some miRNA target prediction methods propose criteria that
are typically based on statistical considerations (signal to noise ratio,
a posteriori probability, etc.) to decide where to cut off the list of pre-
dicted targets to be considered for experimental validation. With this
approach it has been inferred that a miRNA targets on average hun-
dreds of genes, the number varying between a couple and thousands
of genes [134, 138, 8, 191, 69] for individual miRNAs.
why does a particular high-confidence predicted tar-
get not change in response to mirna over-expression?
It is not uncommon to find out that a substantial fraction of high-
confidence predicted targets do not respond in a particular validation
experiment. Of course, a trivial possibility is that the prediction is er-
roneous. In section 3.3.4 we will discuss several scenarios in which the
target cannot be validated experimentally even though it is indeed a
target.
transcript x is a target of mirna y according to method
z , yet it does not have a "mirna y seed match” in the
3’utr . An frequently overlooked cause for discrepancies between
target prediction methods or between the predictions and validation
experiments is that the sequences associated with specific transcript
identifiers change between database releases. Thus, predicted miRNA
targets that have been downloaded from the web sites associated with
specific methods may differ in sequence from the transcripts that one
can download at a later date from databases such as NCBI, Ensembl
or DDBJ.
3.3.4 The complexity of gene regulation and its impact on designing accu-
rate miRNA target prediction methods
In order to establish that there is a direct interaction between a miRNA
and an mRNA target, one possibility consists in perturbing the miRNA
binding site by deletion or mutation. This approach was largely used
to understand the fundamentals of miRNA target recognition [24], and
is well suited for confirming a small set of putative targets experi-
mentally. However, this approach is not practical for the identification
and validation of all target sites of a miRNA. For this purpose, the
alternative approach that consists in perturbing the miRNA by over-
expression, knock-down or mutation was widely used to find what
genes are targeted by miRNAs [123, 8, 191]. The down-side of such ex-
periments is that the perturbation of the miRNA will percolate through
the regulatory networks of the cell, which respond at different time
scales, which in the end will complicate the interpretation of the per-
turbation experiment. This is one reason why for instance, not all mR-
NAs that are down-regulated following miRNA over-expression har-
bor a miRNA seed match [138]. "Secondary" effects superimpose with
the "direct" miRNA-induced gene silencing effects, complicating the
selection of "positive" and "negative" binding sites that one would use
to train the predictive model. We will review here briefly the scenarios
in which an incorrect selection of "positive" or "negative" binding sites
is made, particularly those due to such secondary effects.
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Figure 10: Hypothetical networks illustrating the co-regulation of a gene (A, B)
by a miRNA and a transcription factor, with the miRNA regulating
the transcription factor. Gene A harbors a non-functional miRNA
binding site while Gene B carries a functional miRNA binding site.
The most obvious causes for an incorrect identification of positives
and negatives are the technical measurement error (noise) and the in-
trinsic biological variability. Such errors can be reduced by improving
the technology and performing a larger number of replicated measure-
ments. Another obvious factor is the concentration of the reactants
(mRNA, miRNAs). The target mRNA needs to be expressed at a level
that allows its detection and an accurate estimation of the change in
response to the miRNA. If these conditions do not hold for the cell
line used in the miRNA perturbation experiment, the mRNA will not
be identified as a target. The concentration of the miRNA matters as
well: knocking out a miRNA which is only present in trace amount or
over-expressing a miRNA whose expression already very high in the
cell line in which the experiment is performed is unlikely to produce
a measurable change in the expression of the targets.
The “secondary effects” come from the interaction of the perturbed
miRNA with the gene regulation network of the host cell. Because
regulatory networks have not been sufficiently characterized quantita-
tively, one cannot simply predict the secondary effects of a miRNA
over-expression. Nonetheless, given that miRNAs and transcription
factors co-regulate targets, with the miRNA often regulating the tran-
scription factor or the transcription factor regulating the miRNA [192],
such effects are expected to be important. Consider the example of a
hypothetical experiment in which one over-expresses a miRNA that si-
lences a transcription factor which actives the transcription of mRNA
A. We assume that A harbors a non-functional miRNA binding site
(Figure 10). By inferring "positive" miRNA binding sites from mR-
NAs whose levels go down following the miRNA over-expression,
one would treat mRNA A as a functional target of the over-expressed
miRNA (a false "positive"). On the other hand, we can consider the
hypothetical case of a miRNA which silences a transcription factor
that represses a mRNA B. Let us further assume that mRNA B har-
bors a functional binding site for the over-expressed miRNA (Figure
10). Over-expressing the miRNA will lead to a down-regulation of the
transcriptional repressor which could then result in an up-regulation
of mRNA B despite the direct regulation by the miRNA. In this case,
from the measured changes in expression, we would treat mRNA B as
non-functional miRNA target (a false "negative"). Other known exam-
ples of such secondary effects include the targeting of components of
the miRNA pathway itself such as Dicer [67, 191] or TNRC6 [95], or
of enzymes involved in chromatin structure [50, 198] by the perturbed
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miRNA. In addition, the over-expression of a miRNA has been shown
to impact the post-transcriptional regulatory network of a cell through
competition with the endogenously expressed miRNAs [118].
Other post-transcriptional regulatory mechanisms (that may be trig-
gered in the miRNA perturbation experiment) have been reported to
interfere with miRNA regulation. For instance, under stress conditions
RNA binding proteins can relieve miRNA-mediated translational re-
pression [17], and miRNAs may even switch from acting as repressors
to acting as activators [220]. Along the same lines, the RNA-binding
protein Dnd1 can relief miRNA-dependent inhibition by blocking the
access of the miRNA to its site [113]. Thus, there are a variety of factors
that can change the functionality of miRNA target sites in a context-
dependent manner.
Strongly expressing a transcript with multiple sites complementary
to a given miRNA was shown to derepress the targets of that miRNA [53,
75] which suggests that miRNA targeting is transcriptome-dependent;
in the context of a certain transcriptome, a miRNA binding may be
functional, but in the presence of another strongly expressed mRNA
that recruits most copies of the miRNA, the same target may be dere-
pressed and therefore appear non-functional [190, 7]. As the transcrip-
tome largely depends on the tissue and the experimental conditions,
taking into account the cell type-specific transcriptome may lead to
more accurate identification of positive and negative sites and more
accurate miRNA target predictions.
Finally, although it is generally accepted that miRNAs silence their
target genes both through repressing the translation of the transcript
and by promoting deadenylation leading to the degradation of the
target mRNA [66, 64], it can not be excluded that a set of target mR-
NAs are only repressed translationally without undergoing degrada-
tion [95]. For these sites, the transcriptomics approach is bound to
generate false "negatives".
These examples illustrate that obtaining sets of positive and neg-
ative miRNA binding sites from miRNA perturbation and omics ex-
periments is not trivial and is necessarily associated with a certain
amount of "noise". The advantage of the large amount of data pro-
duced by omics experiments is that this "noise" is expected to cancel
out if enough sites from different experiments with different miRNAs
are used to train miRNA target prediction algorithms. The fact that
miRNA target sites obtained from heterogeneous sources share simi-
lar properties argues for this scenario [95].
The discussion above also suggests that there are miRNA targets that
have been predicted computationally but have not been validated ex-
perimentally because in the experimental context used to validate the
target, the real effect of the miRNA on the putative target is masked
by one or factors mentioned above. Reconciliating miRNA target pre-
dictions with validation experiments will require to take the precise
context of the validation experiments into account.
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microRNA transfection
FLAG/HA-EIF2C2 cells were transfected with miR-7/miR-7* duplex
(5’-UGGAAGACUAGUGAUUUUGUUGU/5’-CAACAAAUCACAGUCUGCCAUA)
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and miR-124/miR-124* duplex
(5’-UAAGGCACGCGGUGAAUGCCA/5’-CGUGUUCACAGCGGACCUUGA)
or mock and Lipofectamine RNAiMAX as described by the manufac-
turer (see also Supplementary Figure 48). Briefly, 15 cm tissue culture
plate was transfected with 900 pmol miRNA duplex and 22 µl Lipofec-
tamine RNAiMAX.
RNA isolation from cell lysate and FLAG-protein immunoprecipi-
tates from FLAG/HA-EIF2C2 expressing cells were lysed in 3 cell pel-
let volumes of 50 mM HEPES-KOH, pH 7.4, 150 mM KCl, 2 mM EDTA,
0.5 mM DTT, 1 mM NaF, and 0.5% NP-40. RNA from the lysate was
isolated by adding 3 volumes of RNA extraction solution (4 M guani-
dinium isothiocyanate, 25 mM Na-citrate, 0.5% N-Lauroylsarcosinate,
50 mM beta-mercaptoethanol and 50% acidic phenol) and 0.2 volumes
of chloroform. RNA was ethanol-precipitated from the aqueous phase.
FLAG/HA-tagged EIF2C2 was immunoprecipitated with anti-FLAG
M2 agarose beads (Sigma). Beads were washed three times with 50
mM HEPES-KOH, pH 7.4, 300 mM KCl, 2 mM EDTA, 0.5 mM DTT, 1
mM NaF, and 0.05% NP-40. RNA isolation from immunoprecipitated
RNPs was performed as described previously [153]. RNA for microar-
ray analysis was further purified using RNeasy mini spin columns
(QIAGEN). Quality of the RNA was assessed with an the Agilent Bio-
analyser.
Dual Luciferase assay of EIF2C2-bound mRNAs
HEK293 cells were co-transfected in 96-well format (40.000 cells/well)
with 100 ng of the respective psiCHECK vector and 10 pmoles of
miRNA duplex or 10 pmoles of GFP siRNA duplex
(5’-GGCAAGCTGACCCTGAAGTTT/5’-ACTTCAGGGTCAGCTTGCCTT)
as control with Lipofectamine 2000 (Invitrogen). Cells were lysed in
1xPassive Lysis Buffer (Promega) 15 h after transfection and analyzed
using the Dual-Luciferase Reporter System (Promega) as described by
the manufacturer on a BIO-TEK Clarity 96-well plate reader with dou-
ble injectors.
Dual Luciferase assay of TNRC6A with miR-30a
HeLa cells were transfected in 24-well plates with 5 ng of respec-
tive psiCHECK vector using Lipofectamine 2000 (Invitrogen) or co-
transfected with 20 nM miR-30a antagomiR (Ambion). Cells were lysed
24 h after transfection and luciferase activities were measured using
the Dual-Luciferase Reporter System (Promega) as recommended in
the manufacturer instructions.
Microarray experiments
Two µg of purified total RNA from HEK293 cell lysate or from im-
munoprecipitated RNPs were used in the One-Cycle Eukaryotic Target
Labeling Assay (Affymetrix) according to the manufacturer’s protocol.
Biotinylated cRNA targets were then cleaned up, fragmented, and hy-
bridized to Human Genome U133 Plus 2.0 Array (Affymetrix).
3.4 methods 39
Computational analysis of one-channel Affymetrix microarrays from Selbach
et al. [191] and Krützfeldt et al. [123]
The CEL files of Selbach et al. [191] were downloaded from http://psilac.mdc-
berlin.de/download/ and the antagomiR-122 data of Krützfeldt et al.
[123] was retrieved from the GEO database of NCBI (accession: GSE3425).
We imported the CEL files into the R software (www.R-project.org)
using the BioConductor affy package [74]. The probe intensities were
corrected for optical noise, adjusted for non-specific binding and quan-
tile normalized with the gcRMA algorithm [233].
Per gene log2 fold change were obtained through the following pro-
cedure. We first fitted a lowess model of the probe log2 fold change
using the probe AU content. We used this model to correct for the tech-
nical bias of AU content on probe-level log2 fold change reported by
Elkon and Agami [57]. Subsequently, probe set-level log2 fold changes
were defined as the median probe-level log2 fold change. Probe sets
with more than 2 probes mapping ambiguously (more than 1 match)
to the genome were discarded, as were probe sets that mapped to
multiple genes. We then collected all remaining probe sets matching
a given gene, and averaged their log2 fold changes to obtain an ex-
pression change per gene. For sequence analyses, we selected for each
gene the RefSeq transcript with median 3’ UTR length corresponding
to that gene.
Finally, we considered all genes for which at least one probeset was
called present in the transfection experiments as expressed, and went
on analyzing only these genes while ignoring all other genes.
Computational analysis of two-channel Agilent microarrays from Karginov
et al. [110] and Baek et al. [8]
The Baek data set was downloaded from the GEO database of NCBI
(accession GSE11968). For the Karginov data set we started with the
text file output of the Agilent scanner, which was kindly provided to
us by Ted Karginov.
We extracted the rProcessedSignal, gProcessedSignal, LogRatio, rIsWellAboveBG,
gIsWellAboveBG fields for each probe, keeping only probes for which
both gIsWellAboveBG and rIsWellAboveBG flags were true in all ex-
periments. We then quantile-normalized the green and red channel
intensities which we obtained from the rProcessedSignal and gPro-
cessedSignal fields of all experiments together. We computed probe-
level log2 fold changes from the quantile-normalized rProcessedSig-
nals and gProcessedSignals.
After discarding probes mapping to multiple genes, we collected all
probes matching a given gene, and we estimated the log2 fold change
per gene as the average log2 fold change of the probe sets associated
with it. Finally, for each gene we selected for further sequence analysis
the RefSeq transcript with median 3’ UTR length corresponding to that
gene.
Computational analysis of two-channel Agilent microarrays from Linsley et al.
[140] and Grimson et al. [83]
We downloaded the processed differential expression data from GEO
(accessions: GSE6838 and GSE8501) together with the probe to tran-
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script mapping provided by the authors as a SOFT formatted file. For
subsequent analysis, we kept only probes associated to RefSeq tran-
scripts according to the annotation. We used all the experiments in
the Grimson et al. [83] series. From the microarray data provided by
Linsley et al. [140], we kept only those experiments that had quasi-
replicates (transfections in both HCT116 and DLD-1 cells). These in-
volved let-7c, miR-103, miR-106b, miR-141, miR-15a, miR-16, miR-17,
miR-192, miR-200a, miR-20a and miR-215 transfections and microar-
ray measurements at 24h (GEO accessions: GSM156546, GSM156550,
GSM156545, GSM156549, GSM156543, GSM156576, GSM156532, GSM156541,
GSM156534, GSM156542, GSM156580, GSM156544, GSM156547, GSM156551,
GSM156548, GSM156552, GSM156553, GSM156555, GSM156554, GSM156556,
GSM156557, GSM15655).
Computational analysis of SILAC assay from Baek et al. [8]
We downloaded the data provided by the authors in the supplemen-
tary material of the paper and used it without any specific post-processing.
Computational analysis of pSILAC assay from Selbach et al. [191]
We downloaded the “all peptide evidence” flat file from http://psilac.mdc-
berlin.de/download/.
We mapped all peptides in the pSILAC data set against the RefSeq
Protein database from Aug, 14th 2008 using wu-blastp 2.0 and a seed
word length of 5, discarding alignments with gaps or with more than
one mismatch. We further discarded peptides that mapped to more
than one protein.
Per-protein log2 fold changes were computed for all proteins cred-
ited with 3 to 15 peptides log2 fold changes across replicates and gel
slices.
EIF2C2 binding affinities in the Karginov data set
Transcript degradation was quantified as the logarithm of the ratio of
transcript expression in the lysates of miRNA-transfected and mock-
transfected cells. The miRNA-specific EIF2C2 binding was quantified
as the ratio of two ratios: EIF2C2-IP of miRNA-transfected and mock-
transfected cells and lysates of miRNA-transfected and mock-transfected
cells (Supplementary Figure 49).
Extraction of positives and negatives from replicated transfection experiments
Among the transcriptomics data sets we reanalyzed, the experiments
performed by Grimson et al. [83], Selbach et al. [191], Baek et al. [8] and
Krützfeldt et al. [123] did not feature biological replicates. For these
data sets, we considered the top 250 down-regulated (or up-regulated
for Krützfeldt et al. [123]) transcripts that carried precisely one 7mer or
8mer seed match. After discarding all seed matches located in the CDS,
we ended up with a set of positive seed matches. The negatives were ob-
tained through selecting the 250 least-changing transcripts with seed
matches, that is the 250 transcripts whose log2 expression fold changes
were closest to 0 when comparing the miRNA-transfected samples to
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the mock-transfected samples. After discarding all seed matches lo-
cated in the CDS, we ended up with a set of negative seed matches.
The experiments performed by Linsley et al. [140] and Karginov et al.
[110] on the other hand featured biological replicates. For these data
sets, we applied a method that we designed for selecting transcripts
that, with high probability, are affected in expression by the miRNA
across all experiments in which the expression of the given miRNA
was perturbed (see Supplementary Material in chapter B). Briefly, we
first need to calculate, for each pairwise microarray comparison (fur-
ther referred to as contrast) k, the probability Pk(f|−) that a transcript
that is not a target, will have a log fold change of f. To estimate the
distributions Pk(f|−) we assumed that they are Gaussian with means
µk and standard deviation σk to be estimated from the data for each
contrast k. We in addition assumed that transcripts that do not carry
at least a heptameric seed-complementary site are unlikely to be real
targets, and thus estimated µk and σk from the observed expression
changes of transcripts without such seed matches. We similarly need
to calculate, for each contrast k, a distribution Pk(f|+) that a transcript
which is a true target of the miRNA, will have a fold-change f. As little
is currently known of the distribution of the severity of the effect that
miRNAs have on the expression of their targets we assumed as little
as possible about the distribution Pk(f|+), namely that a true target
must change expression in the right direction, i.e. f < 0 for a miRNA
over-expression experiment, and f > 0 for a miRNA knock-down ex-
periment, and that expression changes are limited to a finite range
over which the expression change has a uniform distribution. Finally,
based on these distributions, we estimate the posterior probability that
a transcript with fold change f is a functional target in a given exper-
iment. Details are given in the Supplementary Material (Chapter B).
The same procedure was used to construct the sets of positives and
negatives from our miR-124 and miR-7 transfection experiments. The
process is illustrated in Supplementary Figure 50 and the lists of tran-
scripts with a posterior probability of > 0.5 of being functional in both
contrasts of our two miRNA transfection experiments are available for
download on Genome Research website. For the negatives we selected Supplementary
Tables 1 and 2 at
http:
//genome.cshlp.
org/content/19/
11/2009/suppl/DC1
those transcripts with minimal sum of squared log2 fold changes in the
two experiments. Finally, for the feature analysis, we then proceeded
as with experiments where no replicates were performed: we selected
250 positives and 250 negatives according to the criteria defined above
and we discarded those cases in which the seed match was in the CDS.
Extraction of positives and negatives from ElMMo predictions
From our predictions of miRNA target sites inferred to be under evo-
lutionary selection [70] and for each of the experimentally tested and
conserved miRNAs (miR-30a, let-7c, miR-155, miR-1, miR-103, miR-
15a, miR-16, miR-106b, miR-20a, miR-141, miR-200a, miR-181a, miR-
124 and miR-17), we selected the top 250 target sites in the order of
their posterior probability of being under selection. We also selected
an equal number of sites least likely to be under selection.
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Feature definition and computation
To minimize the ambiguity of attributing a specific response to a miRNA
binding site, we only analyzed transcripts that had precisely one miRNA
seed match (complementarity to positions 1-7, 2-8, or 1-8 of the miRNA)
and the site was at least 100 nucleotides away from either of the bound-
aries of the 3’ UTR. A sketch of the transcript regions used for the var-
ious computations below is shown in Supplementary Figure 51. For
each individual putative target site we then computed the following
quantities.
seed accessibility (seed Eopen) was defined in terms of the en-
ergy necessary to open the secondary structure of the target in
the region binding positions 1-8 of the miRNA. This was com-
puted using the program RNAup of the Vienna package [102]
with the following parameters: u=8 (length of the window re-
quired to be single-stranded), w=50 (maximal length of the in-
teracting region). The rest of the parameters were left with their
default values. Other choices of the w parameter did not quali-
tatively affect our results (not shown). The negative value of this
energy can be viewed as a measure of accessibility.
site accessibility (site Eopen) was similarly defined in terms of
the energy required to open the secondary structure of the target
in a region of 20 nucleotides, anchored at the 3’ end by the seed-
complementary region (opposite positions 1-8 of the miRNA).
The computation was performed as described above, except that
we used a window size u of 20 instead of 8.
accessibility of the flanks (flanks Eopen) was defined as the
average accessibility (defined above) of a window of length 20
contained in the regions of 50 nucleotides upstream or 50 nu-
cleotides downstream of the miRNA target site.
seed hybridization energy (seed Eduplex) is the energy ∆Gh of
the hybrid formed between the seed (position 1-8 of the miRNA)
and the seed-complementary site, as given by the RNAduplex
program of the Vienna package [102].
mirna hybridization energy (target site Eduplex) is the energy
of the hybrid formed between the miRNA (positions 1-20) and
the miRNA-complementary site, as given by the RNAduplex pro-
gram.
3’ mirna region hybridization energy (3’ region Eduplex) is
the energy of the hybrid formed between bases 9 to 20 of the
miRNA and the 12 nucleotides upstream of the seed comple-
mentary region of the mRNA, computed with the RNAduplex
program.
pairing contribution of different 3’ regions of the mirna
(pos. 9–12 Eduplex, pos. 13–16 Eduplex, pos. 13–20 Eduplex) is
the difference ∆Gu − ∆Gc between the minimum binding free
energy ∆Gu of the full mRNA-miRNA duplex and the binding
free energy ∆Gc of the same duplex under the constraint that the
nucleotides 9–12, 13–16 or 13-20 of miRNA are unpaired, respec-
tively. The duplex structure with minimum binding free energy
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was computed by the RNAduplex program of the Vienna pack-
age. Starting from this structure, we enforced the constraints at
positions 9–12, 13–16 and 13–20 and computed the correspond-
ing binding free energy ∆Gc using RNAeval from the Vienna
package [102].
seed interaction energy (seed Einteraction) was defined as ∆G =
∆Go +∆Gh, where ∆Go is the energy required to open the sec-
ondary structure of the target in the seed-complementary region,
and ∆Gh is the energy of the hybrid formed between the seed
and the seed-complementary site. ∆Go is obtained as described
in the paragraph “Seed accessibility” above, and ∆Gh is com-
puted using the RNAduplex program [102] with default parame-
ters. Note that we neglected the energy possibly required to open
the structure of the seed region of the miRNA. The probability
of interaction with the seed region of the miRNA (seed Pinterac-
tion) is the corresponding probability, as computed by RNAup.
mirna interaction energy (target site Einteraction) was similarly
defined as ∆G = ∆Go +∆Gh, where ∆Go is the energy required
to open the secondary structure of the target in the miRNA-
binding region of 20 nucleotides anchored at the seed (as de-
scribed above), and ∆Gh is the energy of the hybrid formed be-
tween the miRNA and the miRNA-complementary site. ∆Go is
obtained as described at point 2 above, and ∆Gh is computed
using the RNAduplex program [102] with default parameters.
flanks a , c , g and u contents were defined as the proportions
of A, C, G and U nucleotides within 50 nucleotides upstream
and 50 nucleotides downstream of the miRNA binding site of 20
nucleotides, anchored downstream by the seed-matching region.
3’utr a , c , g and u contents were defined as the proportions of
A, C, G and U nucleotides within the 3’UTR harboring the miRNA
binding site.
transcript a , c , g and u, au contents were defined as the pro-
portions of A, C, G, U and A+U nucleotides in the transcript
harboring the miRNA binding site.
transcript and 3’utr length were obtained from the RefSeq se-
quence and annotation.
relative position was computed by dividing the position in the
3’UTR marking the beginning of the seed complementary region
by the 3’UTR length.
relative distance to 3’utr boundary was computed similarly,
dividing the minimal distance from the beginning of the seed
complementary region to the STOP codon or the poly-A tail by
the length of the 3’UTR.
flanking sequence optimization was designed to measure the
extent to which the nucleotide composition of the regions flank-
ing a miRNA binding site explains the accessibility of the miRNA
binding site. For each target site we generated 100 variants in
which we randomized, independently of each other, the sequence
44 determinants of risc binding and mrna degradation
of the 50 nucleotides upstream and of the 50 nucleotides down-
stream of the miRNA target site, while keeping the mono-nucleotide
frequencies in these regions constant. For the randomized vari-
ants we recomputed the accessibility of the miRNA binding site
as described above. We then calculated the z-statistic of the real
sequence relative to the randomized variants. This computation
gave us one set of z-statistics for the positives and one for the
negatives. We finally used the t-test to compare the means of the
two distributions of z-statistics.
elmmo is the posterior probability that a seed complementary region
is under evolutionary selective pressure described in Gaidatzis
et al. [70].
Testing different linear models for predicting various types of miRNA target
sites
We divided all the data sets that we studied here into three groups,
as described in section 3.2.3. We then performed a principal compo-
nent analysis to determine a set of 14 non-redundant features (listed
in the legend of Figure 9). We then used these features to train three
independent generalized linear models (GLM) with logit link function
[150] on the transcriptomics data sets, on the proteomics data sets, and
a mixture of the transcriptomics and proteomics data sets. In the latter
case, we weighted each putative miRNA target site proportionally to
the inverse of the data set size, to have the resulting model minimize
the prediction error equally on both data sets.
To avoid over-estimating the performance of the three GLMs when
testing them on the data sets on which they were trained, we per-
formed 10-fold cross-validation. In other words, we split our data set
in 10 parts, trained the model using the first 9 parts of the data set,
and evaluated its sensitivity and specificity on the last. We reiterated
this procedure 10 times and used the numbers that came out of it to
plot the cross-validated receiver operating characteristic (ROC) curve.
The ROC curves for GLMs trained on a different data sets and for
other miRNA target predictions algorithms were computed using the
standard procedure [201].
To simulate ROC curves from biological replicates of varying repro-
ducibilities, we sampled 25000 points from bivariate gaussians with
correlation coefficients r of 0.4 and 0.8, which covers the range of re-
producibilities of log2 fold changes that we observed in the experimen-
tal data sets that we analyzed here. We then considered the 10% (2500)
smallest values from the first simulated replicate as fold changes in
a transfection experiment for “true target sites” and attempted to use
the second simulated replicate to predict the “true target sites”. The
two ROC curves show to what extent knowing one simulated data set
enables one to predict the other depending on whether the replicates
are in moderate (r = 0.4) or good agreement with each other (r = 0.8).
Evaluating the competition between the endogenous and the transfected miRNA
Khan et al. [118] recently reported that transfected miRNAs compete
with the endogenous miRNAs for RISC loading. To evaluate this effect
in the context of our study, we applied the analysis methods of Khan
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et al. [118] to all 44 microarrays performed in the HCT116 Dicer -/-, 8,
10, 14 and 24 hours after miRNA or siRNA transfection (GEO acces-
sions: GSM156513, GSM156514, GSM156515, GSM156516, GSM156517,
GSM156518, GSM156519, GSM156520, GSM156567, GSM156568, GSM156569,
GSM156570, GSM156571, GSM156572, GSM156573, GSM156574, GSM156525,
GSM156526, GSM156527, GSM156536, GSM156521, GSM156522, GSM156523,
GSM156524, GSM156531, GSM156532, GSM156533, GSM156534, GSM156545,
GSM156546, GSM156547, GSM156548, GSM156553, GSM156554, GSM156557,
GSM156559, GSM156565, GSM156566, GSM156575, GSM156576, GSM156577,
GSM156578, GSM156579, GSM156580, GSM156581) and to microarrays
that monitored the mRNA expression changes at 8 and 32 hours after
the transfection of five miRNAs published by Selbach et al. [191].
To be able to compare our results with those of Khan et al. [118], we
modified slightly the microarray data processing described in sections
3.4 and 3.4: at the step where we choose a representative RefSeq mRNA
for each gene monitored on the microarray we chose the RefSeq mRNA
with longest 3’ UTR instead of the RefSeq with median length 3’ UTR.
We determined the set “X” of mRNAs whose 3’ UTRs carried a
match to positions 2 to 8 of the transfected miRNA. We then deter-
mined the set “D” of mRNAs carrying a 2-8 seed match to one of the
top 10 miRNA families most expressed in the cell line (HCT116 Dicer
-/- or HeLa) used in the experiment. We used the miRNA family ex-
pression profiles reported on Supplementary Figure 2 of Khan et al.
[118]. We determined the set “B” of mRNAs that carried seed matches
to neither the transfected miRNA nor the top 10 endogenous miRNA
families. Finally, we applied a linear transformation to the log2 fold
change such that the log fold changes of the mRNA belonging to the
B set had mean 0 and variance 1.
We then computed the average log fold changes of the X, X ∩D,
X \D,D \X and BmRNA sets. Doing so for each set of mRNAs and for
each time point gave us one measurement of mRNA log fold change
per experiment (i.e. per transfected miRNA), which we combined by
averaging over all experiments performed at the same time point and
computing the 95% confidence interval on the mean log fold changes.
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4.1 introduction
Gene expression in eukaryotes is extensively controlled at the post-
transcriptional level by hundreds of miRNAs, which are bound by Arg-
onaute (Ago/EIF2C) proteins and mediate destabilization and/or in-
hibition of translation of partially complementary target mRNAs [13].
But Ago is just one out of hundreds of RNA-binding proteins (RBPs)
and ribonucleoprotein complexes (RNPs) [151] that modulate the mat-
uration, stability, transport, editing and translation of RNA transcripts
in vertebrates [147, 156, 200]. Each of these RBPs contain one or more
domains able to specifically recognize target transcripts. To under-
stand how the interplay of these RNA-binding factors affects the regu-
lation of individual transcripts, high resolution maps of in vivo protein-
RNA interactions are necessary [116].
A combination of genetic, biochemical and computational approaches
is typically applied to identify RNA-RBP or RNA-RNP interactions.
Microarray profiling of RNAs associated with immunopurified RBPs
(RIP-Chip) [209] defines targets at a transcriptome level, but its appli-
cation is limited to the characterization of kinetically stable interac-
tions and does not directly identify the RBP recognition element (RRE)
within the long target RNA. Nevertheless, RREs with higher informa-
tion content can be derived computationally from RIP-Chip data, e.g.
for HuR [43] or for Pumilio [76].
More direct RBP target site information is obtained by combining
in vivo UV crosslinking [81, 222] with immunoprecipitation [49, 149]
followed by the isolation of crosslinked RNA segments and cDNA se-
quencing (CLIP) [214]. CLIP was used to identify targets of the splicing
regulators NOVA1 [136], FOX2 [235] and SFRS1 [186] as well as U3
snoRNA and pre-rRNA [80], pri-miRNA targets for HNRNPA1 [87],
EIF2C2/AGO2 protein binding sites [38] and ALG-1 target sites in
C. elegans [241]. CLIP is limited by the low efficiency of UV 254 nm
RNA-protein crosslinking, and the location of the crosslink is not read-
ily identifiable within the sequenced crosslinked fragments, raising the
question of how to separate UV-crosslinked target RNA segments from
background non-crosslinked RNA fragments also present in the sam-
ple.
Here we describe an improved method for isolation of segments of
RNA bound by RBPs or RNPs, referred to as PAR-CLIP (Photoactivatable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation). To
facilitate crosslinking, we incorporated 4-thiouridine (4SU) into tran-
scripts of cultured cells and identified precisely the RBP binding sites
by scoring for thymidine (T) to cytidine (C) transitions in the sequenced
cDNA. We uncovered tens of thousands of binding sites for several
important RBPs and RNPs and assessed the regulatory impact of bind-
ing on their targets. These findings underscore the complexity of post-
transcriptional regulation of cellular systems.
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4.2 results
4.2.1 Photoactivatable nucleosides facilitate RNA-RBP crosslinking in cul-
tured cells
Random or site-specific incorporation of photoactivatable nucleoside
analogs into RNA in vitro has been used to probe RBP- and RNP-
RNA interactions [121, 152]. Several of these photoactivatable nucle-
osides are readily taken up by cells without apparent toxicity and
have been used for in vivo crosslinking [65]. We applied a subset of
these nucleoside analogs (Figure 11A) to cultured cells expressing the
FLAG/HA-tagged RBP IGF2BP1 followed by UV 365 nm irradiation.
The crosslinked RNA-protein complexes were isolated by immunopre-
cipitation, and the covalently bound RNA was partially digested with
RNase T1 and radiolabeled. Separation of the radiolabeled RNPs by
SDS-PAGE indicated that 4SU-containing RNA crosslinked most effi-
ciently to IGF2BP1. Compared to conventional UV 254 nm crosslink-
ing, the photoactivatable nucleosides improved RNA recovery 100- to
1000-fold, using the same amount of radiation energy (Figure 11B). We
refer to our method as PAR-CLIP (Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation) (Figure 11C).
We evaluated the cytotoxic effects upon exposure of HEK293 cells
to 100 µM and 1 mM of 4SU or 6SG in tissue culture medium over a
period of 12 h by mRNA microarrays. The mRNA profiles of 4SU or
6SG treated cells were very similar to those of untreated cells (Table S1),
suggesting that the conditions for endogenous labeling of transcripts
were not toxic.
To guide the development of bioinformatic methods for identifica-
tion of binding sites, we first studied human Pumilio 2 (PUM2), a
member of the Puf-protein family (Figure 12A) known for its highly
sequence-specific RNA binding [224].
4.2.2 Identification of PUM2 mRNA targets and its RRE
PUM2 protein crosslinked well to 4SU-labeled cellular transcripts (Fig-
ure 12B). The crosslinked segments were converted into a cDNA li-
brary and Solexa sequenced [89]. The sequence reads were aligned
against the human genome and EST databases. Reads mapping uniquely
to the genome with up to one mismatch, insertion or deletion were
used to build clusters of sequence reads (Figure 12C, Supplementary
Methods, and Table S2). We obtained 7,523 clusters originating from
about 3,000 unique transcripts, 93% of which were found within the
3’ untranslated region (UTR) (Figure 53) in agreement with previous
studies [230]. All sequence clusters with mapping and annotation in-
formation are available online1.
PhyloGibbs analysis [197] of the top 100 most abundantly sequenced
clusters (Table S3), as expected, yielded the PUM2 RRE, UGUANAUA [73]
(Figure 12D). Unexpectedly, over 70% of all sequence reads that gave
rise to clusters showed a T to C mutation compared to the genome (Fig-
ure 53). Ranking of sequence read clusters according to the frequency
of T to C mutation further enriched for the PUM2 RRE (Figure 53) in-
dicating that the T to C mutation is diagnostic of sequences interacting
with the RBP. The T to C changes were not randomly distributed: the
1 http://www.mirz.unibas.ch/restricted/clipdata/RESULTS/index.html
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Figure 11: PAR-CLIP methodology (A) Structure of photoactivatable nucleo-
sides (B) Phosphorimages of SDS-gels that resolved 5’-32P-labeled
RNA-FLAG/HA-IGF2BP1 immunoprecipitates (IPs) prepared from
lysates from cells that were cultured in media in the absence or
presence of 100 µM photoactivatable nucleoside and crosslinked
with UV 365 nm. For comparison, a sample prepared from cells
crosslinked with UV 254 nm, was included. Lower panels show
immunoblots probed with an anti-HA antibody. (C) Illustration of
PAR-CLIP. 4SU-labeled transcripts were crosslinked to RBPs and
partially RNase-digested RNA-protein complexes were immunop-
urified and size-fractionated. RNA molecules were recovered and
converted into a cDNA library and deep sequenced.
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Figure 12: RNA recognition by PUM2 protein (A) Domain structure of PUM2
protein. (B) Phosphorimage of SDS-gel of radiolabeled FLAG/HA-
PUM2-RNA complexes from non-irradiated or UV-irradiated 4SU-
labeled cells. The lower panel shows an anti-HA immunoblot. (C)
Alignments of PAR-CLIP cDNA sequence reads to corresponding
regions in the 3’UTR of ELF1 and HES1 Refseq transcripts. The
number of sequence reads (# reads) and mismatches (errors) are
indicated. Red bars indicate the PUM2 recognition motif and red-
letter nucleotides indicate T to C sequence changes. (D) Sequence
logo of the PUM2 recognition motif generated by PhyloGibbs analy-
sis of the top 100 sequence read clusters. (E) T to C positional muta-
tion frequency for PAR-CLIP clusters anchored at the 8-nt recogni-
tion motif from all motif-containing clusters (Table S3). The dashed
line represents the average T to C mutation frequency within these
clusters. See also Figure 53.
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T corresponding to U7 of the RRE mutated at higher frequency com-
pared to the Ts corresponding to U1 and U3 (Figure 12E). Our analyses
suggest that the reverse transcriptase specifically misincorporated dG
across from crosslinked 4SU residues and that local amino acid envi-
ronment also affected crosslinking efficiency. Uridines proximal to the
RRE also exhibited an increased T to C mutation frequency, indicating
that crosslinks also form in close proximity to an RRE and that our
method even captured PUM2 binding sites that did not have a U7 in
its RRE.
4.2.3 Identification of QKI RNA targets and its RRE
To further validate our method, we applied it to the RBP Quaking
(QKI), which contains a single heterogeneous nuclear ribonucleopro-
tein K homology (KH) domain (Figures 13A,B). The RRE ACUAAY
was determined by SELEX [71], but in vivo targets are largely un-
defined. Mice with reduced expression of QKI show dysmyelination
and develop rapid tremors or "quaking" 10 days after birth. Previous
studies suggested that QKI participates in pre-mRNA splicing, mRNA
export, mRNA stability and protein translation [36].
PhyloGibbs analysis of the 100 most abundantly sequenced clusters
(Table S3) yielded the RRE AYUAAY (Figures 13C,D), similar to a mo-
tif identified by SELEX [71]. We found approx. 6,000 clusters mapping
to 2,500 transcripts. Close to 75% of these clusters were derived from
intronic sequences, supporting the hypothesis that QKI is a splicing
regulator (Chenard and Richard, 2008) and 70% of the remaining ex-
onic clusters fall into 3’UTRs (Figure 54).
Mutation analysis of the clustered sequence reads showed that the T
corresponding to U2 in AUUAAY was frequently altered to C whereas
the T corresponding to U3 in AUUAAY or ACUAAY remained unal-
tered (Figure 13E). Crosslinking of 4SU residues located in immediate
vicinity to the RRE was mostly responsible for exposing the motif with
C2, showing that crosslinking inside the recognition element is not a
precondition for its identification. Hence, the discovery of RREs is un-
likely to be prevented by sequence-dependent crosslinking biases as
long as deep enough sequencing captures these interaction sites at and
nearby the RRE.
4.2.4 T to C mutations occur at the crosslinking sites
To better characterize the T to C transition observed in crosslinked
RNA segments, we UV 365 nm crosslinked oligoribonucleotides con-
taining single 4SU substitutions to recombinant QKI (Figures 13F,G).
The crosslinking efficiency varied 50-fold and mirrored the results of
the mutational analysis (Figure 13G). The least effective crosslinking
was observed for placement of 4SU at position 3 of the QKI RRE
(4SU9), and the most effective crosslinking was found at position 2
of the QKI RRE (4SU10); the crosslinking efficiency for two positions
outside of the RRE (4SU2 and 4SU4) was intermediate. Neither of these
substitutions affected RNA-binding to recombinant QKI protein as de-
termined by gel-shift analysis, whereas mutations of the recognition
element weakened the binding between 2.5- and 9-fold (Table S1).
Next, we sequenced libraries prepared from non-crosslinked as well
as QKI-protein-crosslinked oligoribonucleotides containing 4SU at in-
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Figure 13: RNA recognition by QKI protein (A) Domain structure of QKI
protein (B) Phosphorimage of SDS-gel resolving radiolabeled RNA
crosslinked to FLAG/HA-QKI IPs from non-irradiated or UV-
irradiated 4SU-labeled cells. The lower panel shows the anti-HA
immunoblot. (C) Alignments of PAR-CLIP cDNA sequence reads
to the corresponding regions in the 3’UTRs of the CTNNB1 and
HOXD13 transcripts. Red bars indicate the QKI recognition motif
and red-letter nucleotides indicate T to C sequence changes. (D) Se-
quence logo of the QKI recognition motif generated by PhyloGibbs
analysis of the top 100 sequence read clusters. (E) T to C posi-
tional mutation frequency for PAR-CLIP clusters anchored at the
AUUAAY (left panel) and ACUAAY (right panel) RRE (Table S3); Y
= U or C. The dashed line represents the average T to C mutation fre-
quency within these clusters. (F) Sequences of synthetic 4SU-labeled
oligoribonucleotides with QKI recognition motifs, derived from a se-
quence read cluster aligning to the 3’UTR of HOXD13 shown in (C)
4SU-modified residues are underlined. (G) Phosphorimage of SDS-
gel resolving recombinant QKI protein after crosslinking to radi-
olabeled synthetic oligoribonucleotides shown in (F). (H) Stabiliza-
tion of QKI-bound transcripts upon siRNA knockdown. Changes in
mRNA levels upon QKI knockdown by two distinct siRNAs were
measured by microarray analysis. Shown are the distributions of
changes upon siRNA transfection for transcripts that did (dashed
lines) or did not (solid lines) contain QKI PAR-CLIP clusters. See
also Figure 54.
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dicated positions (Figure 13F). The fraction of sequence reads with T to
C changes obtained from non-irradiated 4SU-containing oligoribonu-
cleotides varied between 10 and 20%, and increased to 50 to 80% upon
crosslinking (Table S1). The variation of the degree of T to C changes
in the crosslinked samples is most likely determined by background
of non-crosslinked oligoribonucleotides. Presumably, the T to C transi-
tion frequency is increased upon crosslinking as a direct consequence
of a chemical structure change of the 4SU nucleobase upon crosslink-
ing to protein amino acid side chains, resulting in altered stacking or
hydrogen bond donor/acceptor properties directing the preferential
incorporation of dG rather than dA during reverse transcription (Fig-
ure 53). At the doses of 4SU applied to cultured cells, about 1 out of 40
uridines was substituted by 4SU as determined by HPLC analysis of
the nucleoside composition of total RNA. Assuming a 20% T to C con-
version rate for a non-crosslinked 4SU-labeled site, we estimated that
the average T to C conversion rate of 40-nt sequence reads derived
from background non-crosslinked sequences will be near 5%. Clusters
of sequence reads with average T to C conversion above this threshold,
irrespective of the number of sequence reads, most certainly represent
crosslinking sites. The ability to separate signal from noise by focusing
on clusters with a high frequency of T to C mutations rather than clus-
ters with the largest number of reads, represents a major enhancement
of our method over UV 254 nm crosslinking methods.
To assess whether the transcripts identified by PAR-CLIP are reg-
ulated by QKI, we analyzed the mRNA levels of mock-transfected
and QKI-specific siRNA-transfected cells with microarrays. Transcripts
crosslinked to QKI were significantly upregulated upon siRNA trans-
fection, indicating that QKI negatively regulates bound mRNAs (Fig-
ure 13H), consistent with previous reports of QKI being a repressor [36].
4.2.5 Identification of IGF2BP family RNA targets and its RRE
We then applied PAR-CLIP to the FLAG/HA-tagged insulin-like growth
factor 2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1-3) (Figures 14A,B),
a family of highly conserved proteins that play a role in cell polar-
ity and cell proliferation [237]. These proteins are predominantly ex-
pressed in the embryo and regulate mRNA stability, transport and
translation. They are re-expressed in various cancers [22, 45] and IGF2BP2
has been associated with type-2 diabetes [187]. The IGF2BPs are highly
similar and contain six canonical RNA-binding domains, two RNA
recognition motifs (RRMs) and four KH domains (Figure 14A). There-
fore, target recognition for this protein family appears complex, with
only a small number of coding and non-coding RNA targets being
known so far. A precise definition of the RREs is missing [237].
The three IGF2BPs recognized a highly similar set of target tran-
scripts (Table S1), suggesting similar and redundant functions. Phy-
loGibbs analysis of the clusters derived from mRNAs (Figure 14C and
Table S3) yielded the sequence CAUH (H=A, U, or C) as the only con-
sensus recognition element (Figure 14D), contained in more than 75%
of the top 1000 clusters for IGF2BP1, 2 or 3 (Figure 55). In total, we
identified over 100,000 sequence clusters recognized by the IGF2BP
family that map to about 8,400 protein-coding transcripts. The annota-
tion of the clusters was predominantly exonic (ca. 90%) with a slight
preference for 3’UTR relative to coding sequence (CDS) (Figure 55).
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Figure 14: RNA recognition by the IGF2BP protein family (A) Domain struc-
ture of IGF2BP1-3 proteins. (B) Phosphorimage of an SDS-gel re-
solving radiolabeled RNA crosslinked to FLAG/HA-IGF2BP1-3 IPs.
The lower panel shows anti-HA immunoblots. (C) Alignments of
IGF2BP1 PAR-CLIP cDNA sequence reads to the corresponding re-
gions of the 3’UTRs of EEF2 and MRPL9 transcripts. Red bars in-
dicate the 4-nt IGF2BP1 recognition motif and nucleotides marked
in red indicate T to C sequence changes. (D) Sequence logo of the
IGF2BP1-3 RRE generated by PhyloGibbs analysis of the top 100
sequence read clusters. (E) T to C positional mutation frequency
for PAR-CLIP clusters anchored at the 4-nt recognition motif from
all motif-containing clusters (Table S3). The dashed line represents
the average T to C mutation frequency within these clusters. (F)
Phosphorimage of native PAGE resolving complexes of recombi-
nant IGF2BP2 protein with wild-type (left panel) and mutated tar-
get oligoribonucleotide (right panel). Sequences and dissociation
constants (Kd) are indicated. (G) Destabilization of IGF2BP-bound
transcripts upon siRNA knockdown of IGF2BP1, 2, and 3. Distri-
butions of transcript level changes for IGF2BP1-3 PAR-CLIP target
transcripts versus non-targeted transcripts are shown. See also Fig-
ures 55 and 56.
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The mutation frequency of all sequence tags containing the element
CAUH (H = A, C, or U) showed that the crosslinked residue was posi-
tioned inside the motif, or in the immediate vicinity (Figure 14E). The
consensus motif CAUH was found in more than 75% of the top 1000
targeted transcripts, followed in more than 30% by a second motif, pre-
dominantly within a distance of three to five nucleotides (Figure 55).
In vitro binding assays showed that nucleotide changes of the CAUH
motif decreased, but did not abolish the binding affinity (Figure 14F
and Table S1).
To test the influence of IGF2BPs on the stability of their interacting
mRNAs, as reported previously for some targets [237], we simultane-
ously depleted all three IGF2BP family members using siRNAs and
compared the cellular RNA from knockdown and mock-transfected
cells on microarrays. The levels of transcripts identified by PAR-CLIP
decreased in IGF2BP-depleted cells, indicating that IGF2BP proteins
stabilize their target mRNAs. Moreover, transcripts that yielded clus-
ters with the highest T to C mutation frequency were most destabi-
lized (Figure 14G), indicating that the ranking criterion that we de-
rived based on the analysis of PUM2 and QKI data generalizes to other
RBPs.
For comparison to conventional and high-throughput sequencing
CLIP [136, 214], we also sequenced cDNA libraries prepared from UV
254 nm crosslinking. Of the 8,226 clusters identified by UV 254 nm
crosslinking of IGF2BP1, 4,795 were found in the PAR-CLIP dataset.
Although UV 254 nm crosslinking identified the identical segments of
a target RNA as PAR-CLIP, the position of the crosslink could not be
readily deduced, because no abundant diagnostic mutation was ob-
served (Figure 56).
4.2.6 Identification of miRNA targets by AGO and TNRC6 family PAR-
CLIP
To test our approach on RNP complexes, we selected the protein com-
ponents mediating miRNA-guided target RNA recognition. In animal
cells, miRNAs recognize their target mRNAs through base-pairing in-
teractions involving mostly 6-8 nucleotides at the 5’ end of the miRNA
(the so called “seed”) [13]. Target sites were thought to be predomi-
nantly located in the 3’UTRs of mRNAs, and computational miRNA
target prediction methods frequently resort to identification of evolu-
tionarily conserved sites that are located in 3’UTRs and are comple-
mentary to miRNA seed regions [13, 175]. We isolated mRNA frag-
ments bound by miRNPs from HEK293 cell lines stably expressing
FLAG/HA-tagged AGO or TNRC6 family proteins [130]. The AGO
IPs revealed two prominent RNA-crosslinked bands of 100 and 200
kDa, representing AGO, and likely TNRC6 and/or DICER1 protein.
The TNRC6 IPs showed one prominent RNA-crosslinked protein of
200 kDa (Figure 15A).
From clusters (Figure 15B) formed by at least 5 PAR-CLIP sequence
reads and containing more than 20% T to C transitions (Table S2), we
extracted 41 nt long regions centered over the predominant T to C tran-
sition or crosslinking site. The length of the crosslink-centered regions
(CCRs) was selected to include all possible registers of miRNA/target-
RNA pairing interactions relative to the crosslinking site.
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Figure 15: AGO protein family and TNRC6 family PAR-CLIP (A) Phos-
phorimage of SDS-gels resolving radiolabeled RNA crosslinked to
the FLAG/HA-AGO1-4 and FLAG/HA-TNRC6A-C IPs. The lower
panel shows the immunoblot with an anti-HA antibody. (B) Align-
ment of AGO PAR-CLIP cDNA sequence reads to the correspond-
ing regions of the 3’UTRs of PAG1 and OGT. Red bars indicate
the 8-nt miR-103 seed complementary sequence and nucleotides
marked in red indicate T to C mutations. (C) miRNA profiles
from RNA isolated from untreated HEK293 cells, non-crosslinked
FLAG/HA-AGO1-4 IPs, and combined AGO1-4 PAR-CLIP libraries.
The color code represents relative frequencies determined by se-
quencing. miRNAs indicated in red were inhibited by antisense
oligonucleotides for the transcriptome-wide characterization of the
destabilization effect of miRNA binding. (D) T to C positional mu-
tation frequency for miRNA sequence reads is shown in black, and
the normalized frequency of occurrence of uridines within miRNAs
is shown in red. The dashed red line represents the normalized
mean U frequency in miRNAs. See also Figure 57.
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PAR-CLIP of individual AGO proteins yielded on average about
4,000 clusters that overlapped, supporting our earlier observation that
AGO1-4 bound similar sets of transcripts [130]. We therefore combined
the sequence reads obtained from all AGO experiments, which yielded
17,319 clusters of sequence reads at a cut-off of 5 reads (Table S4). These
clusters distributed across 4,647 transcripts with defined GeneIDs, cor-
responding to 21% of the 22,466 unique HEK293 transcripts that we
identified by digital gene expression (DGE).
PAR-CLIP of individual TNRC6 proteins yielded on average about
600 clusters that also overlapped substantially, again consistent with
our observation that TNRC6 family proteins bind similar transcripts [130].
We therefore combined all sequence reads from all TNRC6 experi-
ments, yielding 1,865 clusters and CCRs (Table S4). More than 50%
of these TNRC6 CCRs fell within 25 nt of an AGO CCR, and 26% over-
lapped by at least 75%, indicating that AGO and TNRC6 members
bind to the same sites (Figure 57).
4.2.7 Comparison of miRNA profiles from AGO PAR-CLIP to non-crosslinked
miRNA profiles
To relate the potential miRNA-target-siteâcontaining CCRs to the en-
dogenously expressed miRNAs, we determined the miRNA profiles
from total RNA isolated from HEK293 cells, and miRNAs isolated
from non-crosslinked AGO1-4 IPs by Solexa sequencing [89], and com-
pared them to the profile from the miRNAs present in the combined
AGO1-4 PAR-CLIP library. miRNA profiles obtained from total RNA
and IP of the four AGO proteins in non-crosslinked cells correlated
well (Figure 15C and Table S5) supporting our observation that AGO1-
4 bind the same targets [130]. The most abundant among the 557 iden-
tified miRNAs and miRNAs* were miR-103 (7% of miRNA sequence
reads), miR-93 (6.5%), and miR-19b (5.5%). The 25 and 100 most abun-
dant miRNAs accounted for 72% and 95% of the total of miRNA se-
quence reads, respectively. Comparison of the miRNA profile derived
from the combined AGO PAR-CLIP library with the combined non-
crosslinked libraries showed a good correlation (Spearman correlation
coefficient of 0.56, Figure 15C and Figure 57A).
Importantly, in the AGO PAR-CLIP library, the majority of miRNA
sequence reads derived from prototypical miRNAs [129] displayed T
to C conversion near or above 50%. The T to C conversion was predom-
inantly concentrated within positions 8 to 13 (Figure 15D), residing in
the unpaired regions of the AGO protein ternary complex [227]. Five
of the 100 most abundant miRNAs in HEK293 cells lack uridines at
position 8-13, yet only 2 of those miRNAs, miR-374a and b, showed
no crosslinking, because uridines at residues 14 and higher can still
be crosslinked (Table S5). This frequency of crosslinks was substan-
tially lower in the miRNAs whose expression did not correlate between
AGO-IP and AGO PAR-CLIP samples compared to the miRNAs whose
expression correlated well (Figure 57).
4.2.8 mRNAs interacting with AGOs contain miRNA seed complementary
sequences
Independent of any pairing models for miRNAs and their targets, we
first determined the enrichment of all 16,384 possible 7-mers within the
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Figure 16: AGO PAR-CLIP identifies miRNA seed-complementary sequences
in HEK293 cells. (A) Representation of the 10 most significantly en-
riched 7-mer sequences within PAR-CLIP CCRs. T/C indicates the
predominant T to C transition within clusters of sequence reads. (B)
T to C positional mutation frequency for clusters of sequence reads
anchored at the 7-mer seed complementary sequence (pos. 2-8 of
the miRNA) from all clusters containing seed-complementary se-
quences to any of the top 100 expressed miRNAs in HEK293 cells.
The dashed line represents the average T to C mutation frequency
within the clusters. (C) Identification of 4-nt base-pairing regions
contributing to miRNA target recognition. CCRs with at least one
7-mer seed complementary region to one of the top 100 expressed
miRNAs were selected. The number of 4-nt contiguous matches in
the CCRs relative to the 5’ end of the matching miRNA was counted.
(D) Analysis of the positional distribution of CCRs. The number of
clusters annotated as derived from the 5’UTR, CDS or 3’UTR of tar-
get transcripts is shown (green bars). Yellow bars show the expected
location distribution of the crosslinked regions if the AGO proteins
bound without regional preference to the target transcript. See also
Figure 58.
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17,319 AGO CCRs, relative to random sequences with the same dinu-
cleotide composition. The most significantly enriched 7-mers, except
for a run of uridines, corresponded to the reverse complement of the
seed region (position 2-8) of the most abundant HEK293 miRNAs, and
they were most frequently positioned 1-2 nt downstream of the pre-
dominant crosslinking site within the CCRs (Figure 16A). This places
the crosslinking site near the centre of the AGO-miRNA-target-RNA
ternary complex, where the target RNA is proximal to the Piwi/R-
Nase H domain of the AGO protein [227]. The polyuridine motif lies
within the region of target RNA that may be able to basepair with the
3’ half of miRNA loaded into AGO proteins [227, 228]. Therefore, these
stretches of uridine may contribute directly to miRNA-target RNA hy-
bridization or, as has been suggested previously, they may represent
an independent determinant of miRNA targeting specificity [83, 95].
To further examine the positional dependence of target RNA crosslink-
ing, we aligned the CCRs containing 7-mer seed complements to the
100 most abundant miRNAs and plotted the position-dependent fre-
quency of finding a crosslinked position (Figure 16B). This identified
two additional crosslinking regions, which correspond to the unpaired
5’ and 3’ ends of the target RNA exiting from the AGO ternary com-
plex, indicating that the window size of 41 nt centered on the predom-
inant crosslink position always included the miRNA-complementary
sites.
We then computed the number of occurrences of miRNA-complementary
sequences of various lengths in the CCRs and calculated their enrich-
ment (Table S6). The most significant enrichment was generally ob-
tained with 8-mers that were complementary to miRNA seed regions
(pos. 1-8). Inspection of the region between 3 nt upstream and 9 nt
downstream of the predominant crosslinking site reveals that approx-
imately 50% of the CCRs contain 6-mers corresponding to one of the
top 100 expressed miRNAs (Figure 57), with a 1.5-fold enrichment over
random 6-mers. Given that 6-mers still showed some degree of excess
conservation in comparative genomics studies [70, 135] (Table S6) and
that our analysis was focused on a narrow window directly down-
stream of the crosslinking site, our results suggest that the majority of
the CCRs represent bona fide miRNA binding sites. Furthermore, the
number of miRNA seed complements for all known miRNAs corre-
lated well with the expression levels of miRNAs found in HEK293 cells,
and less well with miRNA profiles of other tissue samples (Figure 58B).
The nucleotide composition of CCRs that contained at least one 7-mer
seed complementary to one of the top 100 expressed miRNA showed a
slightly elevated U-content (approx. 30% U) compared to those CCRs
not containing seed matches (Figure 58C), which was expected from
previous bioinformatic analyses of functional miRNA-binding sites.
4.2.9 Non-canonical and 3’end pairing of miRNAs to their mRNA targets
is limited
Structural and biochemical studies of the ternary complex of T. ther-
mophilus Ago, guide and target indicated that small bulges and mis-
matches could be accommodated in the seed pairing region within
the target RNA strand [227]. We therefore searched for putative tar-
get RNA binding sites that did not conform to the model of perfect
miRNA seed pairing, but rather contained a discontinuous segment
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of sequence complementarity to either target or miRNA with a mini-
mum of 6 base pairs. We only considered pairing patterns if they were
significantly enriched in CCRs compared to dinucleotide randomized
sequences, and if the CCRs containing them did not at the same time
contain perfectly pairing seed-type sites. We identified 891 CCRs with
mismatches and 256 with bulges in the seed region (Table S7). Mis-
matches occurred most frequently across from position 5 of the miRNA
as G-U or U-G wobbles, U-U mismatches and A-G mismatches (A re-
siding in the miRNA). Therefore, it appears that only a small fraction
of the miRNA target sites that we isolated (less than 6.6%), contained
bulges or loops in the seed region.
To assess the role of auxiliary base pairing outside of the seed region,
we selected CCRs that contained a 7-mer seed match to one of the 100
most abundant miRNAs. Supporting earlier computational results [83],
we also detected a weak signal for contiguous 4-nt long matches to
positions 13-15 of the miRNA (Figure 16C).
4.2.10 miRNA binding sites in CDS and 3’UTR destabilize target mRNAs
to different degrees
The majority (84%) of AGO CCRs originated in exonic regions, with
only 14% from intronic, and 2% from undefined regions. Of the exonic
CCRs, 4% corresponded to 5’UTRs, 50% to CDS, and 46% to 3’UTRs
(Figure 16D).
Evidence of widespread binding of miRNAs to the CDS was re-
ported before [52, 135]. However, miRNAs are believed to predomi-
nantly act on 3’UTRs [13], with relatively few reports providing exper-
imental evidence for miRNA-binding to individual 5’UTRs or CDS [52,
67, 145, 165, 208]. To obtain evidence that AGO CCRs indeed contain
functional miRNA-binding sites, we blocked 25 of the most abundant
miRNAs in HEK293 cells (Figure 15C) by transfection of a cocktail of 2’-
O-methyl-modified antisense oligoribonucleotides and monitored the
changes in mRNA stability by microarrays (Figure 17A). Consistent
with previous studies of individual miRNAs [83], the magnitude of
the destabilization effects of transcripts containing at least one CCR de-
pended on the length of the seed-complementary region and dropped
from 9-mer to 8-mer to 7-mer to 6-mer matches (Figure 17B). We did
not find evidence for significant destabilization of transcripts that only
contained imperfectly paired seed regions.
Next, we examined whether the change in stability of CCR-containing
transcripts correlated with the number of binding sites. We found that
multiple sites were more destabilizing compared to single sites (Fig-
ure 17C), and that multiple binding sites may also reside within a
single 41-nt CCR (Figure 58). Both of these findings are in agreement
with previous observations [83]. Then we analyzed the impact on sta-
bility for transcripts with CCRs exclusively present either in the CDS
or the 3’UTR; there were not enough transcripts to assess the impact of
CCRs derived from the 5’UTR. CDS-localized sites only marginally re-
duced mRNA stability (Figure 17D), independent of the extent of seed
pairing. To gain more insights into miRNA binding in the CDS, we
examined the codon adaptation index (CAI) [193] around crosslinked
seed matches, and found that the sequence environment of crosslinked
seed matches differed from that of non-crosslinked seed matches in
the CAI. The bias in codon usage extended for at least 70 codons up-
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Figure 17: Relationship between various features of miRNA/target RNA inter-
actions and mRNA stability (A) FLAG/HA-AGO2-tagged HEK293
cells were transfected with a cocktail of 25 2’-O-methyl modified an-
tisense oligoribonucleotides, inhibiting miRNAs marked in red in
Figure 15C, or mock transfected, followed by microarray analysis
of the change of mRNA expression levels. (B) Transcripts contain-
ing CCRs were categorized according to the presence of n-mer seed
complementary matches and the distributions of stability changes
upon miRNA inhibition are shown for these categories. (C) Tran-
scripts were categorized according to the number of CCRs they con-
tained. (D) Transcripts were categorized according to the positional
distribution of CCRs. Only transcripts containing CCRs exclusively
in the indicated region are used. (E) Codon adaptation index (CAI)
for transcripts containing 7-mer seed complementary regions (pos.
2-8) in the CDS for the miR-15, miR-19, miR-20, and let-7 miRNA
families. (F) LOESS regression of total transcript abundance in HEK
293 cells (log2 of sequence counts determined by digital gene ex-
pression (DGE)) against fold change of transcript abundance (log2)
determined by microarrays after transfection of the miRNA antago-
nist cocktail versus mock transfection of AGO-bound and unbound
transcripts. See also Figure 59.
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as well as downstream of the crosslinked seed matches (Figure 17E),
which also correlates well with the marked increase in the A/U con-
tent around the binding sites that would lead to a codon usage bias.
It was recently reported that miRNA regulation in the CDS was en-
hanced by inserting rare codons upstream of the miRNA-binding site,
presumably due to increased lifetime of miRNA-target-RNA interac-
tions as ribosomes are stalled [86]. These observations suggest that
transcripts with reduced translational efficiency form at least transient
miRNP complexes amenable to UV crosslinking.
The abundance of mRNAs expressed in HEK293 cells varied over
5 orders of magnitude as shown by DGE profiling. When we related
the expression level of CCR-containing transcripts with the magnitude
of transcript stabilization after miRNA inhibition, we found that miR-
NAs preferentially act on transcripts with low and medium expression
levels (Figure 17F). Highly expressed mRNAs appear to avoid miRNA
regulation [204], at least for those miRNAs expressed in HEK293 cells.
However, we cannot fully rule out that the weaker response of highly
abundant targets may be due to lower affinity and reduced occupancy
of miRNA binding sites in highly abundant transcripts.
Earlier studies defining miRNA target regulation were carried out by
transfection of miRNAs into cellular systems originally devoid of these
miRNAs [8, 138, 191]. We transfected miRNA duplexes corresponding
to the deeply conserved miR-7 and miR-124 into FLAG/HA-AGO2
cells, performed PAR-CLIP (Figure 59), and also recorded the effect
on mRNA stability upon miR-7 and miR-124 transfection by microar-
ray analysis. Transcripts containing miR-7- or miR-124-specific CCRs
were destabilized, especially when CCRs were located in the 3’UTR
(Figure 59).
4.2.11 Context-dependence of miRNA binding
Not every seed-complementary sequence in the HEK293 transcriptome
yielded a CCR, thereby providing an opportunity to identify sequence
context features specifically contributing to miRNA target binding and
crosslinking. For seed-complementary sites that were crosslinked and
those that were not crosslinked, we computed the evolutionary selec-
tion pressure by the ElMMo method [70], the mRNA stability scores by
TargetScan context score [83], and sequence composition and structure
measures for the regions around the miRNA seed complementary sites.
The feature that distinguished most crosslinked from non-crosslinked
seed matches was a 25% lower free energy required to resolve local
secondary structure involving the miRNA-binding region (Figure 59),
associated with a 6% increase in the A/U content within 100 nt around
the seed-pairing site. These differences were similar for sites located in
the CDS and 3’UTRs. Compared to non-crosslinked sites, crosslinked
sites are under stronger evolutionary selection (ElMMo) and in se-
quence contexts facilitating miRNA-dependent mRNA degradation (Tar-
getScan context score).
The location of AGO CCRs within transcript regions was non-random
and 7-mer or 8-mer sites within the 3’UTR were preferentially located
near the stop codon or the polyA tail in transcripts with relatively long
3’UTRs (more than 3 kb) (Figure 59). The location of CCRs in the CDS
was biased towards the stop codon for the transfected miR-7 and 124,
but not for the endogenous miRNAs (Figure 59).
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Finally, we wanted to examine how miRNA targets defined by PAR-
CLIP compared in regulation of target mRNA stability to those pre-
dicted by ElMMo [70], TargetScan context score [83], TargetScan Pct [69]
and PicTar [128]. In each case, we selected the same number of highest-
scoring sites containing a 7-mer seed-complement to the top 5 ex-
pressed miRNAs (let-7a, miR-103, miR-15a, miR-19a and miR-20a). The
analysis was limited to 3’UTR sites due to restriction by the prediction
methods. The effect on mRNA stability, as assessed by miRNA anti-
sense inhibition, was overall equivalent for transcripts harboring CCRs
compared to transcripts predicted by ElMMo, TargetScan context score,
TargetScan Pct and PicTar (Figure 59).
4.3 discussion
Maturation, localization, decay and translational regulation of mRNAs
involve formation of complexes of RBPs and RNPs with their RNA
targets [147, 156]. Several hundred RBPs are encoded in the human
genome, many of them containing combinations of RNA-binding do-
mains which are drawn from a relatively small repertoire, resulting
in diverse structural arrangements and different specificities of target
RNA recognition [143]. Furthermore hundreds of miRNAs function
together with AGO and TNRC6 proteins to destabilize target mRNAs
and/or repress their translation [13]. Collectively, these factors and
their presumably combinatorial action constitute the code for post-
transcriptional gene regulation. Here we describe an approach to di-
rectly identify transcriptome-wide mRNA-binding sites of regulatory
RBPs and RNPs in live cells.
4.3.1 PAR-CLIP allows high-resolution mapping of RBP and miRNA target
sites
We showed that application of photoactivatable nucleoside analogs to
live cells facilitates RNA-protein crosslinking and transcriptome-wide
identification of RBP and RNP binding sites. We concentrated on 4SU
after it became apparent that the crosslinking sites in isolated RNAs
were revealed upon sequencing by a prominent transition from T to C
in the cDNA prepared from the isolated RNA segments. Compared
to regular UV 254 nm crosslinking in the absence of photoactivat-
able nucleosides, our method has two distinct advantages. We obtain
higher yields of crosslinked RNAs using similar radiation intensities,
and more importantly, we can identify crosslinked regions by muta-
tional analysis. Studies using conventional UV 254 nm CLIP have not
reported the incidence of deletions and substitutions [38, 136, 214, 241],
except for recent work by Granneman et al. [80] on the U3 snoRNA
that showed an increase of deletions at the RBP binding site. Our own
analysis indicates that mutations in sequence reads derived from UV
254 nm CLIP were at least one order of magnitude less frequent than
T to C transitions observed in PAR-CLIP (Figure 55).
From an experimental perspective, it is important to note that crosslinked
RNA segments, irrespective of the methods of isolation, are always con-
taminated with non-crosslinked RNAs, as shown by consistent iden-
tification of rRNAs, tRNAs, and miRNAs (Table S2). Compared to
crosslinked RNA fragments, these unmodified RNA molecules are
more readily reverse transcribed, which underscores the need for sep-
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aration of crosslinked signal from non-crosslinked noise. We now pro-
vide a method that accomplishes this critical task.
4.3.2 Context dependence of 4SU crosslink sites
It is conceivable that binding sites located in peculiar sequence environ-
ments, e.g. those completely devoid of U, may exist and cannot be cap-
tured using 4SU-based crosslinking. However, such sites are extremely
rare. Only about 0.4% of 32-nt long sequence segments, representative
of the length of our Solexa sequence reads, are U-less, corresponding
to an occurrence of one such segment in every 8 kb of a transcript.
Nonetheless, to provide a means to resolve such unlikely situations,
we explored the use of other photoactivatable nucleosides, such as 6SG
to identify IGF2BP1 binding sites. We found a good correlation be-
tween the sequence reads obtained from a given gene with 4SU and
6SG (Pearson correlation coefficient 0.65, Table S1). Moreover, the se-
quence read clusters, representing individual binding sites, overlapped
strongly: 59% out of the 47,050 6SG clusters were also identified with
4SU, despite of the fact that the environment of IGF2BP1 binding sites
was strongly depleted for guanosine. Interestingly, the sequence reads
obtained after 6SG crosslinking were enriched for G to A transitions,
pointing to a structural change in 6SG analogous to the situation in
PAR-CLIP with 4SU. Because 6SG appears to have lower crosslinking
efficiency compared to 4SU, we recommend to first use 4SU and then
resort to 6SG when the data indicates that the sites of interest are lo-
cated in sequence contexts devoid of uridines. It is important to point
out that neither of these photoactivatable nucleotides appears to be
toxic under our recommended conditions.
4.3.3 miRNA target identification
When applying PAR-CLIP to isolate miRNA-binding sites, we were
surprised to find nearly 50% of the binding sites located in the CDS.
However, miRNA inhibition experiments showed that miRNA bind-
ing at these sites only caused small, yet significant mRNA destabiliza-
tion. In spite of the difference in their efficiency of triggering mRNA
degradation, CDS and 3’UTR sites appear to have similar sequence
and structure features. The sequence bias around CDS sites is associ-
ated with an increased incidence of rare codon usage, which could in
principle reduce translational rate, thereby providing an opportunity
for transient miRNP binding and regulation. Similar observations were
made previously using artificially designed reporter systems [86].
The use of the knowledge of the crosslinking site allowed us to nar-
rowly define the miRNA-binding regions for matching the site with
the most likely miRNA endogenously co-expressed with its targets,
and to assess non-canonical miRNA-binding modes. We were able
to explain the majority of PAR-CLIP binding sites by conventional
miRNA-mRNA seed-pairing interactions [83], yet found that about 6%
of miRNA target sites might best be explained by accepting bulges
or mismatches in the seed pairing region, similar to the interaction
between let-7 and its target lin-41 [221] and those recently observed
in biochemical and structural studies of T. thermophilus Ago pro-
tein [227, 228].
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4.3.4 The mRNA ribonucleoprotein (mRNP) code and its impact on gene
regulation
We were able to identify all of the crosslinkable RNA-binding sites
present in about 9,000 of the top-expressed mRNA in HEK293 cells
representing approximately 95% of the total mRNA molecules of a cell.
One of the surprising outcomes of our study was that each of the ex-
amined RBPs or miRNPs bound and presumably controlled between 5
and 30% of the more than 20,000 transcripts detectable in HEK293 cells.
These results demonstrate that a transcript will generally be bound
and regulated by multiple RBPs, the combination of which will de-
termine the final gene-specific regulatory outcome. Exhaustive high-
resolution mapping of RBP- and RNP-target-RNA interactions is crit-
ical, because it may lead to the discovery of specific combination of
sites (or modules) that may control distinct cellular processes and path-
ways. To gain further insights into the dynamics of mRNPs it will be
important to also map the sites of RNA-binding factors, such as heli-
cases, nucleases or polymerases, where the specificity determinants are
poorly understood. The precise identification of RNA interaction sites
will be extremely useful for interrogating the rapidly emerging data
on genetic variation between individuals and whether some of these
variations possibly contribute to complex genetic diseases by affecting
post-transcriptional gene regulation.
4.4 methods
4.4.1 PAR-CLIP
Human embryonic kidney (HEK) 293 cells stably expressing FLAG/HA-
tagged IGF2BP1-3, QKI, PUM2, AGO1-4, and TNRC6A-C [130] were
grown overnight in medium supplemented with 100 µM 4SU. Living
cells were irradiated with 365 nm UV light. Cells were harvested and
lysed in NP40 lysis buffer. The cleared cell lysates were treated with
RNase T1. FLAG/HA-tagged proteins were immunoprecipitated with
anti-FLAG antibodies bound to Protein G Dynabeads. RNase T1 was
added to the immunoprecipitate. Beads were washed and resuspended
in dephosphorylation buffer. Calf intestinal alkaline phosphatase was
added to dephosphorylate the RNA. Beads were washed and incu-
bated with polynucleotide kinase and radioactive ATP to label the
crosslinked RNA. The protein-RNA complexes were separated by SDS-
PAGE and electroeluted. The electroeluate was proteinase K digested.
The RNA was recovered by acidic phenol/chloroform extraction and
ethanol precipitation. The recovered RNA was turned into a cDNA li-
brary as described [89] and Solexa sequenced. The extracted sequence
reads were mapped to the human genome (hg18), human mRNAs and
miRNA precursor regions. For a more detailed description of the meth-
ods, see the Supplementary Material.
4.4.2 Oligonucleotide transfection and mRNA array analysis
siRNA, miRNA and 2’-O-methyl oligonucleotide transfections of HEK293
T-REx Flp-In cells were performed in 6-well format using Lipofec-
tamine RNAiMAX (Invitrogen) as described by the manufacturer. Total
RNA of transfected cells was extracted using TRIZOL following the in-
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structions of the manufacturer. The RNA was further purified using
the RNeasy purification kit (Qiagen). 2 µg of purified total RNA was
used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix)
according to manufacturer’s protocol. Biotinylated cRNA targets were
cleaned up, fragmented, and hybridized to Human Genome U133 Plus
2.0 Array (Affymetrix). For details of the analysis, see Bioinformatics
section in the Supplementary Material.
4.4.3 Generation of Digital Gene Expression (DGEX) libraries
1 µg each of total RNA from HEK293 cells inducibly expressing tagged
IGF2BP1 before and after induction was converted into cDNA libraries
for expression profiling by sequencing using the DpnII DGE kit (Illu-
mina) according to instructions of the manufacturer. For details of the
analysis, see Bioinformatics section in the Supplementary Material.
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5.1 introduction
Studies in both native expression [130] as well as transfection-induced
miRNA overexpression situations [138, 140] indicate that within a given
tissue, the miRNAs that are most strongly expressed have the largest
impact on mRNA targets. For this reason, deciphering the miRNA-
dependent post-transcriptional regulatory layer in a given tissue or
cell type needs to start from the miRNA expression profile of that
tissue or cell type. Conversely, it is very common that one identifies
differences in miRNA expression between cells at various stages of dif-
ferentiation or between normal and malignant cells, and the natural
question is what mRNAs are most likely to be affected by the change
in miRNA expression. To address these types of questions, we devel-
oped MirZ (www.mirz.unibas.ch), a web service that integrates two re-
sources that we developed in the context of previous research projects:
the smiRNAdb miRNA expression atlas [129], and the ElMMo miRNA
target prediction algorithm [70].
5.2 materials and methods
5.2.1 The smiRNAdb miRNA expression atlas
smiRNAdb [129] is a web-accessible and widely used resource of miRNA
profiles determined by sequencing from hundreds of Homo sapiens,
Mus musculus and Rattus norvegicus samples. The miRNA expression
profiling approach used by smiRNAdb is small RNA sequencing by
classical cloning and sequencing of size-separated small RNAs, which
was used to generate a large atlas of miRNA expression profiles [129].
This approach can be scaled up considerably through deep sequencing
technologies [15, 89, 90]. Microarray-based expression profiling is also
a popular approach, which has been used for instance to characterize
the miRNA expression cancer samples [142]. In contrast to sequenc-
ing, microarray-based profiling does not allow identification of novel
miRNAs.
The web interface of smiRNAdb features an extended repertoire of
on-line analyses such as visualization and hierarchical clustering of
miRNA expression profiles, principal component analysis, comparison
of miRNA expression between two (sets of) samples with the aim of
identifying the miRNAs whose expression differs most between the
samples. We used the Brenda tissue ontology [189, 11] as a guide in
organizing the samples such that the user can readily identify related
cell lineages or normal and pathological samples derived from a given
tissue type. Our tissue hierarchy has four levels: the organ/system
(e.g. hematopoietic system), subsystem (e.g. lymphoid lineage), cell
type (e.g. B cell), further cell type classification (e.g. B lymphocyte).
MiRNAs themselves can be analyzed independently, grouped by their
2-7 subsequence, or grouped in precursor clusters. Two miRNAs are
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placed in the same precursor cluster if their loci are within 50 kilobases
of each other in the genome, or if they share a mature form.
As an example, one may be interested in comparing miRNA expres-
sion between effector and naive human CD4+ T-lymphocytes. SmiR-
NAdb features a “Sample comparison” tool which was specifically
designed for the pairwise comparison of miRNA (sets of) samples.
The user would select to compare the sample named “hsa_T-cell-CD4-
effector” to the sample named “hsa_T-cell-CD4-naive”. Because the
naive CD4+ T cell sample and the effector CD4+ T cell sample dif-
fer widely in the total number of sequenced miRNAs (1374 vs 89),
the precision of the miRNA frequency estimates in the two samples
will also be very different. This situation is common in sequencing-
based datasets making the identification of miRNAs whose expression
is significantly different a non-trivial problem. At the heart of the tools
offered by smiRNAdb however, is a Bayesian model for computing
the posterior probability that the frequency of a miRNA in the total
miRNA population differs between two (sets of) samples. We compute
this probability assuming a binomial sampling model and integrating
over the unknown miRNA frequencies in the samples. This approach
— described in details in Berninger et al. [16] — takes into account both
the variability between sample sizes and the absolute miRNA counts.
Figure 18 shows the results of comparing the miRNA expression pro-
files of naive vs effector CD4+ cells. The names and sizes of the sam-
ples being compared are shown at the top of the page, followed by the
log-likelihood ratio log(Psame/Pdiff) of two models, one that assumes
that the frequencies of miRNAs are the same and one that assumes
that they can be different between the samples. The log-likelihood ra-
tio takes positive values when the miRNA frequencies are similar and
negative values when they are different. In this case, the log-likelihood
ratio is positive, indicating that overall, the frequencies of miRNAs in
these samples are more likely to have been the same. The list of miR-
NAs ranked from most dissimilar to most similar expression follows.
Each row contains the name of a miRNA, the direction of regulation
(up or down), the cloning counts and frequencies in both samples, and
provides a direct link to the predicted targets of the miRNA. The model
indicates that with a 18% vs 54% cloning frequency, and despite the
small size of the effector CD4+ T cell sample, miR-142-5p is very likely
to be down-regulated in effector cells. Again, this can be inferred from
the negative value of log(Psame/Pdiff) for miR-142-5p. From this page,
the user can select one or several miRNAs that came out differentially
expressed and can browse the list of predicted targets (figure 19). In
the case of miR-142-5p, the top 10 predicted targets include four tran-
scription factors (AFF4, ONECUT2, ZFPM2 and ZNF148), and a kinase
(PRPF4B) involved in pre-RNA splicing. These genes could provide a
starting point for experimental studies on the function of miR-142-5p
in T lymphocytes.
Since the original release of smiRNAdb, we have implemented an
additional tool for performing principal component analysis on the
miRNA expression profiles, we added more possibilities for the user to
download miRNA profile data for further processing, and we started
to incorporate other publicly available small RNA sequencing data sets
from Danio rerio, Drosophila melanogaster and Caenorhabditis elegans. We
reimplemented the software that was originally written in Perl CGI
to use Java Server Faces technology and Apache / Tomcat. The com-
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Figure 18: Screenshot of the web page showing the result from comparing
miRNA expression of human CD4+ effector T cells with the CD4+
naive T cells. Details are provided in the text.
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putations are now performed on a computing cluster, with job distri-
bution managed by the Sun Grid Engine queuing system. Finally, we
enhanced the result screens of our on-line analysis tools with hyper-
links which directly take the user to the miRNA target predictions
within the context of the smiRNAdb query, i.e. preserving the selected
organism, miRNAs, and tissue (if available). Please refer to the web
connectivity map in the supplementary material for an overview of
the new links between smiRNAdb and ElMMo, as well as of the exter-
nal ressources that we use in performing various analyses.
5.2.2 The ElMMo miRNA target prediction algorithm based on comparative
genomic analysis
To be able to address the question of what mRNA is most likely af-
fected by the change in expression of a miRNA, we coupled smiR-
NAdb to a PHP-based web interface to the ElMMo miRNA target pre-
dictions [70].
Returning to the example of the hsa-miR-142-5p miRNA which was
highlighted in section 5.2.1, the web interface allows aside from brows-
ing the predicted targets, a number of other queries. For instance,
given an organism (Homo sapiens in this example), the user can choose
to scan for predicted miRNA target sites not only the default set of
transcripts, which is all known RefSeq [172] mRNAs in the chosen
organism, but also subsets of transcripts. The SymAtlas project [205]
of the Genomics Institute of the Novartis Research Foundation (GNF)
generated microarray-based mRNA expression profiles for a wide range
of tissues. These profiles are incorporated in MirZ, giving the user the
possibility to restrict target prediction to mRNAs that are expressed in
a given cell type. The web interface further allows to scan an arbitrary
number of mRNAs for up to 20miRNAs simultaneously. Alternatively,
the user can limit the number of mRNAs to scan to 20 mRNAs and
then retrieve predicted target sites in these mRNAs for an arbitrary
number of miRNAs.
MiRNAs exert their effector function through ribonucleoprotein com-
plexes (miRNP) that contain, aside from the guiding miRNA a mem-
ber of the Argonaute family of proteins. The determinants of produc-
tive miRNA-target site interactions are not entirely known, but a large
body of work [127, 134, 47, 176, 135, 24] established that perfect com-
plementarity of the 7–8 nucleotides from the 5’ end of the miRNA
— the so-called miRNA “seed” — is critical for target recognition. Al-
though miRNA target sites that do not satisfy this constraint have
been described, at the genome-wide level the accuracy of predicting
such sites is low [135, 70]. Other than perfect seed complementarity,
the location of the putative target site within the 3’ UTR [70, 83, 146],
structural accessibility [141, 117, 207], the nucleotide composition in its
vicinity [83, 161] and the complementarity of specific positions in the
miRNA 3’ end to the target site [83] have all been reported to improve
the accuracy of miRNA target prediction, yet the relative importance of
these features was unknown until we performed the work described in
Chapter 3. Therefore, miRNA-mRNA association were obtained com-
putationally using the ElMMo miRNA target prediction method devel-
oped in the Zavolan lab, which is based on a Bayesian model that only
uses comparative genomics information [70]. Ongoing software devel-
opment efforts in the Zavolan lab aim at generalizing mirz to ClipZ,
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Figure 19: Screenshot of the web page showing the ElMMo miRNA target
predictions for miR-142-5p in all Homo sapiens RefSeq mRNAs. The
target predictions results are organized in two sections. The first
section — located on the upper part of the web page — is miRNA-
centric and features miRNA target predictions statistics as well
as a figure showing the smiRNAdb tissues where the miRNA is
mostly expressed. The second, mRNA-centric section is located on
the lower part of the web page and provides a ranked list of mRNA
predicted to be targeted by miR-142-5p.
which is a service that enables the exploration of miRNA - mRNA,
RNA binding protein - mRNA and miRNA profiles in an integrated
environment.
Going back to our example, figure 19 shows the ElMMo predictions
for miR-142-5p in Homo sapiens. This result screen is organized in two
sections: (1) a miRNA-centric summary featuring per-miRNA target
prediction statistics and a figure showing the smiRNAdb tissues where
the selected miRNAs are mostly expressed, and (2) a mRNA-centric
summary that ranks all mRNAs predicted to be targeted by the se-
lected miRNAs. In this later section, mRNAs are ordered by decreas-
ing expected number of miRNA target sites under selective pressure,
defined as the sum of all target site posterior probabilities for the se-
lected miRNAs. The location of the putative target sites in the 3’UTR
is also indicated.
From the result screen, the user has the possibility to zoom onto a
specific transcript to visualize the multiple genome alignments in the
72 an integrated microrna expression atlas and target prediction server
regions of the predicted target sites, and to find additional information
about the targeted mRNAs from the Genbank database of the National
Center for Biomedical Information (NCBI). Our web service also offers
the possibility to run a Gene Ontology (GO) analysis searching for
GO terms that are significantly over- or under-represented in the pre-
dicted miRNA targets through a modified version of the GeneMerge
software [32]. For instance, in the case of miR-142-5p, the most sig-
nificantly enriched Biological Process GO term is “regulation of tran-
scription, DNA-dependent” (hypergeometric p-value < 10−10, after
Bonferroni multiple testing correction), followed by two “muscarinic
acetylcholine receptor”-associated GO terms (p < 10−10). The mus-
carinic acetylcholine receptor has been shown to be involved in au-
tocrine control of cell proliferation, including the proliferation of im-
mune cells [55]. This type of analyses could thus provide experimental
scientists with clues to the function of miR-142-5p in the naive CD4+
T cells.
The current release of ElMMo features miRNA target predictions for
Homo sapiens, Mus musculus, Rattus norvegicus, Danio rerio, Caenorhabdi-
tis elegans and Drosophila melanogaster. Of these, the Mus musculus and
Rattus norvegicus predictions were not present in our initial publica-
tion [70]. Furthermore, for the remaining organisms, the current pre-
dictions are based on the genome sequences of a larger set of species,
because more fully-sequenced genomes became available since 2007.
We further based our predictions on the most recent mRNA sequences
and 3’UTR annotations provided by the RefSeq database [172]. Con-
cerning the microarray profiles that the user can use to guide miRNA
target discovery in specific tissues and aside from the Homo sapiens
profiles that were used in our original ElMMo release [70], we incor-
porated similar mRNA expression profiles for Mus musculus and Rat-
tus norvegicus. Finally, the ElMMo web interface now informs the user
about the smiRNAdb samples in which the selected miRNAs are most
strongly expressed.
5.2.3 Experimental data
The miRNA sequences that were used for miRNA sample annotation
and for miRNA target prediction were obtained from the miRBase re-
lease 12.0 [82]. For the miRNA profiles, MirZ includes a total of 297
samples: 173 for Homo sapiens [129], 88 for Mus musculus [129], 16 for
Rattus norvegicus [129], 10 for Drosophila melanogaster [6], 9 for Danio
rerio [35], and 1 for Caenorhabditis elegans [184].
For miRNA target predictions, we used the most recent genome as-
semblies available at the University of California Santa Cruz (UCSC) [111]:
hg18 for Homo sapiens, mm9 for Mus musculus, rn4 for Rattus norvegi-
cus, danRer5 for Danio rerio, ce6 for Caenorhabditis elegans and dm3 for
Drosophila melanogaster. We further used the following UCSC genome
assemblies in the pairwise genome alignments: panTro2, rheMac2, mm9,
rn4, canFam2, monDom4, bosTau4 and galGal3 for Homo sapiens; panTro2,
rheMac2, hg18, rn4, canFam2, monDom4, bosTau4 and galGal3 for
Mus musculus; panTro2, rheMac2, hg18, mm9, canFam2, monDom4,
bosTau3 and galGal3 for Rattus norvegicus; tetNig1, fr2 and oryLat2 for
Danio rerio; caeJap1, caePb2, caeRem3, cb3 and priPac1 for Caenorhabdi-
tis elegans; dp4, droAna3, droEre2, droGri2, droMoj3, droPer1, droSec1,
droSim1, droVir3, droWil1 and droYak2 for Drosophila melanogaster.
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mRNAs for all organisms were downloaded from the RefSeq database
on January 21st 2009.
The links between sequence entities in various databases was made
by mapping them all to the Gene database of NCBI [172]. MiRNA
expression profiles, microarray mRNA profiles and miRNA target pre-
dictions are stored as relational databases managed by a PostgreSQL
server (www.postgresql.org).
5.3 conclusion and future directions
Using a concrete example comparing effector to naive CD4+ T-cells, we
showed how MirZ can help isolating miRNAs that may be involved in
a given biological function, and then provide clues into which molec-
ular pathways may be controlled by these miRNAs to achieve their bi-
ological function. The integration of miRNA expression profiles with
genome-wide miRNA target prediction combined with the tools we
implemented — a Bayesian model for sample comparison, multivari-
ate exploratory statistics, GO-term enrichment analysis — makes MirZ
a powerful tool for studying miRNA-based regulation.
Since its publication, the miRNA expression atlas has been a valu-
able resource to the research community, and with the more general
availability of deep sequencing technologies, more miRNA expression
data sets are expected to emerge. Being able to explore and compare
these data sets in a unified framework is highly desirable, and we plan
to further support such analyses by updating MirZ as new data sets
become available. Particularly for Drosophila melanogaster, we currently
only incorporate small-sized samples, and for Caenorhabditis elegans a
whole-worm sample.
The target prediction methods also continue to evolve. In particular,
Chapter 3 examined what additional determinants of miRNA target-
ing specificity can be used to predict functional miRNA binding sites
with better accuracy. The predictions from the corresponding model
could be incorporated in our server in the future.
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M I C R O R N A - M E D I AT E D G E N E S I L E N C I N G AT T H E
M R N A A N D P R O T E I N L E V E L
6.1 introduction
The temporal aspects of miRNA regulation are critical in several do-
mains of biology. A canonical example is the control of lateral hypo-
dermal cell lineage by the let-7 miRNA during C. elegans develop-
ment [178]. In wild-type, let-7 expression is initiated at the L3 stage,
which results in the silencing of the lin-41 gene, which in turns stops
cell division. In the absence of let-7, the cells don’t differentiate. In-
stead, they keep deviding until they burst through the vulva. A bad
timing in let-7 regulation may therefore be lethal to C. elegans.
A second example where the temporal dynamics of miRNA regu-
lation are critical is the miRNA target identification problem, which
was extensively discussed in chapter 3. The discussion of this chapter
left one question unanswered. By analyzing measurements of changes
in protein and mRNA levels following miRNA transfection, we could
show that structural accessibility, the AU content of the target mRNA
and a few other properties characterize potent miRNA binding sites.
However, we were very surprised to find that the same properties
systematically failed to characterize miRNA binding sites that lead
to down-regulated protein levels. The cause of that inconsistency is
quite an enigma, because changes in protein levels should be the ulti-
mate read-out of miRNA regulation in the sense that any change at the
mRNA level should at least propagate down to the cognate protein, if
not be amplified by concordant diminution of the translation rate [99].
It has been proposed recently that miRNA mostly up-regulate mRNA
decay, leaving translation unchanged [88]. But even under this hypoth-
esis, one should observe that miRNA binding sites leading to down-
regulated protein levels have properties similar to miRNA binding-
sites leading to mRNA degradation and miRNA binding-sites under
evolutionary selective pressure.
One could argue that the measurements from proteomics experi-
ments are not accurate enough to measure miRNA action. But the
analysis suggests this is not the case, as there is statistical evidence that
proteins encoded by mRNAs carrying miRNA binding sites are down-
regulated following the over-expression of the cognate miRNA (see
Selbach et al. [191], Baek et al. [8] and Fig. 40). Another possible ex-
planation could be the sample size, which is around 8 times smaller
in a typical quantitative shotgun proteomics experiment compared to
state-of-the-art microarray data. However, testing for the hypothesis by
under-sampling microarray datasets suggests that this is unlikely to be
the case (Fig. 38) and that there has to be a more fundamental reason
as to why different miRNA apparently regulate different targets at the
mRNA and at the protein levels.
We therefore sought to understand the system better by taking a
closer look at the properties of functional miRNA binding sites in
proteomics experiments. As, miRNAs repress translation and turn up
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Figure 20: A six parameters – two state variables model of gene expression
regulation by miRNAs. M and P represent the mRNA and protein
concentration of a single gene respectively. Four parameters c, l,dM
and dP describe the transcription, translation, mRNA decay and
protein decay rates. The transcription and protein decay rates c and
dP are assumed to be left unchanged by a change in the miRNA
level, while the mRNA decay and translation rates dM and l are
changed by an amount ∆dM and ∆l. Such a model was previously
introduced by Khanin and Vinciotti [120].
mRNA decay, changes in protein levels are influenced by these two
mechanisms of action. Microarray data, on the other hand, focus on
the effect of miRNAs on mRNA decay.
Following a similar approach to Figure 8, where we proposed that
the binding of miRNAs to target sites depends mostly on structural
properties of the miRNA binding site while subsequent mRNA degra-
dation depends on sequence properties, we set to isolate the specific
effect of translation repression from measurements of changes in pro-
tein and mRNA levels, and subsequently, to characterize the properties
of miRNA binding sites that specifically cause translation repression.
To perform this analysis, we first developed a method to estimate
the changes in translation rates induced by a transfected miRNA from
the measured changes in protein and mRNAs levels.
6.2 a simple model to estimate mirna-induced changes
in translation rates
Figure 20 presents a coarse-grained ordinary differential equation model
of gene regulation by a miRNA. In the absence of the miRNA, this
models defines the dynamics of the concentration of one protein P
encoded by one mRNA M as:
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{
dM
dt = c− dMM
dP
dt = lM− dPP
The steady state of that system is: M∗ = cdMP∗ = lcdMdP
Setting M(0) =M0 and P(0) = P0, we can solve the system:
 M(t) =
c
dM
+
(
M0 −
c
dM
)
e−dMt
P(t) = lcdPdM +
l
dP−dM
(
M0 −
c
dM
)
e−dMt +
(
P0 −
l
dP−dM
(
M0 −
c
dP
))
e−dPt
Let us consider that at the beginning of the experiment t < 0, the
system is at steady state:
∀t < 0, (M(t),P(t)) = (M0,P0) =
(
c
dM
,
lc
dMdP
)
At time t = 0, the miRNA is transfected, which has the effect of
changing dM and l (see figure 20):{
dM 7→ dM +∆dM with ∆dM > 0
l 7→ l+∆l with ∆l 6 0
From t = 0 on, the system follows the new dynamics and evolves
towards the new steady state
(M(t∞),P(t∞)) =
(
c
dM +∆dM
,
(l+∆l)c
(dM +∆dM)dP
)
The microarray and shotgun proteomics experiments measure two
different log expression ratios.
From the microarray experiments, we obtain:
log
(
M(t∞)
M(0)
)
= log
(
dM
dM +∆dM
)
In other words, what the microarray really measures at steady-state is
the miRNA-induced relative change in mRNA-decay rate. For instance,
if the log2 fold change in mRNA level following the miRNA transfec-
tion is −1:
log2
(
M(t∞)
M(0)
)
= log2
(
dM
dM+∆dM
)
= −1
⇔ ∆dM = dM
That is, the miRNA caused the mRNA decay rate dM to double.
Similarly, the shotgun proteomics measures the log ratio:
log
(
P(t∞)
P(0)
)
= log
(
l+∆l
l
dM
dM+∆dM
)
= log
(
l+∆l
l
)
+ log
(
M(t∞)
M(0)
)
and so,
log
(
P(t∞)
P(0)
)
− log
(
M(t∞)
M(0)
)
= log
(
1+
∆l
l
)
(6.1)
78 a kinetic model of microrna-mediated gene silencing-1 0 1 2-3-2-1012 Change in mRNA levelChange in protein level all genes (r = 0.35)with seed (r = 0.43) regressiony = x -1 0 1 2-3-2-1012 Change in mRNA levelEstimated change in translation rate log(1 + Δ l/l) all genes (r = -0.45)with seed (r = -0.43) regressiony = -x
Figure 21: Effect of miR-124 transfection on mRNA and protein levels in a
SILAC experiment [8]. Left: correlating changes in mRNA level with
changes in the cognate protein levels for all mRNAs (r = .35) or
mRNAs with seed match (r = .43). The full red line represent the
first principal component of the scatter of all mRNAs with seed
match, while the dotted red line represents the y = x line. Right:
correlating changes in mRNA level with estimated changes in the
translation rate — i.e. log
(
1+ ∆ll
)
— under the model described in
section 6.2, for all mRNAs (r = −.45) or all mRNAs with seed match
(r = −.43). The full red line represents the first principal component
of the scatter of all mRNAs with seed match, while the dotted red
line represents the y = −x line.
In other words, assuming the measurements are performed at the new
steady state (t = t∞), subtracting the change at the protein level from
the change at the mRNA level estimates the miRNA-induced relative
change in the translation rate. In addition, we see that in this model, ob-
serving that the changes in mRNA level differ from changes in protein
level is evidence for miRNA-induced regulation of the mRNA transla-
tion rate (l).
6.2.1 Application to SILAC proteomics and transcriptomics data
The left panel of Figure 21 puts the model we just introduced in the
context of real proteomics and transcriptomics data, namely the joint
Stable Isotope Labeling with Aminoacids in cell Culture (SILAC) pro-
teomics and transcriptomics measurements following miRNA transfec-
tion of Baek et al. [8]. Such experiments measure changes in protein
levels 48h after miRNA transfection in HeLa cells, together with the
miRNA induced changes in mRNA levels 24h after miRNA transfec-
tion. As previously observed by Baek et al. [8], genes with seed match
to the transfected miRNA show decreased mRNA and protein levels,
which induces a positive correlation between changes in mRNA and
protein levels. These observations are consistent with miRNAs repress-
ing gene expression both at the protein and mRNA levels. The correla-
tion is slightly higher for genes with with seed matches (r = .43) than
for all measured genes (r = .35), consistent with a direct effect of miR-
6.2 a simple model to estimate mirna-induced changes in translation rates 79
NAs on the mRNA and protein levels of these target genes. Finally,
for genes with seed match, comparing the regression line (full red) to
the y = x line (dotted red), we see that changes in protein levels are
on average larger than changes in mRNA levels. Under the model’s
assumptions, this would reflect the fact that changes in protein levels
reflect miRNA-induced changes in the translation rate on top of the
effect at the mRNA level.
However, a closer look at the effect of the transfected miRNA on
the translation and degradation of the target mRNAs suggests that the
data is more complex.
The right panel of Figure 21 correlates changes in mRNA level to esti-
mated changes in translation rate upon miRNA transfection. Changes
in translation rates were estimated using the model introduced in sec-
tion 6.2, by subtracting changes in mRNA levels from changes in pro-
tein levels (equation 6.1). Because miRNAs have been shown to repress
translation and increase mRNA decay, one would expect changes in
translation rates to correlate positively with changes in mRNA levels
of miRNA target genes. On the other hand, we do not expect any cor-
relation between the changes in translation rate and the changes in
mRNA levels of genes that are not targeted by the miRNA, as those
should not be affected by the miRNA transfection. However, the right
panel of Figure 21 is in total disagreement with these expectations: es-
timated changes in translation rates correlate negatively with changes
in mRNA levels, as if the larger the drop in mRNA concentration, the
stronger the increase in translation rate. In addition, the correlation is
unexpectedly similar for genes with seed match (r = −.45) compared
to all genes (r = −.43). This would imply that when it comes to trans-
lation regulation, putative miRNA target genes are no different than
other genes.
6.2.2 Application to pulsed-SILAC proteomics and transcriptomics data
To gain more confidence in these observations, we repeated the analy-
sis using the proteomics and transcriptomics data from Selbach et al.
[191], who performed pulsed Stable Isotope Labeling with Aminoacids
in cell Culture (pSILAC). Very briefly, the experimental procedure dif-
fers from the SILAC experiments of Baek et al. [8] in that it measures
changes in the amounts of newly synthesized protein between 8h and
32h after miRNA transfection in HEK293 cells. In parallel, mRNA lev-
els were profiled by microarrays at 0h, 8h and 32h after miRNA trans-
fection. From these measurements, we obtained changes in mRNA lev-
els 32h after miRNA transfection.
The left panel of Figure 22 reveals a pattern similar to that of Fig-
ure 21. Putative target genes of the transfected miRNA show reduced
mRNA and protein levels, resulting in a positive correlation between
changes in mRNA and protein levels. In addition, this correlation is
higher for genes with seed match (r = .43) compared to all measured
genes (r = .19), possibly highlighting the direct regulatory effects of
the transfected miRNAs. However, contrary to Figure 21, changes in
protein levels are not larger than changes in mRNA levels on aver-
age, which is inconsistent with the prediction of our model. In addi-
tion, turning the right panel of Figure 22, we observe a strong nega-
tive correlation between the estimated changes in translation rate and
the changes in mRNA level instead of the expected positive correla-
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Figure 22: Effect of miR-155 transfection on the mRNA and protein levels in a
pSILAC experiment [191]. Left: correlating changes in mRNA level
with changes in the cognate protein levels for all mRNAs (r = .19)
or mRNAs with seed match (r = .43). The full red line represent
the first principal component of the scatter of all mRNAs with seed
match, while the dotted red line represents the y = x line. Right:
correlating changes in mRNA level with estimated changes in the
translation rate — i.e. log
(
1+ ∆ll
)
— under the model described in
section 6.2, for all mRNAs (r = −.85) or all mRNAs with seed match
(r = −.76). The full red line represents the first principal component
of the scatter of all mRNAs with seed match, while the dotted red
line represents the y = −x line.
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tion. This applies both to genes with seed matches and to the general
population of measured genes, similar to the right panel of Figure 21.
These observations also hold if we use matched time points, comparing
changes in mRNA levels between 8h and 32h after miRNA transfection
(not shown).
In conclusion, under the model presented in this section, changes in
protein and mRNA levels after miRNA transfection from both SILAC
and pSILAC experiments show fundamental inconsistencies with the
expectations of current miRNA biology. This then reflects on proper-
ties of functional miRNA binding sites that we inferred from these
datasets in Chapter 3 (see Figure 5). As this model is merely an at-
tempt to represent how miRNAs interfere with gene expression in the
most simple way, it appears important to propose an explanation to
the inconsistencies observed so far from the different analyses we have
performed.
6.3 mirna induced changes in gene expression are far
from steady-state in state-of-the-art proteomics mea-
surements
One possible explanation to these inconsistencies is prompted by the
observation that a minority of genes with seed match do appear to
have reduced translation and lower mRNA levels in response to the
miRNA transfection (Figures 21 and 22). It could therefore be that most
mRNAs harboring a seed match to the transfected miRNA are actually
not functional targets of the transfected miRNA. In other words, they
behave like genes without seed match and therefore, for most of them,
we expect changes in translation rates to be independent from changes
in mRNA decay rates.
Another explanation stems from the observation in the biochemical
literature that miRNAs trigger a rapid inhibition of translation initi-
ation, followed by slower deadenylation and decapping, which ulti-
mately lead to increased mRNA degradation [66, 62]. Could it be that
the time-scales of these two types of regulation have a strong influence
on the mRNA and protein levels of target genes in these experiments,
and that the precise kinetics of miRNA regulation play a major role in
proteomics measurements? Doherty et al. [48] measured that the half-
life of a number of 40S ribosomal subunit proteins are in the 25h-30h
range, which is about the length of a typical proteomics experiment.
Therefore, in a miRNA transfection experiment, fast-decaying protein
A is expected to display stronger down-regulation than slow-decaying
protein B, even if the mRNAs of A and B are equally well bound by
the transfected miRNA. In addition, for protein with long half-lives,
the miRNA-induced down-regulation of the target mRNA levels will
only reflect on the protein levels after a significant delay. Such effects
could result in an apparent decoupling of the changes in protein level
from the changes in mRNA level.
To test these hypotheses, we will now set up a probabilistic model
M0 on top of the ordinary differential equation model of section 6.2.
From the proteomics and transcripts measurements in the presence
and absence of the miRNA, we can obtain two vectors fP = log2
(
P(t∞)
P(0)
)
and fM = log2
(
M(t∞)
M(0)
)
representing the log2 fold change of protein
and mRNA levels following miRNA transfection.
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As previously mentioned in chapters 1 and 3, the best single determi-
nant of miRNA targeting is the presence of a miRNA seed match in the
3’UTR of a mRNA. Therefore, of all mRNAs and proteins present in
the dataset, we will focus on those that have a seed match. But a mRNA
harboring a seed match in its 3’UTR is not necessarily a functional tar-
get of the cognate miRNA. Therefore, we assume that the population
of mRNAs with seed match can be split into two sub-categories: mR-
NAs carrying functional seed matches (+), and mRNAs carrying non-
functional seed matches (−). Under these assumptions, we will now
write a probabilistic model of high-throughput proteomics and tran-
scriptomics measurements following miRNA transfection. Depending
on the ith mRNA/protein being a functional (+) or a non-functional
(−) miRNA target, we can write the probability of measuring a change
fM,i at the mRNA level and fP,i at the protein level as:

P(fM,i|+) = N
(
µM,+,σ2M,+
)
P(fP,i|+) = N
(
fM,i + µP,+,σ2P,+
)
P(fM,i|−) = N
(
µM,−,σ2M,−
)
P(fP,i|−) = N
(
fM,i + µP,−,σ2P,−
) (6.2)
Here, we explicitly assume that the log2 fold changes of target mR-
NAs are Gaussian-distributed around a mean value µM,+ which cap-
tures the average effect of miRNAs on mRNA decay. More precisely,
µM,+ is the log2 relative change in mRNA decay induced by the miRNA,
averaged over all target mRNAs, as established in section 6.2. σM,+
represents the variability of the effect of miRNAs on mRNA decay
across all target mRNAs. µP,+ is the miRNA-induced average change
in the translation rate of target mRNAs, while σP,+ represents the
variability on the changes in protein levels across target mRNAs. We
see that the model implies that fP = fM + µP on average, that is
protein change = mRNA change + translation change, consistent with
equation (6.1).
In addition to these four parameters, we also introduce µM,−, µP,−,
σM,−, σP,− to capture the secondary effects of the miRNA transfec-
tion on mRNAs and protein that are not functional targets of the trans-
fected miRNA. Finally, we define ρ as the (yet unknown) fraction of
functional targets among mRNAs with a seed match to the transfected
miRNA:
ρ := P(+)
This probabilistic model is very similar to the one we used to deter-
mine functional miRNA binding sites from replicated miRNA transfec-
tion and microarray experiments in chapter 3, detailed in section B.1.2.
The major difference is that in the present section, we explicitly model
how miRNAs interfere with gene expression at the protein and mRNA
levels and do not make use of replicates since those are not available
in the two datasets we are analyzing here [8, 191].
6.3.1 Estimating the parameters
We estimate µM,−, µP,−, σM,−, σP,− using the maximum likelihood
estimator of the mean and variance from mRNAs and proteins that
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surely are not miRNA targets, namely all mRNAs (and cognate pro-
teins) that do not harbor a seed match to the transfected miRNA.
The model presented here is a two-component Gaussian mixture
model, where we just fixed one mixture using measurements from
mRNAs and proteins that are not being modeled here because they do
not harbor a seed match. We can write down the posterior probability
of being a functional miRNA target site given the data (fP, fM):
P(+|fM, fP) =
P(fM,fP|+)P(+)
P(fP ,fM)
=
P(fP|fM,+)P(fM|+)P(+)
P(fP|fM)P(fM)
=
P(fP|fM,+)P(fM|+)ρ
P(fP|fM,+)P(fM|+)ρ+P(fP|fM,−)P(fM|−)(1−ρ)
We will now estimate the remaining parameters θ =
(
σM,+,σP,+,µM,+,µP,+, ρ
)
by Expectation Maximization (EM) [44]. The log-likelihood of these pa-
rameters is:

L(θ|fP,i, fM,i,+) = log ρ− logσP,+ − logσM,+ − log 2pi
−12
(
fP,i−(fM,i+µP,+)
σP,+
)2
− 12
(
fM,i−µM,+
σM,+
)2
L(θ|fP,i, fM,i,−) = log(1− ρ) − logσP,− − logσM,− − log 2pi
−12
(
fP,i−(fM,i+µP,−)
σP,−
)2
− 12
(
fM,i−µM,−
σM,−
)2
We can then write down the E-step of the expectation maximization
algorithm as:  X
(t)
i,+ = P
(
+|fP,i, fM,i, θ(t)
)
X
(t)
i,− = P
(
−|fP,i, fM,i, θ(t)
)
and the M-step:
ρ(t+1) =
1
n
n∑
i=1
X
(t)
i,+
µ
(t+1)
M,+ =
∑n
i=1X
(t)
i,+fM,i∑n
i=1X
(t)
i,+
σ
(t+1)
M,+ =
√∑n
i=1X
(t)
i,+
(
fM,i−µ
(t+1)
M,+
)2
∑n
i=1X
(t)
i,+
µ
(t+1)
P,+ =
∑n
i=1X
(t)
i,+(fP,i−fM,i)∑n
i=1X
(t)
i,+
σ
(t+1)
P,+ =
√∑n
i=1X
(t)
i,+
(
fP,i−fM,i−µ
(t+1)
P,+
)2
∑n
i=1X
(t)
i,+
We then iterate between the E- and the M- step until the log-likelihood
L(θ|fP,i, fM,i) converges.
6.3.2 An alternative model
Finally, we introduce an alternative modelM⊥ of (p)SILAC and miRNA
transfection experiments, in which changes in protein level depend
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Dataset Model rho µM,+ σM,+ µP,+ σP,+ L(θ∗|fM, fP)
Baek miR-124 M0 0.28 -0.69 0.73 0.02 0.99 -293.55
Baek miR-124 M⊥ 0.30 -0.68 0.69 -0.78 0.82 -275.55
Selbach miR-155 M0 0.17 -1.93 0.84 1.45 0.80 -268.97
Selbach miR-155 M⊥ 0.40 -1.18 0.94 -0.62 0.72 -237.23
Table 1: Best-fitted parameters of miRNA regulation under models M0 and
M⊥ from the miR-124 transfection data of Baek et al. [8] and the miR-
155 transfection data of Selbach et al. [191].
only on the action of miRNA on the translation rate, not on changes in
the cognate mRNA levels:

P(fM,i|+) = N
(
µM,+,σ2M,+
)
P(fP,i|+) = N
(
µP,+,σ2P,+
)
P(fM,i|−) = N
(
µM,−,σ2M,−
)
P(fP,i|−) = N
(
µP,−,σ2P,−
) (6.3)
Like with model M0, we use the EM algorithm to fit the parameters.
To do so requires minor changes in the E- and M-steps.
So model M⊥ defined by equation (6.3) assumes that changes in
protein levels are independent from changes at the mRNA level, while
model M0 defined by equation (6.2) assumes changes in protein lev-
els reflect the action of miRNAs on the translation rate as well as the
miRNA-induced changes in mRNA level, in agreement with the ordi-
nary differential equation model of section 6.2 and equation (6.1).
6.3.3 The parameters obtained under M0 are inconsistent with the expecta-
tions of miRNA biology
Table 1 shows the best-fitted parameters for models M0 and M⊥ us-
ing the miR-124 transfection data from Baek et al. [8]. We observe that
under the assumptions of both M0 and M⊥, an estimated ρ ' 30%
of genes with seed matches are inferred to be functional target of the
transfected miRNA. The mRNA of these target genes appear to go
down by µM,+ = −.7 on log2 scale, which corresponds to mRNAs
dropping to 60% of their original levels in response to the miRNA.
The estimate of the standard deviation σM,+ is comparable to the av-
erage miRNA effect on mRNA stability, suggesting that the effect of
miRNAs on mRNA levels is quite “noisy”, with a lot of inter-gene
variability. However, differences between M0 and M⊥ stand out dra-
matically when looking at parameters related to translation regulation.
Under M0, miRNAs appear to have virtually no effect on translation
(µP,+ = .02), as if changes in protein levels corresponded to changes
in mRNA levels with large amounts of noise (σP,+ = .99). M⊥ gives a
different picture, where miRNAs reduce protein levels of target genes
by µP,+ = −.78, which corresponds to proteins dropping to 60% of
their original levels.
As the magnitude of the regulatory effect of miRNAs is compara-
ble at the protein level and at the mRNA level, it may be tempting
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to interpret these observations by proposing that miRNA only act by
decreasing mRNA levels, with changes in cognate proteins levels sub-
sequently reflecting the decreased mRNA levels. However, this is not
what model comparison suggests: given the measure of the goodness
of fit in column L(θ∗|fM, fP), we will show in section 6.3.4 that M⊥
fits the data much better M0. This leads to a different interpretation:
protein and mRNA levels may be changing by the same amount on
average, but these changes are not coordinated the way they should be
if mRNAs levels were reflecting on protein levels.
Before elaborating further on model comparison and possible bio-
logical interpretations, we will look at the parameters inferred from
the miR-155 transfection experiment of Selbach et al. [191], shown in
the 3rd and 4th row of Table 1. There, the only common feature seems
to be the amount of gene-to-gene variability (σM,+,σP,+), while the
remaining parameters estimates differ quite significantly. Most strik-
ing is the specific effect of miRNAs on protein levels which is positive
under M0 (µP,+ = 1.45) which would suggest a 2.7-fold increase in
the translation rate of miRNA targets. This is clearly inconsistent with
the estimate under M⊥ (µP,+ = −.62) and the established paradigm in
which miRNAs act as translational repressors.
In summary, it seems like using M0 to estimate the effect of miRNA
regulation on protein and mRNA levels of target genes leads to results
that are inconsistent with the findings of miRNA biology.
We will now examine which of the two models M0 or M⊥ is best
supported by the data.
6.3.4 SILAC and pSILAC experiments support a model in which changes in
protein and mRNA levels are decoupled
To determine which of model M0 or M⊥ agrees most with the data
(fM, fP), we will compute the odds ratio between the two models
given the data. Using Bayes’ theorem and equal a priori probability
of the two models P(M0) = P(M⊥), we get:
log10
(
P(M0|fM,fP)
P(M⊥|fM,fP)
)
= log10
(
P(fM,fP|M0)P(M0)
P(fM,fP)
P(fM,fP)
P(fM,fP|M⊥)P(M⊥)
)
= log10
(
P(fM,fP|M0)
P(fM,fP|M⊥)
)
(6.4)
To compute this odds ratio, we need to integrate the probability of
the data under each model, weighted by the a priori probability of the
parameters:
P(fM, fP |M0) =
∫
P(fM, fP |θ,M0)P(θ)dθ
which can be in principle be evaluated by multi-dimensional nu-
merical integration. Alternatively, we can approximate P(θ) by a Dirac
delta function:
P(θ) '
{
1 if θ = θ∗
0 if θ 6= θ∗
where θ∗ are the parameters inferred by the EM algorithm. Plugging
this approximation in the integral gives
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P(fM, fP |M0) ' P(fM, fP |θ∗,M0)
where P(fM, fP |θ∗,M0) is the probability of the data under the likeli-
est parameters, whose logarithm is reported in the column L(θ∗|fM, fP)
of Table 1. To summarize:
log10
(
P(M0|fM, fP)
P(M⊥|fM, fP)
)
' 1
log 10
(L(θ∗|fM, fP,M0) −L(θ∗|fM, fP,M⊥))
In the miR-124 experiment of Baek et al. [8], the odds are 1 : 108 in
favor of M⊥. The same applies to the miR-155 experiment of Selbach
et al. [191] where the odds are 1 : 1014 in favor of M⊥. This can be con-
firmed visually by sampling proteomics and transcriptomics datasets
under the best-fitted parameters and then comparing the datasets “ex-
pected” byM0 andM⊥. As Figure 23 shows, the datasets generated by
M0 and M⊥ look very different qualitatively. Comparing the top row
of Figure 23, it is clear that the data simulated under M⊥ reproduces
the data of Baek et al. [8] shown on Figure 21 best. This can be seen
from the shape of the scatters of all genes vs genes with seed match,
as well as from the correlation coefficients and the position of the first
principal component relative to the y = x line. Turning to the data
from Selbach et al. [191], it is also clear that the data simulated from
M⊥ reproduces Figure 22 best.
Therefore, we can conclude from our analysis that in the proteomics
data of Baek et al. [8] and Selbach et al. [191], there is no strong cou-
pling between changes in mRNA levels and changes in protein levels.
In other words, in these datasets, protein and mRNAs levels are chang-
ing for different reasons. While the mRNA and protein levels of genes
targeted by the transfected miRNA both go down in these experiments,
it is also clear that changes in mRNA levels are not reflected in the
changes in protein levels. Of course, we expect that changes in mRNA
would ultimately propagate to protein levels. But this appears not to
be the case at the time-points at which the measurements were per-
formed, which suggests that the mRNA and protein levels are far from
the steady-state we assumed in section 6.2, and that the steady-state
ODE model we introduced cannot be used to interpret the proteomics
data of Baek et al. [8] and Selbach et al. [191]. Instead, our results sug-
gest that interpreting changes in protein levels in such experiments
requires explicit modeling of the transient behavior of mRNA and pro-
tein levels.
6.4 a detailed ode model of mirna-mediated gene regu-
lation
6.4.1 Questions we would like to address
There are three concrete motivations to modeling the kinetics of miRNA-
mediated gene regulation.
First of all, such a model could be used to provide a final answer
to the interrogations prompted in Chapter 3 as to why miRNA bind-
ing sites that lead to down-regulated protein levels in a miRNA trans-
fection experiment do not share the properties of functional miRNA
binding sites. To do so, one could first show that the statistical over-
representation of the miRNA seed motif within the 3’UTR of mRNAs
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Figure 23: Sampling proteomics and transcriptomics datasets from M0 (left
column) and M⊥ (right column) using parameters best-fitted to the
miR-124 experiment of Baek et al. [8] (top row) and the miR-155
experiment of Selbach et al. [191]. Shown are scatters of the simu-
lated changes in protein and mRNA levels for all genes (grey dots),
genes with seed match (black circles), and genes with functional
seed match (red dots). As in Figures 21 and 22, we report the corre-
lation coefficients between changes in protein and mRNA levels for
all genes, or genes with a seed match to the transfected miRNA. The
full red line represents the first principal component of the scatter
for genes with seed match.
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coding for down-regulated proteins improves if one uses the model to
“correct” the measured changes in protein and mRNA levels [191, 8]
for gene-dependent parameters such as mRNA and protein turn-over,
or the affinity of the miRNA to the target mRNA. In case this can be
proven, one would then proceed to show that miRNA binding sites
leading to down-regulated protein levels in a miRNA transfection ex-
periment have the expected properties of functional miRNA binding
sites (accessibility, sequence composition, etc.) if we use the model-
“corrected” changes in protein level instead of the measured changes.
Second, one could use the model to suggest improvements to high-
throughput experiments aimed at identifying functional miRNA tar-
get genes by means of perturbing miRNA expression. Based on the
model predictions of changes in mRNA and protein levels over time,
one would compute an optimal experimental time-point for the genes
of interest, defined as the amount of time after miRNA perturbation
after which changes in the mRNA and protein levels of predicted
target genes are expected to be largest. One would then perform a
miRNA transfection experiment and measure changes in gene expres-
sion at the optimal time-point as well as at a standard time-point
(such as 48h after transfection). From such data, one would attempt
to show that the data gathered at the optimal time-point is statistically
better behaved than the standard time-point, for instance by compar-
ing the over-representation of the miRNA seed motif in differentially-
regulated genes at the two experimental time points.
Finally, one could investigate open questions regarding the mecha-
nism of miRNA action. One such question is whether miRNAs repress
mRNA translation in addition to increasing mRNA decay. A large
body of experimental work suggests that this is the case [231, 211, 66,
62, 240, 64, 46, 63]. The major strength of such studies is that they make
it possible to obtain a detailed, reductionist view on the mechanism of
miRNA action. But this comes at the expense of working with artifical
reporter systems that display a strong response to miRNAs, or with
well-controlled minimal cell-free set-ups which may or may not accu-
rately model miRNA regulation in vivo. In addition, such studies can
only examine a limited amount of miRNA target genes or miRNA tar-
get sites, giving only little insight on miRNA regulation at the genome
scale. For instance, maybe miRNAs increase the decay rate of all target
mRNAs while only repressing the translation of a minority of them.
Such hypothesis can only be addressed by high-throughput studies,
such as those performed by Hendrickson et al. [99] and Guo et al. [88],
which lead to conflicting results: Hendrickson et al. [99] observed that
genes targeted by miRNAs show concordant changes in mRNA levels
and translation rate, while Guo et al. [88] proposed that the effect of
miRNAs on protein levels can be explained by changes in mRNA lev-
els, that is miRNA do not repress translation. Another open question
is whether RISC complexes recycle at 100% after the target mRNA is
degraded, or if some RISC is also lost in the process. Using our model
and an approach similar to the one we use in section 6.3, we could
look at these questions by making competing models of miRNA ac-
tion with different topologies reflecting the alternative hypotheses, fit
the models to the data, and determine which is likelier given high-
throughput [8, 191, 99, 88] or detailed, small scale data.
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state of the field To answer these three questions requires an
accurate model of the kinetics of miRNA action. Several studies have
proposed such models, yet with goals different from the ones we set
to ourselves here.
Bartlett and Davis [14] developed a model of siRNA action which
cannot be used our purpose as it focuses on siRNA-mediated mRNA
cleavage and does not take miRNA-induced translation repression into
account.
Khanin and Vinciotti [120] introduces an ODE model of miRNA ac-
tion which takes time-varying miRNA levels into account but does not
model the evolution of protein levels over time. Khanin and Higham
[119] introduces a model of miRNA action at the mRNA and protein
levels while Maya [148] looks at a 2- and 3-step stochastic version
of the same model, including one miRNA – 2 targets models. These
two models assume that miRNAs have an instant and simultaneous
effect on the translation and decay rates of target mRNAs. This may
or may not be appropriate when it comes to modeling experimental
measurements, where the transfected miRNA first needs to compete
with endogenous miRNAs to load into an Ago protein. The effect of
that competition — a slight up-regulation of the endogenous miRNA
target genes — are clearly observable in high-throughput studies [118],
which suggests that these effects and the induced delay in gene regula-
tion are important and need to be taken into account. In addition, it is
not clear whether one can make the assumption that miRNAs inhibit
translation and increase mRNA decay on the same time scale [66, 62].
Therefore the assumption that miRNAs have a simultaneous effect on
the translation and decay rates of target mRNAs may not hold when
it comes to modeling the kinetics of miRNA action.
Other work on modeling miRNA-mediated gene regulation include
Levine et al. [133], which proposes a model of small RNA gene silenc-
ing in bacteria, and Zhdanov [239] that examines the requirements for
efficient mRNA repression by miRNAs. Finally, Stanhope et al. [202]
introduces a regression model to characterize the relationship between
miRNAs levels and target mRNA levels, taking factors such the RISC
occupancy into account. However, none of these study explicitly take
the timing of miRNA action into account.
Maybe the closest work to the one we envision here is Wang et al.
[225], which models the kinetics of miRNA action using ODE and
stochastic simulations to identify key steps in the miRNA regulation
pathway and quantify stochastic noise strength along the pathway. A
model is introduced, that has a topology similar to the one we pro-
pose in section 6.4.2, but with a purpose different than ours, which is
reflected by two important differences: the competition of the exoge-
nous miRNAs with the preexisting endogenous miRNAs is not mod-
eled, and miRNAs are assumed only to mediate translation repression
while leaving the mRNA decay rate unchanged. In addition, about
a third of the reactions rates in that model are presently unknown
because they were never measured. Wang et al. [225] addressed this
problem by plugging in biologically plausible values into the model.
But to go beyond a qualitative description of the kinetics of miRNA
regulation, one probably needs to obtain data-fitted estimates of the
reaction-rates. Finally, the study does not provide a measure of how
accurately the model can reproduce the data. In our work, we aim at
addressing these three points specifically.
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Figure 24: A 17 parameters – 9 state variables ordinary differential equation
model of miRNA-mediated gene regulation. Not shown on the fig-
ure are R, the total amount of RISC/Ago, and the inducible pro-
moter leakage rate. Details are in the text. States are described in
Table 2 and reaction rates in Table 3.
6.4.2 Model structure
We use an ordinary differential equation model to describe how one
miRNA regulates the mRNA and protein levels of a single target gene.
The topology of the proposed model illustrated on figure 24 attempts
to summarize the mechanism of miRNA action established by genetics
and biochemistry [62, 66]. The state variables are described in Table 2
and the reaction rates in Table 3. Briefly, in the absence of exogenous
miRNAs (X = 0), endogenous miRNA (E) are synthesized (cE), decay
(dE), load into a free Ago A with rate bEAE or unload from a loaded
Ago AE with rate uEAE. These miRNAs do not target the mRNA M
that codes for a fluorescent protein P, which decays at the rate dPP.
mRNAs are produced at constant rate c, decay at rate dMM and are
translated at rate Ml.
At time t = 0, we induce the transcription of an exogenous miRNA
X. Upon induction, mature miRNAs will be produced at rate cX and
decay at rate dXX. This miRNA needs to compete for free Ago with
the preexisting endogenous miRNAs before it can load into a free Ago
with rate bXAX. Once the RISC complex AX is formed, it can either
dissociate with rate uXAX or bind a free target mRNA M to form a
ternary Ago-miRNA-mRNA complex MX with rate bAMAXM. As a
result, the translation rate of the bound mRNA drops from l to lA per
mRNA copy. The ternary complex will then recruit the GW182/TNRC6
protein which will ultimately lead to deadenylation and decapping of
the target mRNA at rate dcpMX. The deadenylated, decapped mRNA
MP cannot be translated anymore and its decay rate increases from
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State Description
E free endogenous miRNAs
X free exogenous miRNA
A free Ago
AE Ago-bound endogenous miRNAs
AX Ago-bound exogenous miRNA
M free target mRNA
MX Ago-miRNA-mRNA ternary complex
MP deadenylated, decapped mRNA
P target protein
Table 2: The 9 state variables in the model.
Reaction rate Description
cE,dE biosynthesis and degradation of endogenous miRNAs
cX,dX biosynthesis and degradation of exogenous miRNAs
bE,uE association and dissociation rate of
endogenous-miRNA loaded RISC complexes
bX,uX association and dissociation rate of
exogenous-miRNA loaded RISC complexes
c,dM biosynthesis and degradation of the target mRNA
l translation rate of the free target mRNA
lA translation rate of the RISC-bound mRNA
dP target protein decay rate
dcp deadenylation and decapping rate of the RISC-bound target mRNA
uMp degradation of the deadenylated, decapped target mRNA
and RISC recycling rate
Table 3: The 15 model reactions rates to be estimated. In addition, we may
also need to estimate the total number of RISCs R and the inducible
promoter leakage rate, resulting in a total of 17 parameters.
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dM to uMp while the exogenous-miRNA loaded RISC is recycled to
AX.
The reaction rates will be estimated from experimental measure-
ments by a strategy which will be described in section 6.4.4. Given
these reaction rates, we define the ODE system driving these dynam-
ics as:

dE
dt = cE − dEE− bEAE+ uEAE
dX
dt = cX − dXX− bXAX+ uXAX
dAE
dt = bEAE− uEAE
dAX
dt = bXAX− uXAX − bAMAXM+ uMPMP + dMMX
dMX
dt = bAMAXM− dMMX − dcpMX
dM
dt = c− dMM− bAMAXM
dP
dt = lM+ lAMX − dPP
dMP
dt = dcpMX − uMPMP
A = R− (AE +AX +MX +MP)
6.4.3 Steady state and initial conditions
At the initial condition t = 0, the system is assumed to be at steady-
state. There is no miRNA X at t = 0 and cX = 0,∀t < 0. However, this
assumption is not very realistic because we know the inducible miRNA
expression construct used here to be “leaky”: the transcription rate of
the exogenous miRNA before we induce its expression may take any
value from 0% up to α ' 30% of the rate when fully induced. In other
words, if cmaxX is the transcription rate when the miRNA expression
construct is fully induced,{
cX ∈ [0,αcmaxX ], t < 0
cX = c
max
X , t > 0
So, for the initial conditions, if we assume that the miRNA transcrip-
tion is not leaky (∀t < 0, cX = 0), the initial conditions are:
E(0) = cEdE
X(0) = 0
AE(0) =
R
dEuE
bEcE
+1
AX(0) = 0
MX(0) = 0
M(0) = cdM
P(0) = lcdMdP
MP(0) = 0
If we assume, however that the construct is very leaky (∀t < 0, cX =
αcmaxX ), the initial conditions are:
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
E(0) = cEdE
X(0) =
αcmaxX
dX
AE(0) =
kE
kX
AX(0)
AX(0) = max
(
−kX
b+
√
∆
2(kE+kX+1)
,−kX b−
√
∆
2(kE+kX+1)
)
MX(0) =
c
(dM+dcp)
(
dM
bAMAX(0)
+1
)
M(0) = c
dM+bAMAX(0)
P(0) = c(dM+bAMAX(0))dP
(
l+ lAbAMdM+dcpAX(0)
)
MP(0) =
c
uMP
(
dM
dcp
+1
)(
dM
bAMAX(0)
+1
)
where
kE =
bEcE
dEuE
kX =
bXcX
dXuX
=
αbXc
max
X
dXuX
b =
(
kE+1
kX
+ 1
)
dM
bAM
+ cdM+dcp
(
dcp
uMP
+ 1
)
− R
∆ = b2 + 4
(
kE+1
kX
+ 1
)
dMR
bAM
If we are unable to determine the leakage rate experimentally, we
could assume that the initial conditions are uniformly distributed in
the 9-dimensional cube whose boundaries are specified by the two sets
of initial conditions above.
6.4.4 Parameter estimation
prior on the parameters We determined plausible ranges for
the model parameters from various biological constants measured in
the literature. These ranges assume the exogenous miRNA X to be ab-
sent and are designed to exclude implausible parameter values rather
than guessing the precise parameter values. On a time-unit of one hour
(1h): 
bE,bX ∈ [10−4, 103]
uE,uX ' .1 ∈ [10−3, 10]
bAM ∈ [10−4, 103]
uMP ∈ [10−3, 103],> dM
dcp ∈ [10−4, 103]
R ∈ [102, 108]
cE, cX ∈ [102, 105]
c ∈ [10−2, 2000]
dE,dX,dM ' .07 ∈ [10−3, 5],
l ∈ [1, 104]
lA ∈ [0, l]
dP ∈ [.1, .5]
observables and a priori measurement error Not all state
variables of the detailed model illustrated on Figure 24 are easily mea-
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surable. In the present study, we will obtain measurements of the fol-
lowing variables:
• M+MX +MP
• X+AX +MX +MP
• P
The experimental techniques to measure the quantities above are
designed to measure relative amounts, not absolute ones. It is there-
fore common practice to only measure changes in the quantities above
— i.e. Y(t)
Y(0) — which circumvents the difficulty of calibrating the mea-
surements to obtain absolute concentrations.
M+MX +MP ±20%
X+AX +MX +MP ±20%
P ±40%
The relative amounts of target mRNA M+MX +Mp will be mea-
sured by qPCR, while the relative amounts of exogenous miRNAs
X + AX +MX +MP will be measured using a qPCR protocol spe-
cially designed to quantify short RNAs [194, 35, 177, 188]. In practice,
it should be achievable to perform 5 – 20 time-points and 3 – 10 repli-
cates. Based on the system specifications of this section, our initial plan
is to:
1. estimate the transcription rate c, translation rate l, mRNA decay
rate dM and protein decay rate dP from transcription and trans-
lation inhibition experiments
2. obtain Bayesian estimates of the remaining 11 reaction rates from
time-series measurements of the exogenous miRNA and the tar-
get gene mRNA and protein levels, using a sequential Monte
Carlo approach [29], which would produce confidence intervals
on the model parameters in addition to point estimates.
6.5 our detailed model of mirna regulation is consis-
tent with independent experimental measurements
6.5.1 Analytical analysis
In the absence of the measurements we envision, we can still perform
qualitative and steady-state analysis of the ODE system. This system
is non-linear and admits a unique steady-state. Linearizing the sys-
tem around that steady-state shows that it is stable given biologically
meaningful parameters (positive rates and species concentrations).
Under the steady-state assumptions, one can examine under what
conditions over-expressing a miRNA leads to down-regulation of the
target mRNA. One can show that:
M ′
M
< 1⇔ dM < uMp
where M ′ and M are the target mRNA levels at steady-state, in the
presence and absence of the exogenous miRNA. Under the model’s as-
sumptions, and at steady-state, miRNAs decrease the levels of target
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mRNAs if and only if the decay rate of deadenylated, decapped mR-
NAs is larger compared to capped, polyadenylated mRNAs. This is in
agreement with the biology of mRNA turn-over as the 5’ cap and the
polyA tail protect mRNAs from digestion by exonucleases. Interest-
ingly, under the model’s assumptions, the converse is also true which
can lead to interesting speculations: if RISC binding to the mRNA
could somehow relocate the mRNA to a compartment where it is
not accessible to exonucleases, it is expected that miRNAs could up-
regulate their targets. A miRNA-mediated up-regulation of the target
mRNA was previously reported by Vasudevan et al. [220], and it may
be interesting to think about the underlying mechanism with this idea
in mind.
Similarly, one could ask under what conditions changes in protein
levels are expected to be larger than changes in mRNA levels. At
steady-state, one can show that:
P ′
P
M
M ′
< 1⇔ lA
l
uMp
uMp + dcp
< 1
where P ′ and P are the protein levels in the presence and absence
of the exogenous miRNA. Because we have no reason to expect that
the translation rate lA of RISC bound mRNAs is larger than the trans-
lation of RISC free mRNAs l, we have lA 6 l. Recent work by Fabian
et al. [64] has proposed that the RISC interacts with the PolyA Bind-
ing Protein (PABP), thereby interacting with the circularization of the
mRNA, which should have a negative effect on the translation rate, so
we can reasonably assume that lA < l. The term on the right must
be smaller than one since all rates are positive. Therefore, under the
assumptions of the model, target proteins should experience stronger
down-regulation than target mRNAs, which is in agreement with the
experimental literature (see Zipprich et al. [240] for instance). Accord-
ing to the model, this would also be the case if miRNAs did not lead
to deadenylation and decapping of their target mRNAs (dcp = 0),
or if miRNAs caused an instant disintegration of the target mRNAs
(uMp →∞).
In conclusion, independent of the precise values of the reactions, our
model can qualitatively reproduce fundamental properties of miRNA-
mediated gene regulation.
6.5.2 Estimating the rates of exogenous siRNA-Ago complex formation from
Fluorescence Cross-Correlation Spectroscopy measurements
Using Fluorescence Cross-Correlation Spectroscopy (FCCS), Ohrt et al.
[163] performed several time-series measurements of the fraction of
Ago-bound siRNA following the microinjection of labeled siRNA. In
addition, using the same technique, the fraction of Ago bound to the
microinjected siRNA was also quantified over time. We sought to an-
alyze this dataset with the goal of obtaining coarse-grained estimates
of the RISC loading and unloading rates as well as of the decay rate of
small RNAs to be used as a starting point to estimate the remaining 11
parameters of our model.
To do so, we devised a simplified model of small RNA loading into
RISC illustrated on Figure 25. An amount of siRNA X0 is microinjected
at time t = 0. The free siRNA X degrades at the rate dXX and loads
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X
A
AX
Ø
dX
bX
uX
empty Ago
siRNA
(X
0 
)
g
loaded Ago
Figure 25: A simple model of a microinjected siRNA associating and dissoci-
ating with Ago.
into a free Ago A with rate bX to form a complex AX that dissociates
at rate uX.
We assumed that only a constant fraction g of all Ago A is free
to associate with a free siRNA X while the remaining fraction 1 − g
of Agos A is bound to endogenous miRNAs. This is a simplification
from the detailed model introduced in section 6.4.2 where the compe-
tition between endogenous and exogenous miRNAs would result in g
implicitly changing over time as exogenous miRNAs make room for
themselves to load into Ago.
In addition, this simplified model does not take ternary complex
formation into account. Therefore, from the different FCCS time-series
performed by Ohrt et al. [163], we focused on the cytoplasmic mea-
surement as miRNA regulation is thought to be happening in the cy-
toplasm, following of the microinjection of the siTK3 siRNA. We chose
to focus on this siRNA since it was designed to perfectly target the Re-
nilla luciferase mRNA used in these experiments: compared to siRNA
with imperfect complementarity, we expect this siRNA to trigger rapid
degradation of the target mRNA by cleavage as opposed to binding
the target for a longer time and trigger the slower miRNA pathway
(GW182, deadenylation, decapping, etc.). In other words, with the siTK3
siRNA, the time spent by the siRNA in a ternary Ago-siRNA-mRNA
complex should be minimal, which is more in agreement with the sim-
ple model we use here.
The model sketched on Figure 25 translates into the following ODE
system:
{
dX
dt = −dXX− bXg(R−AX) + uXAX
dAX
dt = bXg(R−AX)X− uXAX
(6.5)
where R is the total amount of RISC and the initial conditions are
X(0) = X0, AX(0) = 0. However, Ohrt et al. [163] measured the fraction
of Ago in complex ρ = AXR and the fraction of siRNA in complex
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Figure 26: Fitting the cytoplasmic siTK3 Fluorescence Cross-Correlation Spec-
troscopy time-series of Ohrt et al. [163]. Red and black dots repre-
sent the measured fraction of Ago2 and siRNA molecules in com-
plex over time (in hours), while the full red and black curves show
the fitted time-course of the model defined by equation 6.6. Finally,
the dotted red and black lines represent the predicted siRNA and
Ago2 steady-state of the model while the best-fitted parameter val-
ues are printed in the top right corner of the figure (hourly rates).
γ = AXAX+X . Substituting ρ and γ in equation (6.5) results in a new
ODE system:
{
dγ
dt = dXγ(1− γ) + bXR(g− ρ)(1− γ) − uXγ
dρ
dt = bXR(g− ρ)ρ
1−γ
γ − uXρ
(6.6)
Under the initial conditions (γ(0) = 0, ρ(0) = 0), dρdt
∣∣∣
t=0
is unde-
fined. But going back to the definition of ρ = AXR , we get:
dρ
dt
∣∣∣∣
t=0
=
1
R
dAX
dt
∣∣∣∣
t=0
= bXgX0 (6.7)
The model defined by equations (6.6) and (6.7) has 5 parameters:
g,uX,dX,bXR and X0bX. We obtained estimates of these parameters
by minimizing the squared model prediction error using the method of
Nelder and Mead [160]. The prediction error was minimized starting
from 500 random parameters sets. Figure 26 shows the FCCS time-
series data together with the prediction of the model based on the
best-fitted parameters. Note that the fraction of siRNA in complex
does not converge to 0 but .4, indicating that the total amount of
siRNA decreases about 1.4 = 2.5 times as fast as the amount of Ago-
bound siRNA, consistent with Ago-loaded siRNAs being protected
from degradation.
The model is able to accurately fit the measurements and the val-
ues of the best-fitted parameters were consistent across runs, except
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Figure 27: Best fitting the model parameters while fixing g to .1, .2, .3, .4, .6 or
1.
for the fraction g of available Ago which varied significantly from one
run to next. This is best shown by Figure 27, where the model parame-
ters were best-fitted starting with 500 random parameter values while
constraining g to a value between 0 and 1. While g = .61 fitted the
measurement best, any value between .3 and 1 resulted in models that
fitted the data just as well. This is in contrast with the 4 remaining
parameters, which took comparable values independent of g changing
between .3 and 1, suggesting that the data is not very informative re-
garding the fraction of Ago that is available to the microinjected siRNA.
As long as g is larger than the maximum fraction of Ago in complex
— 20%, which occurs ∼8h after transfection here — parameters can be
found to fit the FCCS measurements.
As for the remaining parameters, the siRNA decay rate dX is esti-
mated to .077 – .09 per hour, which corresponds to a half-life of ∼8h.
This is comparable to the half-lives of most mRNAs in B-cells which
were measured to be in the 3h – 11h range [68]. The siRNA-Ago dis-
sociation rate was estimated to be around ∼ .13h−1 per RISC complex.
Finally, under the model’s assumptions, there was an estimated aver-
age of X0R ' 2microinjected siRNAs per Ago. However, these estimates
need to be taken with a grain of salt, as there are likely to be biased. For
instance, we do not model Ago-siRNA-mRNA ternary complex forma-
tion, which probably increases the amount of time siRNAs spend in
Ago. Therefore, uX is probably higher than we estimated it here. Nev-
ertheless, the parameter estimates we obtained fit reasonably with our
expectations and make a good starting point to estimate the remaining
parameters of the model.
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Figure 28: Simulating the induction of an exogenous miRNA X at time 0.
Left: Simulated evolution of the number of molecules per cell (y-
axis) over time (x-axis, in hours). Full horizontal lines represent the
steady-state values of the different model species in the presence of
the exogenous miRNA. Right: Simulated log2 fold changes (y-axis)
in the protein (red) and mRNA (black) levels of the target gene with
respect to time after miRNA induction (x-axis, in hours). The hor-
izontal dotted lines represent the log2 fold changes of the protein
and mRNA in the presence of the exogenous miRNA steady-state,
while the vertical dotted lines mark the time points at which the
steady-states are reached.
6.5.3 Simulations and timing
Prior to performing the time-series measurements described in sec-
tion 6.4.4, we set to study the behavior of the model using guessed
but plausible parameters. To do so, for each of the 15 parameter, we
plugged in the middle of the confidence intervals defined in section 6.4.4
into the model, except for uX and dX, for which we used the values
determined in section 6.5.2.
Using these estimates, we simulated time-courses for all the model
species following the induction of the exogenous miRNA at time 0.
The simulation results are shown on left panel of Figure 28. In these
simulations, we observe that the induction of the exogenous miRNA
causes the amount of free miRNA X and Ago-bound miRNA AX to
grow over time until it reaches a new steady-state ∼40h after induction,
resulting in an expected drop of the levels of the target protein P. Inter-
estingly, with a ratio of ∼6 free endogenous miRNAs per RISC-loaded
endogenous miRNA, the majority of miRNAs are not loaded in a RISC
in these simulations. This is also observed in the FCCS measurements
of Ohrt et al. [163], where the fraction of loaded siRNA never exceeds
50%. Finally, in spite of the target protein levels dropping to a third of
their original levels, the amount of free and bound miRNAs appears
to be barely affected, which may indicate that it could be possible for
a miRNA to repress a target gene significantly, without having to take
over a dramatic proportion of RISCs.
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Parameter Effect on protein regulation Effect on mRNA regulation
c slower slower
dM weaker, faster weaker, faster
l stronger and faster, none if lAαl none
dP faster none
bAM stronger, faster stronger, faster
dcp stronger stronger, faster
uMp none stronger, faster
lA weaker, faster none
Table 4: Perturbation analysis of gene-dependent parameters. The effect of
turning up each parameter on the regulation of the protein and mRNA
levels of the target gene are indicated in their respective columns.
In addition, we simulated the log2 fold changes in the protein and
mRNA of the target gene, shown on the right panel of Figure 28. There,
the protein and mRNA levels of the target gene drop together and
reach the new steady-state almost simultaneously, ∼40h after miRNA
induction. That the protein and mRNA reach the steady-state at the
same time is mostly due to the fact that we are simulating a protein
with a half-life of 3h (dP = .25): with a protein with a half-life of 24h,
the steady-state is reached after 100h (not shown). On the mRNA level,
however, this time-scale of 40h is in agreement with the typical time-
scale of miRNA transfection experiments (see Figure 4 of Khan et al.
[118] for instance). In addition, we see that protein levels change more
compared to mRNA levels, with protein and mRNA levels dropping to
33% and 50% of their original levels, respectively. This is expected from
the results of section 6.5.1, and again in agreement with the established
knowledge in miRNA biology [66, 62].
6.5.4 Perturbation analysis
In order to get a better understanding of the effect the different gene-
dependent parameters may have on the time-scale and magnitude of
miRNA-mediated gene regulation, we performed a parameter pertur-
bation analysis. We individually tuned each parameter up and down
while keeping all other parameters constant, which allowed us to ex-
plore the regulatory consequences of changing the parameters. The re-
sults of this analysis are shown on Figure 29. For instance, the panel in
the second column of the second row looks at the effect of the miRNA-
loaded RISC – target mRNA binding rate bAM. As we increase bAM
from 10−5 to 5.10−4, the magnitude of the down-regulation increases
both at the protein and mRNA levels, while the steady is reached
sooner. In other words, the better the miRNA affinity to its target, the
faster and the stronger the regulation.
Table 4 summarizes the perturbation analysis for all parameters. It
appears clearly that all gene-dependent parameters influence how fast
target genes are regulated at the protein level, at the mRNA level,
or both, as well as the strength of the regulation. For instance, our
model predicts that mRNAs harboring several high-affinity miRNA
binding sites — which should result in a high bAM — are stronger
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Figure 29: Parameter perturbation analysis of the detailed ODE model intro-
duced in section 6.4.2. Each panel is concerned with the effect of an
individual parameter — specified in the title together with its orig-
inal value — on the kinetics of miRNA-mediated gene regulation.
The dotted red and black lines represent the log2 fold change in the
protein and mRNA levels of the target gene following the induction
of the miRNA under the original parameters. These parameters are
then progressively turned up and down in constant steps around
two extreme values which appear on the figures next to the corre-
sponding trajectories. The black and red dots mark the time points
at which protein and mRNA reach steady-state levels.
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regulated. This is consistent with observations from miRNA transfec-
tion microarray experiments, where the extent of the pairing to the 5’
end of the miRNA and the number of miRNA binding sites correlates
with the amount of mRNA degradation [83]. In addition, our model
also predicts that slow-decaying mRNAs (small dM) should experi-
ence a stronger regulation than fast-decaying mRNAs, which remains
to be tested in high-throughput.
When it comes to the time-scale of miRNA-induced regulation, for
most parameters, tuning the parameter in such way that the regula-
tory effect increases also makes the regulation faster. For instance, the
model predicts that fast-decaying proteins (high dP) translated from
slowly transcribed mRNAs (small c) carrying several high-affinity miRNA
binding sites (high bAM) should experience faster down-regulation.
Again, these predictions remain to be tested.
Exceptions to the strong regulation = fast regulation pattern
are the mRNA decay rate dM and the translation rate of Ago2-bound
mRNAs lA, which highlight a limitation of this kind of “single pa-
rameter” analysis. The analysis performed in this section does not
take dependencies between parameters into account, which leads to
problems given the parametrization we used here. For instance, if we
turn up the mRNA decay dM enough, it will at some point reach
the value dM = uMp. In that case, the model predicts that miRNAs
have no effect on mRNA levels (see section 6.5.1), which highlights
the source of the problem: the degradation rate uMp of deadenylated,
decapped mRNAs is probably not a constant, but varies relatively to
dM. If a given polyadenylated, capped mRNA degrades fast, then we
expect that it will degrade even faster when deadenylated and de-
capped. Therefore, a more sound parametrization of the model may
be uMp = kcpdM or uMp = kcp + dM, where kcp represents the in-
crease in mRNA decay resulting from loosing the cap structure and
the polyA-tail. In section 6.7.3, we will briefly introduce a method that
may be useful at finding all parameter dependencies of this type so
they can be eliminated, which should result in a better model.
6.6 conclusion
In this chapter, we analyzed high-throughput quantitative proteomics
and transcriptomics measurements following miRNA transfection. Us-
ing competing, simple models of the mechanism of miRNA-mediated
gene regulation, we showed that changes at protein levels measured by
state of the art SILAC and pSILAC miRNA target identification proto-
cols are far from steady-state and do not accurately reflect the ultimate
effect of miRNA regulation. This may explain why functional miRNA
binding sites do not necessarily lead to down-regulated protein levels
in a miRNA transfection experiment, and suggests that the precise ki-
netics of miRNA-mediated regulation need to be taken into account
when designing and analyzing such experiments.
For this purpose, we introduced a detailed ODE model of the ki-
netics of miRNA-mediated gene regulation and sketched a strategy to
estimate the model parameters from experimental measurements. We
presented different open problems that this model may help resolving
and showed that the steady-state predictions of the model are consis-
tent with key observations of the miRNA literature. As a preliminary
to estimating all the parameters of the model, we set to estimate pa-
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rameters related to the RISC loading and unloading of small RNAs
from published measurements. Plugging plausible parameters values
into the detailed ODE model and simulating a miRNA induction ex-
periment, we obtained time-courses where the time scale and the mag-
nitude of miRNA-mediated gene regulation is consistent with those of
typical miRNA transfection experiments. Finally, all gene-dependent
parameters appear to incluence either the timing or the magnitude, or
both aspects of miRNA regulation.
6.7 future work
A weakness in those latest simulations is that parameter estimates
were at best estimated from measurements performed in a different
context using coarse-grained models, or at worse guessed from pub-
lished measurements in the literature. As a preliminary to interpreting
the model predictions further, the parameters need to be estimated
more rigorously, which may require complementary experimental ap-
proaches and/or changes to the model in order to make these parame-
ters identifiable under the inherent constraints and limitations of exper-
imental approaches. In addition, complementary analyses are needed
to confirm the reason that justifies building such a model, to check
the validity of the model’s assumptions, and to validate the model’s
predictions.
6.7.1 Confirming that a model of the kinetics of miRNA-mediated gene reg-
ulation is necessary
That the kinetics and transient of miRNA-mediated gene regulation
need to be taken into account when designing and analyzing high-
throughput quantitative proteomics experiments was so far only estab-
lished on miRNA transfection datasets where a miRNA is transiently
over-expressed before being eliminated by decay. For this reason, pro-
teomics and transcriptomics measurements must be performed 2 to
3 days following miRNA transfection. A complementary approach
when it comes to miRNA target identification consists in stably over-
expressing or knocking out a miRNA by genetic means. This allows for
much longer time intervals between the induction or knock-out of the
miRNA and the proteomics and transcriptomics measurements. There-
fore, we expect the proteomics and transcriptomics measurements from
such systems to be at steady-state. Baek et al. [8] and Selbach et al. [191]
performed miRNA genetic knock-out experiments and the correspond-
ing proteomics and transcriptomics measurements could be used to
confirm our hypothesis by examining the properties of miRNA bind-
ing sites leading to up-regulated protein levels, and by performing the
model comparison analysis of section 6.3.4.
In addition, Guo et al. [88] recently published genome-wide ribo-
some profiles following miRNA transfection or knock-out. Such pro-
files provide a direct read out on miRNA-mediated translation regula-
tion and it would therefore be interesting to examine whether miRNA
binding sites leading to lower translation rates share the properties of
functional miRNA binding sites.
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6.7.2 Checking model assumptions
The present model relies on a set of explicit and implicit assumptions,
which need to be validated experimentally prior to trusting the model
predictions. Such validation experiments include:
• Making sure Ago levels do not change upon inducing the miRNA
(qPCR, western blot)
• Making sure that the production and degradation rates of en-
dogenous miRNAs do not change when inducing the new miRNA
• After estimating the rates cM,dM, l,dP of the target gene in the
absence of the 3’UTR recognized by the miRNA, induces the ex-
pression of exogenous miRNA and making sure these param-
eters stay constant over time: they could change because the
induced miRNA may interfere with the transcription, mRNA
degradation, translation or protein turn-over machinery, which
would flaw parameter estimation.
In addition, one may need to add a nuclear mRNA compartment to
the model or remove cell nuclei experimentally prior to quantifying
miRNAs, as nuclear-located miRNAs cannot interfere with translation
regulation.
6.7.3 Parameter estimation
identifiability So far, we have not looked at the question of the-
oretical identifiability: given error-free, high-frequency sampled time-
course measurements of the observables of the system, are the param-
eters uniquely identifiable in principle?
Let {xi, i = 1, . . . ,n} be the error-free measurements performed on
time-points {ti, i = 1, . . . ,n}, and let {x(ti, θ), i = 1, . . . ,n} be the corre-
sponding model predictions under the parameters θ. We can infer the
model parameters θ∗ that are most in agreement with the measure-
ments by minimizing the squared model prediction error:
θ∗ = argminθ
n∑
i=1
(x(ti, θ) − xi)
2
But assuming we have obtained such parameters θ∗ and reached
the global minimum of the squared model prediction error landscape,
how can we make sure that no other parameter combinations would
just as accurately reproduce the data? In other words, is it possible
to find a perturbation to the parameters that would result in different
parameters but with an identical squared model prediction error?
Figure 30 shows the model prediction error landscape for the toy
error function (x,y) = (xy− 1)2. This error function has two parame-
ters x and y, while 1 represents the measurements. For all (x,y) such
as x = 1y , we have (x,y) = 0. Therefore, this model prediction error
function does not provide information on the individual values of x
and y, only on the value of the product xy. This mirrors the observa-
tion of Table 4 in section 6.5.4 where tuning lA in proportion to l had
no effect on the time-course of protein and mRNAs following miRNA
induction. However, what if the model prediction error does not have a
closed-form and cannot be studied analytically? This is the case in our
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Figure 30: A toy example of a model prediction error landscape. Shown are
contour (left) and perspective (right) representations of function
(x,y) = (xy − 1)2, where x > 0 and y > 0 are the “model pa-
rameters”, 1 is the “data” and (x,y) is the model prediction error.
detailed model, where the model prediction eror
∑n
i=1 (x(ti, θ) − xi)
2
needs to be evaluated numerically. In this case, we can still attempt
to find local dependencies between parameters using a numerical ap-
proach.
Let (θ) =
∑n
i=1 (x(ti, θ) − xi)
2 be the squared model prediction er-
ror. ddθ
∣∣
θ=θ∗ = 0 since θ
∗ is an extremum of . Therefore, the Hessian
of  computed at θ∗
d2
dθ2
∣∣∣∣
θ=θ∗
summarizes the information regarding how small perturbations to
the parameters around θ∗ affect the squared model prediction error.
Finally, an eigenvector decomposition of the Hessian matrix reveals
along the directions along which perturbations to the parameters have
strongest and weakest effects on the squared model prediction error.
In the case of (x,y) = (xy− 1)2 and θ∗ = (1, 1), we have
d2
dθ2
∣∣∣∣
θ=θ∗
=
(
1 1
1 1
)
The eigenvalues of this Hessian are 2 and 0, corresponding to the
vectors
(
1
1
)
and
(
−1
1
)
respectively. In other words, perturbing x
and y in the same direction by the same small amount will result in a
maximum increase of the model square prediction error while perturb-
ing x and y in opposite directions by the same small amount will leave
the squared model prediction error unchanged, as shown by simple
observation of the definition of  above. Therefore, the eigenvectors
with corresponding egenvalues close to 0 reveal local dependencies
between parameters.
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Preliminary application of this local perturbation analysis around
the parameters introduced in section 6.4.4 shows that the parameters
of the model are far from being identifiable from time-courses of just
three observables. But upon taking the rates governing RISC loading
and unloading of miRNAs out of the analysis, parameters best-fitting
the experimental measurements become uniquely determined, except
for the translation rate of the Ago-bound mRNA (lA) and the decay
rate of endogenous miRNAs (dE) (not shown). This indicates that
parameters would be close to being identifiable if the biophysics of
miRNA-RISC complex formation were known.
In the future, we plan to refine this analysis along the ideas exposed
in Brown and Sethna [26] with two goals in mind. First of all, we will
seek to determine individual, non-identifiable parameters that only
have a negligible influence on the time-course of the model species
we are interested in. For instance, the rates governing endogenous
miRNA-RISC complex formation are likely to be hard to identify while
having only a small influence on the time-courses of mRNA and pro-
tein levels. But we have limited interest in these rates beyond modeling
the competition of small RNAs for RISCs, so we may not need precise
estimates of the corresponding individual parameters anyway. Second,
we will determine collections of parameters that are non-identifiable
under the current observables so that we can come up with alternative
solutions to estimate them. Possible solutions to estimating such de-
pendent parameters are described in the rest of the present subsection.
simplify the system make it identifiable Parameters occur-
ring in eigenvectors corresponding to small eigenvalues are likely not
to be identifiable given the observables. One solution may be to sim-
plify the model by collapsing the corresponding reactions into fewer,
abstracter reactions.
Pushing the logic of the argument to the extreme, we need to check
how much difference it would make to follow Khanin and Higham
[119] in assuming that miRNA induce simultaneous changes in the
translation and mRNA decay rates, as opposed to explicitly modeling
the competition of small RNAs for RISC, the initial translation repres-
sion and the subsequent delayed mRNA degradation.
Finally, we need to examine whether time-scale separation can be
used to eliminate certain states and rates. For instance, can we assume
that Ago-miRNA-association/dissociation is fast and is therefore at
equilibrium compared to other reactions? Maybe a careful comparison
between the time-courses of Ago loading from Ohrt et al. [163] and
mRNA down-regulation of Wang and Wang [226] can help answering
this question. More generally, it may be important to screen all the
reactions in our detailed model to check if it can be simplified further.
measure additional quantities Our preliminary local param-
eter perturbation analysis (section 6.7.3) suggested that if we knew
the biophysics of miRNA-RISC complex formation, we may be very
close to being able to identify the remaining parameters. This suggests
that adding biophysics measurements — the fraction of bound Ago-
miRNA over time for instance —- to the observables may be crucial
in solving the parameter estimation problem. Or maybe it would be
possible to measure subpopulations of mRNAs, such as the fraction of
deadenylated target mRNA among all reporter mRNAs.
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applying other perturbations The exogenous miRNA induc-
tion rate cX is easily tunable experimentally. Therefore, we will in-
vestigate whether differential inductions of the exogenous miRNA —
i.e. performing several time-course measurements of the observables
under different cX but keeping all other rates constant — can help
identifying the parameters. It may also be possible to knock down
one or several component of the system, or induce the expression of
the exogenous miRNA for a limited period of time only. We will de-
termine which of these perturbations are most informative using the
framework developed by Bandara et al. [10].
performing single-cell measurements The stochastic fluc-
tuations of the molecules cross-reacting in a genetic network carry in-
formation on the reaction rates of the underlying network, including
on rates that may be difficult to measure by other means. We could
profit from this effect by attempting to perform parameter estimation
within a framework that is able to extract information from cell-to-cell
fluctuations in the number of molecules [158], as opposed the option
we have been considering so far that only uses information from cell
population average measurements.
Experimentally, this would involve the combination of FACS (Fluorescence-
Activated Cell Sorting) measurements of luciferase intensities, and sin-
gle molecule RNA FISH measurements of the target mRNA [174]. FACS
is commonly available in molecular biology institutions while single
molecular RNA FISH only requires standard wide-field microscopy.
Specific experimental procedures were developed for single-cell mea-
surements of miRNAs [33].
6.7.4 Validating the model
Future work will also put the model prediction in the context of the
regulatory consequences of knock-downs of RNAi components on tar-
get gene mRNA and protein levels in Drosophila, such as those per-
formed by Eulalio et al. [60]. Such experimental results would allow
us to check whether the model generalizes qualitatively to biological
contexts that were not used to fit the parameters and thereby test if the
model is also predictive in biological conditions it has never “experi-
enced”.
Finally, to quantitatively validate the model, one may test the predic-
tions of the parameter perturbation analysis in section 6.5.4 on high-
throughput datasets. For instance, the mRNA decay rates were mea-
sured by several studies Yang et al. [234], Cheadle et al. [34], Friedel
et al. [68], Iwamoto et al. [104] as well as human protein decay rates [48].
Using such measurements, one could test whether the predicted ef-
fect of the mRNA decay rates on the time-scale of miRNA regula-
tion can be observed in large microarray time-series of miRNA over-
expression [226, 118]. One could also test whether the predicted effect
of the mRNA and protein decay rates on the magnitude of miRNA
regulation is in agreement with the measured changes in protein lev-
els following miRNA transfection [191, 8]. Doing so would increase
the confidence in the model, or highlight discrepancies indicative of
an overlooked phenomenon in miRNA regulation. Either ways, the
process would lead to a better understanding of miRNA biology.
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a.1 supplementary methods
a.1.1 Bioinformatics analyses
We imported the CEL files from the Affymetrix Mouse Genome 430 2.0
Array into the R software [173] by using the BioConductor affy pack-
age [74]. The probe set intensities were then background-corrected,
adjusted for nonspecific binding, and quantile normalized with the
GCRMA algorithm [233]. Probe sets with more than 2 probes map-
ping ambiguously (more than 1 match) to the genome were discarded,
as were probe sets that mapped to multiple genes. We then collected
all probe sets matching a given gene, and we selected for further anal-
ysis the Refseq transcript with median 3’UTR length corresponding to
that gene. The log-intensities of probe sets mapping to the gene were
averaged to obtain the expression level per Refseq transcript. Finally,
we used Limma [199] to estimate the fold change and the P value of
the difference in expression between 375KO and wild type for each
transcript.
To investigate whether the transcripts responding to a particular
treatment are enriched or depleted in matches to the miR-375 miRNA,
we ranked the transcripts according to their estimated fold change. We
labeled the 5% most down-regulated transcripts as “down” and the 5%
most up-regulated transcripts as “up”. What one means by “miRNA
seed” varies to some extent from one study to another. Most commonly
this term refers to positions 1-8, 1-7, 2-8, or 2-7 of the miRNA. Because
the effect on mRNA stability depends on the extent of miRNA-mRNA
sequence complementarity, we generally want to separately analyze
putative sites with different degrees of complementarity. miR-375 has,
however, a CG dinucleotide at positions 7-8, leading to a very low
number of sites that are complementary to positions 2-8 or 1-8 of this
miRNA. Because of the high variance associated with these low num-
bers of sites, we used for our analysis only sites that are complemen-
tary to positions 1-7 (not including those that are also complementary
to positions 1-8) of miR-375. We call the 1-7 miR-375 seed complemen-
tary sequence with a mismatch at position 8 the “miR-375 motif”. We
counted how many times the miR-375 motif occurred in the 3’UTRs of
transcripts labeled as “up” or “down”. This number is represented in
the plots as a black dot. To assess whether the number of miR-375 mo-
tifs is unusually high or low compared with what would be expected
for a “random miRNA”, we computed a “background” motif count
distribution as follows. We considered all possible “random miRNA
seeds.” These are all of the possible octamers. For each of these, we
determined the number of occurrences of “background motifs” in all
of the 3’UTRs of transcripts monitored by the microarray. These are all
3’UTR positions that match perfectly the 1-7, but not the 8th position of
the “random miRNA”. We then selected the 5% of these background
motifs (i.e., 3,277) whose number of occurrences in the entire set of
3’UTRs was closest to that of the miR-375 motif. We computed the
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expected number of occurrences of these in the 3’UTRs of the “up”
and “down” transcripts. This was defined as observed occurrences of
the background motifs in the “up” or “down” transcripts 3’UTRs ob-
served occurrences of the miR-375 motif in the entire 3’UTRs set/ob-
served occurrences of the background motifs in the entire 3’UTRs set.
The distribution of the number of occurrences of background motifs
is represented as follows: the blue boxes show the interquartile range
and the red line the median. The range bounded by the black whiskers
indicates the interval that is 1.5 times the interquartile range, and the
red dots show all background motifs whose number of occurrences
does not fall within this range. The black dot represents the count of
miR-375 motifs. The P value of the enrichment is given by the fraction
of the background motifs that have at least as many occurrences as
the miR-375 motif in the “up” transcripts, and the significance is repre-
sented by the location of the black dot within the box plot representing
the distribution of background motifs. Finally, the P value of the deple-
tion is given by the fraction of the background motifs that have at most
as many occurrences as the miR-375 motif in the “down” transcripts.
a.1.2 Isolated Islet Secretion and Capacitance Measurements
Islet secretion studies were performed on size-matched islets isolated
from 10-week-old animals following collagenase digestion and overnight
culture and performed as described [170]. Exocytosis of secretory gran-
ules was monitored in single α or β cells by capacitance measurements
as described previously [170, 56]. The measurements were performed
in the standard whole-cell configuration of the patch-clamp technique
at 32-33◦C and the identity of β cells was subsequently confirmed after
the experiment by immunocytochemistry.
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Figure 31: Deletion of the miR-375 gene by homologous recombination.
(A) Targeting strategy for deletion of the miR-375 locus by replace-
ment with dsRed cDNA and the neomycin (Neo)-resistance cassette
by homologous recombination in ES cells. Targeting arms are shown
as white boxes, and the probe 3’ to the right targeting arm that was
used for Southern blot analysis is shown as a black bar. No fluo-
rescence signal was observed from dsRed of heterozygous or null
mice. (B) Analysis of genomic DNA from wild-type (+/+), miR-375
heterozygous (+/-), and miR-375 homozygous (-/-) mice after diges-
tion with BstEII. (C) In situ hybridization in pancreatic sections from
wild-type (WT) and mutant (375KO) mice with a probe for miR-
375. Black circles indicate islets in miR-375-null mice. (Bar, 25 µm.)
(D) Northern blot of total RNA isolated from 10-week-old WT and
375KO tissues: pancreatic islets (Isl), pituitary gland (Pi), adrenal
gland (Ad), stomach (St), duodenum (Du), jejunum (Je), ileum (Il),
and colon (Co). Blot was reprobed for tRNA as a loading control
and quantified by densitometry. (E) Growth curve of 375KO and
wild-type mice.
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Figure 32: Single-cell capacitance measurements in pancreatic α and β cells
of 375KO and littermate control mice. (A) Secretion was evoked
by a train of depolarizations from -70 mV to 0 mV in isolated β
cells from 10-week-old male 375KO (black signals) and wild-type
(gray signals) mice. (B) Mean increase in membrane capacitance of
isolated β cells elicited by individual depolarizations of the train
(∆Cm,n−∆Cm,n−1) displayed against the pulse number (n). (C) To-
tal mean increase in membrane capacitance elicited by individual
depolarizations of pancreatic β cells from 375KO and wild-type
mice. (D-F) As in A-C but using α cells. *, P < 0.01; **, P < 0.001.
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Figure 33: Identification of miR-375 target genes. (A-D) Quantification of the
number of occurrences of miR-375 motifs in the 3’UTRs of both up-
regulated and down-regulated transcripts in 375KO tissues. Black
dots indicate the number of occurrences of miR-375 motifs in the
5% most up- and down-regulated genes (right and left plots, re-
spectively). The distribution of the number of occurrences of motifs
complementary to “random miRNAs” in these transcripts is rep-
resented as a box plot: blue boxes show the interquartile range,
the black whiskers indicate the range of 1.5 times the interquar-
tile range, and the red dots represent the motifs whose number of
occurrences falls outside of this range. The “random” miRNAs are
selected to have approximately the same number of complemen-
tary motifs as miR-375 in the entire set of 3’UTRs. (E) Density plot
showing that transcripts with a miR-375 motif (dashed red line) or
an evolutionarily-conserved miR-375 motif (solid blue line) are up-
regulated in the 375KO relative to transcripts that do not contain
this motif.
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Figure 34: (A) Detection of miR-375 expression by in situ hybridization in
pituitary anterior and posterior regions and (B) in adrenal sections
from wild-type and 375KO mice using a sequence specific probe for
miR-375. miR-375 is detected in the adrenal medulla and the zona
glomerulosa (g) of the cortex and not the fasciculata (f) or reticularis
(r). (Bar, 50 µm.)
Figure 35: Real-time PCR analysis of miR-375 targets in islets, brain, heart,
and lung. Gene expression in the indicated tissues was normalized
to U6 levels.
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b.1 supplementary methods
b.1.1 Plasmids and cell culture
FlPin293 cells stably expressing FLAG/HA EIF2C2 were described in
Landthaler et al. [130].
The DNA oligonucleotides used for the amplification of 3’ UTRs
were the following (restriction sites are underlined):
CHMP4A-1: 5’-CCGCTCGAGTAAATCTGGGCTTGTCTTCCTAATGCTACC,
CHMP4A-2: 5’-GAATGCGGCCGCGGGAACAAGGGCATTATAACTGCTATCAAAG;
LOC134145-1: 5’-CCGCTCGAGACTTGACTGGGAGTGTTTTTCTGAAATATTGTAG,
LOC134145-2: 5’-GAATGCGGCCGCAAGTTTAGTTAAAGATGTGACCATCTTACTTCATTAC;
AXIN1-1: 5’-CCGCTCGAGCAAAGTGGAGAAGGTGGACTGATAG,
AXIN1-2: 5’-GAATGCGGCCGCTCATTATTATCCAAGTACCTTTGAAAAGATAATTAATTG;
ANXA5-1: 5’-CCGCTCGAGTGTCACGGGGAAGAGCTCCCTG,
ANXA5-2: 5’-GAATGCGGCCGCTCATTAATCTTTTGAATACAATCATCATAATTTTACAGG;
KANK1-1: 5’-CCGCTCGAGTATGCAAATAGCCCTTTATTTACATGCCAC,
KANK1-2: 5’-GAATGCGGCCGCTTTGAAAATATGGCAAGAGTCTAAGGCACTTC;
PGRMC2-1: 5’-CCGCTCGAGACTTTGTAAACAACCAAAGTCAGGGGCCTTC
PGRMC2-2: 5’-GAATGCGGCCGCGTACATGCTTTATTAAAATGGTACTTGTATTTACAG;
RNF128-1: 5’-CCGCTCGAGTCTGTGTAAATAGAAAACTTGAACCATTAGTAATAAC,
RNF128-2: 5’-GAATGCGGCCGCACATTTTATATTTAAAGAGAATCAATACAAATTGGGAC.
b.1.2 Extraction of positives and negatives from replicated transfection ex-
periments
For the set of “positives” we wanted to select transcripts that, with high
probability, are affected in expression across all experiments in which
the expression of a miRNA was perturbed. We therefore developed
a probabilistic model that, for each transcript containing one or more
miRNA seed matches, uses the expression data from over-expression
or knock-down experiments of the corresponding miRNA, to calcu-
late the probabilities that the transcript’s expression is affected by the
miRNA in each of these experiments.
For the purpose of this model, we define a miRNA seed match as
a 7mer or 8mer perfect match to the miRNA seed. We assume that
our data consists of K pairs of expression measurements, each corre-
sponding to either a miRNA over-expression or miRNA knock-down
experiment, which we will refer to as “contrasts”. We will let fkt denote
the log2 fold-change of expression of transcript t in contrast k.
distribution of fold-changes for non-targets For our
model we first need to calculate, for each contrast k, the probability
Pk(f|−) that a transcript that is not a target, will have a log fold change
of f. To estimate the distributions Pk(f|−) we assumed that they are
Gaussian with means µk and standard deviation σk to be estimated
from the data for each contrast k. We in addition assumed that tran-
scripts that do not carry at least a heptameric seed-complementary site
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are unlikely to be real targets, and thus estimated µk and σk from the
observed expression changes of transcripts without seed matches.
distribution of fold-changes for targets We similarly need
to calculate, for each contrast k, a distribution Pk(f|+) that a transcript
which is a true target of the miRNA, will have a fold-change f. As lit-
tle is currently known of the distribution of the severity of the effect
that miRNAs have on the expression of their targets we will assume
as little as possible about the distribution Pk(f|+). The only thing that
we will assume is that a true target must change expression in the
right direction, i.e. f < 0 for a miRNA over-expression experiment,
and f > 0 for a miRNA knock-down experiment, and that expression
changes are limited to a finite range. That is, we will assign a uniform
distribution. For example, in the case of a contrast related to a miRNA
over-expression:
Pk(f|+) =
{
1
|Fk|
if Fk 6 f < 0
0 otherwise
where Fk = mint(fkt ) is the largest negative log2 fold-change ob-
served in contrast k. The distribution is defined in a similar fashion for
contrasts related to a miRNA knock-down, except it is uniform over
positive instead of negative values.
computing the probability of a functionality pattern
given the data The simplest assumption that one could make
is that each transcript t is either a true target in each contrast or
not a target in any of the contrasts. However, inspection of the data
strongly suggested that a transcript t can show a strong response in
some experiments and no responses in others. Therefore we developed
a more general model in which a transcript can be a “functional tar-
get” in some experiments and a non-target in other experiments. We
define a functionality pattern α as α ∈ S := {+,−}K. For instance,
α = (α1,α2) = (−,+) means that the transcript is not a functional
target in the first contrast but it is a functional target of the miRNA in
the second contrast.
LetD be the whole set of microarray dataD := {fkt }t={1,...,T},k={1,...,K},
with T being the number of transcripts and K the number of con-
trasts. Let further Dt be the microarray data we have about transcript
t, Dt := {fkt }k={1,...,K}.
Consider the case where we have K = 2 contrasts. What would like
to compute ultimately is the posterior probability that a transcript t,
which is harboring a seed match (transcripts without seed matches
are assumed non-targets per definition), is a functional target of the
miRNA whose expression we perturbed in the 2 experiments given
the observed log2 expression fold changes f
1
t , f
2
t . Using Bayes’ theorem,
we have
P(+,+|f1t , f
2
t ) =
P(f1t , f
2
t |+,+)ρ++∑
α∈S P(f1t , f2t |α)ρα
.
Here we have introduced the prior probabilities ρα which give the
probabilities that a randomly chosen transcript with a seed match will
have functionality pattern α. For example ρ++ is the prior probabil-
ity that a randomly chosen transcript with seed match is functional
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in both contrasts. As shown below, the ρα are unknown parameters
which we set by maximizing the probability of the data D.
fitting prior probabilities Under our model, the probability
of the observed fold-changes Dt for a given transcript t is given by
P(Dt|ρ) =
∑
α
ρα
K∏
k=1
Pk(f
k
t |αk) =
∑
α
ραP(Dt|α), (B.1)
where αk is the k-th component of the functionality pattern α (either
− or +), and we have defined the probability P(Dt|α) of the data Dt
given pattern α in the last equality. The probability of the entire data
set is simply the product over all transcripts t:
P(D|ρ) =
T∏
t=1
[∑
α
ραP(Dt|α)
]
. (B.2)
We now want to maximize P(D|ρ) with respect to the prior probabil-
ities ρα while satisfying the constraint
∑
α ρα = 1. This can be done
using the method of Lagrange multipliers. We let L(ρ) denote the log-
likelihood of the parameters ρ, i.e.
L(ρ) = log [P(D|ρ)] . (B.3)
The optimal ρα then satisfy the following equations
∂L(ρ)
∂ρα
= c ∀α, (B.4)
where c is a constant (the Lagrange multiplier).
We find for the derivative of the log-likelihood
∂L(ρ)
∂ρα
=
T∑
t=1
P(Dt|α)∑
β ρβP(Dt|β)
. (B.5)
From the above equation it is easy to see that∑
α
ρα
∂L(ρ)
∂ρα
= T . (B.6)
Combining this with equation (B.4) we find that the Lagrange multi-
plier is given by
c = T (B.7)
and from this it follows that, at the optimum, the ρα satisfy:
ρα =
1
T
T∑
t=1
P(Dt|α)ρα∑
β ρβP(Dt|β)
. (B.8)
We can solve these equations using an Expectation-Maximization (EM)
procedure. We start with a random distribution ρ and use the above
equation as an update equation, i.e. at each iteration with replace ρ
with ρ˜ according to the equation
ρ˜α =
1
T
T∑
t=1
P(Dt|α)ρα∑
β ρβP(Dt|β)
, (B.9)
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until the distribution no longer changes. It is easy to show that the
second derivatives of the log-likelihood are all negative, i.e.
∂2L(ρ)
∂ρα∂ρβ
6 0 ∀α,β. (B.10)
Therefore, the log-likelihood L(ρ) is a convex function and the EM pro-
cedure will lead to the unique global optimum which we will denote
by ρ∗.
posterior probabilities of functionality Using the fitted
priors ρ∗α we can now calculate, for each transcript t, the posterior
probabilities P(α|Dt) that it has functionality pattern α. Using Bayes’
theorem we have
P(α|Dt) =
P(Dt|α)ρ
∗
α∑
β P(Dt|β)ρ
∗
β
. (B.11)
In particular, for the cases where there are two contrasts (like in our
data) we can calculate the posterior probabilities P(+ + |Dt) that the
transcript is functional in both contrasts (see Supplementary Figure 50).
We sorted all transcripts by this probability P(++ |Dt) and selected the
positives as the top n transcripts in this list.
negatives On the other hand, as negatives we wanted to select
transcripts that behave consistently, i.e. not responding, in replicated
experiments. We therefore computed the sum of squared log2 fold
changes of each transcript in the two experiments and we chose a num-
ber of transcripts matching the number of positives starting from the
lowest to the highest value.
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Figure 36: Correlation between the degree of EIF2C2 binding and the extent of
mRNA degradation in transcripts in which the single miRNA seed-
complementary site is located in the 3’UTR or anywhere in the tran-
script for the miR-124 and miR-7 EIF2C2-IP. Each row shows a given
comparison for the replicate experiments: miR-124 seed match any-
where in the transcript, miR-124 seed match in 3’ UTR, miR-7 seed
match anywhere in the transcript, miR-7 seed match in 3’ UTR. The
values of the Pearson correlation coefficients are indicated on the
plots and the number of transcripts used for each plot is indicated
in the corresponding title.
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Figure 37: Predictive power of different features of putative miRNA target
sites (rows) in predicting functional sites across the 74 data sets
(columns). The data sets covered transcriptomics and proteomics
measurements after miRNA transfection, transcriptomics measure-
ments after miRNA knock-down, profiling of mRNAs bound to
EIF2C/miRNA complexes, and target prediction based on compar-
ative genomics. The column label indicates the source of the data
set, the miRNA that was perturbed and the type of measurement
that was performed, and the total number of sites involved in the
analysis (positives + negatives). The heat-map shows the t-values
comparing the distributions of feature values in functional vs non-
functional miRNA target sites. The red color indicates positive pre-
dictors of miRNA functionality, while the blue color negative pre-
dictors of miRNA functionality. The dendrograms of features and
data sets were produced through hierarchical clustering using Ward
linkage on the euclidean space of t-values. Supplementary Figure
52 in which the same data sets are sorted by the GC-content of
the miRNA shows that the target site properties are not miRNA-
specific.
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Figure 38: The smaller sample size in the proteomics miRNA transfection ex-
periments cannot, on its own, explain the lack of predictive power
that the features that we considered have for the proteomics data.
Left panel: detail of the Supplementary Figure 37, showing the pre-
dictive power of different features on the proteomics experiments of
Selbach et al. [191]. The shot-gun proteomics approach used by the
authors (as well as by Baek et al. [8]) makes it possible to quan-
tify the change in concentration of 2000–3000 proteins following
the transfection of a miRNA. Except for a few exceptions, most of
the features we examined are not predictive of the functionality of
miRNA binding sites in this series of experiments. Right panel: we
replicated the feature analysis shown on Supplementary Figure 37
using only 2000 randomly selected genes from the miRNA transfec-
tion experiments analyzed with microarrays by Linsley et al. [140].
We then determined the predictive power of different features of
the miRNA binding sites using the same selection criteria as for
the proteomics datasets, i.e. comparing the 75 most down-regulated
mRNAs to the 75 least regulated mRNAs. Despite the reduction of
the sample size by a factor 3 – 7.5, the predictive power of most
sequence features as well as of some structure features is still de-
tectable in most experiments. Therefore, the sample size cannot
explain on its own why none of features we study appear to be
predictive of the miRNA binding sites identified by the proteomics
experiments.
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Landthaler EIF2C−IP: miR−124 mRNA degr. (308 sites)
Landthaler EIF2C−IP: miR−124 mRNA degr. | bound (114 sites)
Landthaler EIF2C−IP: miR−124 EIF2C2 binding (309 sites)
Baek transcriptomics: miR−124 mRNA degr. (315 sites)
Karginov EIF2C−IP: miR−124 EIF2C2 binding (307 sites)
Karginov EIF2C−IP: miR−124 mRNA degr. | bound (104 sites)
Baek proteomics: miR−124 transl. repr. (77 sites)
Karginov EIF2C−IP: miR−124 mRNA degr. (318 sites)
Grimson transcriptomics: miR−181a 12h mRNA degr. (262 sites)
Baek proteomics: miR−181a transl. repr. (82 sites)
Grimson transcriptomics: miR−181a 24h mRNA degr. (283 sites)
Baek transcriptomics: miR−181a mRNA degr. (281 sites)
Selbach transcriptomics: miR−155 32h mRNA degr. (282 sites)
Selbach transcriptomics: miR−155 8h mRNA degr. (270 sites)
Selbach proteomics: miR−155 transl. repr. (75 sites)
Selbach proteomics: miR−16 transl. repr. (43 sites)
Linsley transcriptomics: miR−16 mRNA degr. (196 sites)
Selbach transcriptomics: miR−16 32h mRNA degr. (172 sites)
Selbach transcriptomics: miR−16 8h mRNA degr. (161 sites)
Baek transcriptomics: miR−1 mRNA degr. (275 sites)
Selbach proteomics: miR−1 transl. repr. (65 sites)
Selbach transcriptomics: miR−1 32h mRNA degr. (274 sites)
Baek proteomics: miR−1 transl. repr. (85 sites)
Selbach transcriptomics: miR−1 8h mRNA degr. (248 sites)
difference in ElMMo posterior
−0.1 0.0 0.1 0.2 0.3 0.4
Figure 39: Difference between the average ElMMo posterior of functional vs
non-functional miRNA target sites in different experiments.
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Figure 40: Fraction of the mRNAs obtained by applying a given “prediction”
method that have reduced protein production according to the pSI-
LAC experiments of Selbach et al. [191].
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Figure 41: Expected number of evolutionarily selected binding sites for the
7 most abundant miRNAs in HeLa cells [129] in the 10% most up-
regulated and down-regulated transcripts in individual transfection
experiments of Selbach et al. [191]. The expected number of sites
were computed by summing the ElMMo posteriors over all puta-
tive binding sites for a miRNA within every 3’UTR. Each panel rep-
resents one transfection experiment, where the transfected miRNA
is indicated in the title. The expected number of binding sites in up-
and down-regulated transcripts where compared using Wilcoxon’s
ranks sum test. The corresponding p-values were computed un-
der the alternative hypothesis that up-regulated transcripts harbor
more miRNA binding sites under evolutionary pressure than down-
regulated transcripts and were corrected for multiple testing using
the Bonferroni method.
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Figure 42: The competition between endogenous miRNAs and the transfected
miRNA is transient in time. The y-axis shows average the log fold
change of mRNAs carrying seed matches to the transfected miRNA
in their 3’ UTR (X), seed matches to the transfected miRNA but not
to the most expressed endogenous miRNAs (X - D), seed matches
to both the transfected miRNA and the top expressed endogenous
miRNAs (X and D), seed matches to the most expressed endoge-
nous miRNAs but not the transfected miRNA (D - X), and seed
matches to neither the transfected miRNA nor the endogenous miR-
NAs (B). The error bars show the 95% confidence interval on the
mean after averaging over all miRNA transfection experiments per-
formed at the same time point. Left: re-analysis of 44 microarray ex-
periments performed 6, 10, 14 and 24 hours after miRNA / siRNA
transfection in HCT116 Dicer -/- cells [140]. Right: re-analysis of 10
microarray experiments performed 8 and 24h after miRNA transfec-
tion in HeLa cells [191].
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Figure 43: Luciferase reporter assay confirming that TNRC6A (also known as
GW182) is a direct target of the endogenously expressed miR-30a
in HeLa cells. The TNRC6A 3’UTR was cloned downstream of the
coding region of the Renilla luciferase (RL) and the vector system
subsequently transfected into HeLa cells, either alone (TNRC6A)
or together with the miR-30a antisense inhibitor (TNRC6A + an-
tagomiR). The y-axis shows the change in Renilla luciferase activity
normalized to the firefly luciferase (FL, control).
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Figure 44: Principal component analysis of a subset of features computed over
5964 miRNA binding sites (positives and negatives) from the com-
parative genomics data set. Although Figure 6 shows that, when
considered independently, both structure as well as sequence fea-
tures are predictive of miRNA target site functionality, it does not
show to what extent these features are redundant. To determine
this, we collected all 5964 miRNA binding sites from the compar-
ative genomics dataset (comprising positives as well as negatives)
and considered the following set of features: transcript A, G, C and
U content, flanks AU content, the seed, target site and flanks Eopen,
flanking sequence optimization, seed and target site Einteraction.
We then centered and rescaled this subset of features and deter-
mined how many principal components are needed to describe this
subset of features. The first two principal components accounted
for 65.7% of the total variance, with the third component and next
components accounting for a substantially smaller amount of the
variance compared to the first two principal components (left panel).
We then projected the subset of features onto the plane spanned by
the first two principal components and determined that sequence
features clustered well with the first principal component, while
all structure features except “flanks Eopen” clustered together with
the second principal component (right panel). This suggests that,
except for “flanks Eopen” which correlates with the G and C con-
tent, sequence and structure features are not redundant and char-
acterize miRNA binding sites in a complementary way. Performing
the same analysis on the smaller transcriptomics and proteomics
datasets yielded the same results.
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Figure 45: Correlation between change in protein and mRNA levels in the
let-7, miR-155, miR-16, miR-1 and miR-30a pSILAC experiments of
Selbach et al. [191]. The x-axis shows the log2 fold change in expres-
sion between miRNA-transfected to mock-transfected HeLa cells.
The black lines indicate the cut-offs in mRNA and protein level fold
change beyond which we consider the mRNA or the protein differ-
entially expressed. Red and black dots respectively represent tran-
scripts that carry at least one match or do not carry any match to the
seed of the transfected miRNA. The three percentages respectively
indicate the proportion of transcripts carrying at least on miRNA
seed match that are down-regulated at the protein level only, at the
mRNA level only, or both at the levels of the protein and mRNA. r
is the Pearson correlation coefficient between the change in protein
and mRNA levels.
130 supplementary material to the chapter on the determinants of mirna targeting
Figure 46: miR-124 and miR-7-mediated repression of 3’UTRs fused to lu-
ciferase reporter genes. psiCHECK reporter constructs were gen-
erated by fusing the full-length 3’UTRs of the genes indicated to
the Renilla Luciferase. Dual Luciferase activity from HEK293 cells
cotransfected with each reporter psiCHECK construct and miR-
124 or miR-7 duplex was compared to cotransfection of each re-
porter construct with control RNA duplex. Transfections of parental
psiCHECK vector without inserted 3’UTR (psiCHECK) is shown.
Renilla Luciferase versus firefly luciferase activities are indicated. Er-
ror bars represent standard deviation computed over 10 replicates.
B.2 supplementary figures 131
Figure 47: Correlation between the extent of mRNA degradation following
miR-124 transfection in the 6 biological replicates of the transcripts
of the Karginov et al. EIF2C2-IP dataset. The axes show log10 fold
changes in pairs of replicates. The Pearson correlation coefficient
between log10 fold changes of replicates ranges from 0.44 to 0.76
depending on the pair of experiments being considered.
132 supplementary material to the chapter on the determinants of mirna targeting
Figure 48: miRNA transfection and immunoprecipitation. Cells stably express-
ing FLAG/HA-EIF2C2 were mock-transfected (-) and transfected
with a miR-7/miR-7* and miR-124/miR-124* duplex (+), respec-
tively. 15 hours after transfection cells were lysed and the epitope-
tagged protein was immunoprecipitated from cytoplasmic extracts
with FLAG-antibody. RNA was extracted from the cleared cell
lysate and the immunoprecipitate (IP). 15 µg total cellular RNA and
one fifth of IPed RNA was separated on a 12% polyacrylamide gel,
blotted, and probed for miR-16, miR-7, and miR-124, respectively.
10 and 4 femtomole (fmol) of synthetic miR-16, miR-7, and miR-124,
were loaded as standards.
B.2 supplementary figures 133
  
Degradation: miR-Ly / mock-Ly
EIF2C2-binding miRNA: miR-IP / miR-Ly
EIF2C2-binding mock: mock-IP / mock-Ly
miR-specific EIF2C2-binding: (miR-IP / miR-Ly) / (mock-IP / mock-Ly)
HEK293 cells with tagged EIF2C2
Mock transfection miRNA (124 or 7) transfection
Lysate Lysate
EIF2C2-IP EIF2C2-IP
Degradationmock-Ly miR-Ly
mock-IP miR-IP
miR-specific 
EIF2C2 binding
RISC binding 
(all miRNAs)
RISC binding 
(all miRNAs)
Figure 49: Sketch of the computation of the binding and degradation mea-
sures: EIF2C2-binding in miRNA transfection is given by the ra-
tio of transcript levels in the immunoprecipitate and in the lysate
of miR-transfected cells (miR-IP/miR-Ly); EIF2C2-binding in mock-
transfection is given by the ratio of transcript levels in the im-
munoprecipitate and in the lysate of mock-transfected cells (mock-
IP/mock-Ly); miR-specific EIF2C2-binding is given by the ratio of
the previous two ratios, (miR-IP/miR-Ly)/(mock-IP/mock-Ly).
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Figure 50: Selection of positive and negative examples for EIF2C2 binding and
mRNA degradation upon miR-124 (left) and miR-7 (right) trans-
fection. Upper panels show the correlation between EIF2C2 bind-
ing measures in the replicate experiments. The transcripts marked
with red were considered “bound” and those marked in black “not
bound”. The procedure for this selection is described in the supple-
mentary text. Middle panels show the correlation between degrada-
tion of bound transcripts (in red in the upper panels) in replicate ex-
periments. Transcripts marked in red were considered “bound and
degraded”, those in violet “bound but not degraded”. Lower pan-
els reproduce the upper panels, except that transcripts that were
considered “bound” are further shown in the color that indicates
whether they were or not also considered degraded. These figures
show that the degree of degradation is not simply proportional to
the degree of EIF2C2 binding.
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Figure 51: Sketch of the transcript regions used in the computation of struc-
tural and sequence features.
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Figure 52: The features predictive of miRNA targeting are not determined by
the GC content of the mature miRNA. The present figure shows a
heat map similar to ones shown on Figure 5 and Supplementary Fig-
ure 37, but in which we reordered the columns (data sets) according
to the GC content of the transfected miRNA. The left-most columns
correspond to GC-poor miRNAs while the right-most columns fea-
ture data sets involving GC-rich miRNAs.
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c.1 supplementary figures
c.2 supplementary tables
Supplementary tables S1 to S7 are available in the online supplemen-
tary material of Hafner et al. [90].
c.3 supplementary experimental procedures
Oligonucleotides and siRNA duplexes
The following oligodeoxynucleotides were used for PCR and cDNA
cloning into pENTR4 (Invitrogen), restriction sites are underlined:
PUM2, ATGAATCATGATTTTCAAGCTCTTGCATTAG,
ATAAGAATGCGGCCGCTTACAGCATTCCATTTGGTGGTCCTCCAATAG;
QKI, ACGCGTCGACATGGTCGGGGAAATGGAAACG,
ATAAGAATGCGGCCGCTTAGCCTTTCGTTGGGAAAGCC;
IGF2BP1, ACGCGTCGACATGAACAAGCTTTACATCGGCAACCTC,
ATAAGAATGCGGCCGCTCACTTCCTCCGTGCCTGGGCCTG;
IGF2BP2, ACGCGTCGACATGATGAACAAGCTTTACATCGGGAAC,
ATAAGAATGCGGCCGCTCACTTGCTGCGCTGTGAGGCGAC;
IGF2BP3, ACGCGTCGACATGAACAAACTGTATATCGGAAACCTCAG,
ATAAGAATGCGGCCGCTTACTTCCGTCTTGACTGAGGTGGTC;
The following oligoribonucleotides were used for QKI protein in
vitro binding and crosslinking studies and were purchased from Dhar-
macon:
GUAUGCCAUUAACAAAUUCAUUAACAA
G(4SU)AUGCCAUUAACAAAUUCAUUAACAA
GUA(4SU)GCCAUUAACAAAUUCAUUAACAA
GUAUGCCA(4SU)AACAAAUUCAUUAACAA
GUAUGCCAU(4SU)AACAAAUUCAUUAACAA
4SU, 4-thiouridine.
The following siRNA duplexes (sense/antisense) were used for knock-
down experiments and synthesized on a modified ABI 392 RNA/DNA
synthesizer using Dharmacon synthesis reagents.
QKI duplex 1, GAAGAGAGCAGUUGAAGAAUU,
UUCUUCAACUGCUCUCUUCUU;
QKI duplex 2, CCAAUUGGGAGCAUCUAAAUdT,
UUUAGAUGCUCCCAAUUGGUdT;
IGF2BP1, GGGAAGAAUCUAUGGCAAAUU,
UUUGCCAUAGAUUCUUCCCUU;
IGF2BP2, GGCAUCAGUUUGAGAACUAUU,
UAGUUCUCAAACUGAUGCCUU;
IGF2BP3, AAAUCGAUGUCCACCGUAAUU,
UUACGGUGGACAUCGAUUUUU.
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Figure 53: Analysis of PUM2-PAR-CLIP clusters. Related to Figure 12.
(A) Analysis of the transcript regional preferences and the muta-
tional pattern of crosslinked sequences of PUM2. The number of
exonic sequence read clusters annotated as derived from the 5’UTR,
CDS or 3’UTR of a target transcript is shown (green bars). Yellow
bars show the expected location distribution of clusters if PUM2
binds without regional preference to the set of target transcripts.
(B) Mutational pattern observed with 4SU-PAR-CLIP for PUM2. The
left panel indicates the mutation frequency of each of the four nu-
cleotides relative to the frequency of occurrence of these nucleotides
in all sequence reads; the right panel shows, for each of the four nu-
cleotides, the frequency of mutation towards each of the three oth-
ers. In the right panels, white indicates high mutation frequency to-
wards a particular nucleotide. 4SU-PAR-CLIP yields about a 15-fold
increased mutation preference for T, nearly always to C. (C) Fraction
of clusters containing the PUM2-recognition motif, versus the total
number of clusters above a given cut-off on a particular property as
indicated in each figure legend (G upstream: number of sequence
reads with a G at position -1; T to C: number of sequence reads with
a T to C mutation; number of sequences: total number of sequence
sequence reads in the cluster, number_of_Us: number of uridines in
the sequence read cluster). For each cut-off on a given property, the
fraction of clusters with at least one binding site above the given
cut-off is shown. Cut-off increases from right to left. The best sig-
nal is obtained by sorting according to the frequency of crosslink-
ing events. (D) The increase in T to C transitions after 4SU-protein
crosslinking can be rationalized by structural changes in donor/ac-
ceptor properties of 4SU after crosslinking to proximal amino acid
side chains and subsequent incorporation of dG rather than dA in
the reverse transcription; R representing a side chain. (E) Fraction
of clusters with the recognition element (as indicated) for PUM2
versus the number of distinct crosslinking sites within a cluster in-
dicated by a T to C change. The fraction of sites containing at least
one recognition motif rises with the number of crosslinking sites. (F-
H) Enrichment of binding motifs for PUM2 for the consensus motif
UGUANAUA (F) as well as the short variant UGUA (G) compared
to CCRs with randomized sequences. Panel (H) shows the fraction
of clusters with at least one, two or three UGUANAUA motifs. Most
clusters contain only one binding site.
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Figure 54: Analysis of QKI-PAR-CLIP clusters. Related to Figure 55. (A) Anal-
ysis of the transcript regional preferences and the mutational pat-
tern of crosslinked sequences of QKI. The number of exonic se-
quence read clusters annotated as derived from the 5’UTR, CDS or
3’UTR of a target transcript is shown (green bars). Yellow bars show
the expected location distribution of clusters if QKI binds without
regional preference to the set of target transcripts. (B) Mutational
pattern observed with 4SU-PAR-CLIP for QKI. The left panel indi-
cates the mutation frequency of each of the four nucleotides relative
to the frequency of occurrence of these nucleotides in all sequence
reads; the right panel shows, for each of the four nucleotides, the
frequency of mutation towards each of the three others. In the right
panels, white indicates high mutation frequency towards a particu-
lar nucleotide. 4SU-PAR-CLIP yields about a 6-fold increased mu-
tation preference for T, nearly always to C. (C) Fraction of clusters
containing the PUM2-recognition motif, versus the total number of
clusters above a given cut-off on a particular property as indicated
in each figure legend (G upstream: number of sequence reads with
a G at position -1; T to C: number of sequence reads with a T to C
mutation; number of sequences: total number of sequence sequence
reads in the cluster, number_of_Us: number of uridines in the se-
quence read cluster). For each cut-off on a given property, the frac-
tion of clusters with at least one binding site above the given cut-off
is shown. Cut-off increases from right to left. The best signal is ob-
tained by sorting according to the frequency of crosslinking events.
(D) Fraction of clusters with the recognition element (as indicated)
for QKI versus the number of distinct crosslinking sites within a
cluster indicated by a T to C change. The fraction of sites containing
at least one recognition motif rises with the number of crosslinking
sites. (E) Enrichment of the A(C/U)UAA binding motif in CCRs of
QKI. Panel (F) shows the fraction of clusters with at least one, two
or three motifs. A significant fraction of clusters contains two or
more binding sites.
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Figure 55: Analysis of IGF2BP1-3-PAR-CLIP clusters. Related to Figure 14.
(A) Analysis of the transcript regional preferences and the muta-
tional pattern of crosslinked sequences of IGF2BP1-3. The num-
ber of exonic sequence read clusters annotated as derived from
the 5’UTR, CDS or 3’UTR of a target transcript is shown (green
bars). Yellow bars show the expected location distribution of clus-
ters if IGF2BP1-3 bind without regional preference to the set of tar-
get transcripts. (B) Comparison of the mutational patterns observed
with traditional UV 254 nm CLIP of HEK293 cells stably express-
ing FLAG/HA-tagged IGF2BP1 and that observed with UV 365 nm
CLIP of cells grown in 6SG or 4SU containing medium. For each
experimental condition two panels are shown: the left one indicates
the mutation frequency of each of the four nucleotides relative to the
frequency of occurrence of these nucleotides in all sequence reads;
the right one shows, for each of the four nucleotides, the frequency
of mutation towards each of the three others. In the right panels,
white indicates high mutation frequency towards a particular nu-
cleotide. In general, transitions are more frequent than other mu-
tation types. Traditional 254 nm CLIP generates mutations prefer-
ably on Gs (left panel). Mutations after UV254 CLIP were twice as
frequent at G compared to any other position (left panel) and pre-
dominantly identified as G to A transition (shown by the matrix in
the right panel). Treatment of cells with 6SG (middle two panels,
top row) resulted in a marked preference for mutations at G, about
one order of magnitude compared to the other nucleotides with a
preferred substitution of the G with an A. The preference for muta-
tions at G is much more pronounced relative to that observed in the
254 nm crosslinked cells. 4SU-CLIP yields about a 30-fold increased
mutation preference for T, nearly always to C. (C) Same analysis as
in (B) for IGF2BP2 and 3. The mutational biases for these proteins
are comparable. T is almost exclusively targeted for mutation, and
is preferentially sequenced as C.
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Figure 55: (D) Distance between two neighboring CAU-motifs in crosslinked
IGF2BP1 PAR-CLIP clusters (blue line) and in randomized tran-
scripts (red line). CAU-motifs are enriched within 3-5 nt distance of
each other in the crosslinked regions compared to randomized se-
quence sets. Only IGF2BP1 is shown because IGF2BP2 and 3 show
the same results. (E-F) Enrichment of the CAU (E) or CAU-N(0-
10)-CAU (F) binding motif for IGF2BP1 over randomized sequence
sets of the same nucleotide composition. Equivalent analyses for
IGF2BP2 and IGF2BP3 yield similar results (data not shown).
2’-O-methyl oligoribonucleotides and miRNA duplexes
The following sequences were chemically synthesized on an ABI394
RNA/DNA synthesizer using 5’silyl-2’orthoester chemistry1 (Dharma-
con):
anti-let-7a: AACUAUACAACCUACUACCUCA-NH2;
anti-miR-10a: CACAAAUUCGGAUCUACAGGGUA-NH2;
anti-miR-15a: CGCCAAUAUUUACGUGCUGCUA;
anti-miR-15b: CACAAACCAUUAUGUGCUGCUA;
anti-miR-16: UGUAAACCAUGAUGUGCUGCUA;
anti-miR-17-5p: CUACCUGCACUGUAAGCACUUUG;
anti-miR-18a: CUAUCUGCACUAGAUGCACCUUA-NH2;
anti-miR-19a: UCAGUUUUGCAUAGAUUUGCACA;
anti-miR-19b: UCAGUUUUGCAUGGAUUUGCACA;
anti-miR-20a: CUACCUGCACUAUAAGCACUUUA;
anti-miR-20b: CUACCUGCACUAUGAGCACUUUG;
anti-miR-21: UCAACAUCAGUCUGAUAAGCUA;
anti-miR-25: UCAGACCGAGACAAGUGCAAUG;
anti-miR-27: AACUAUACAAUCUACUACCUCA;
anti-miR-30a: CUUCCAGUCGAGGAUGUUUACA-NH2;
anti-miR-30b/c: GAGUGUAGGAUGUUUACA-NH2;
anti-miR-92b: ACAGGCCGGGACAAGUGCAAUA;
anti-miR-93: CUACCUGCACGAACAGCACUUUG;
anti-miR-101: UUCAGUUAUCACAGUACUGUA;
anti-miR-103: UCAUAGCCCUGUACAAUGCUGCU;
anti-miR-106b: AUCUGCACUGUCAGCACUUUA-NH2;
anti-miR-186: AGCCCAAAAGGAGAAUUCUUUG;
anti-miR-301: GCUUUGACAAUACUAUUGCACUG;
anti-miR-378: CCUUCUGACUCCAAGUCCAGU;
miR-7/miR-7* duplex:
UGGAAGACUAGUGAUUUUGUUGU, CAACAAAUCACAGUCUGCCAUA;
miR-124/miR-124* duplex:
5â-UAAGGCACGCGGUGAAUGCCA, CGUGUUCACAGCGGACCUUGA
1 -NH2 indicates C6 aminolinker (Dharmacon).
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Figure 56: Comparison of a 4SU-PAR-CLIP with a 6SG-PAR-CLIP cluster and
a HITS-CLIP cluster aligning to the same genomic region. Related
to Figure 14. Alignment of sequences from CLIP experiments with
IGF2BP1 against nucleotides 2784-2868 of the human EEF2 tran-
script (NM_001961). Nucleotides marked in red show the T to C
changes, all other mismatches are marked in orange. Due to space
limitations, not all reads that were sequenced are shown. (A) Align-
ment of sequences obtained from UV crosslinking at 254 nm. Lower
panel: Profile for G to A mutations (red) and for any mutation
(blue). (B) Alignment of sequences obtained after incorporation of
4SU into the transcript and crosslinking at 365 nm. Lower panel:
mutational profile for T to C mutations (red) and for any mutation
(blue). (C) Alignment of sequences obtained after incorporation of
6SG into the transcript and crosslinking at 365 nm. Lower panel: as
in (A).
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Figure 57: AGO-protein family PAR-CLIP. Related to Figure 15. (A) Principal
component analysis of the relative abundance of miRNAs derived
from the combination of the AGO-PAR-CLIP libraries on one hand,
and the non-crosslinked AGO-IPs on the other hand. The first prin-
cipal component is projected onto the plane of log10-frequency in
Ago-IP vs. log10-frequency in CLIP. The slope of the principal com-
ponent was 0.58. Although for many miRNAs the expression levels
measured by the two methods are quite comparable, there is a sub-
set of miRNAs whose expression in the AGO-IP is systematically
lower than the expression estimated based on the AGO-PAR-CLIP
data (shown in blue) (B) The miRNAs that correlate well between
the AGO-IP and the AGO-PAR-CLIP data (panel A: difference in
log10 frequencies in Ago CLIP vs Ago IP smaller than 0.6, shown
in green) are miRNAs with high frequency of T to C mutations
in the AGO-PAR-CLIP, whereas miRNAs that were sequenced at
least once in the Ago CLIP but were not detected in the Ago IP
(blue) have a low frequency of T to C mutations. (C)-(E) AGO and
TNRC6 proteins bind to the same regions on the target transcripts.
(C) Alignments of AGO PAR-CLIP and TNRC6 PAR-CLIP cDNA
sequence reads to regions in the 3’UTRs of OGT (NM_181672), the
CDS of RFC3 (NM_002915) and the CDS of AKR1A1 (NM_006066).
Red bars indicate 8 nt seed complementary sequences and nu-
cleotides marked in red indicate T to C mutations diagnostic of
the crosslinking position. (D) The distance between TNRC6 target
sites and the nearest binding sites of QKI, PUM2, AGO have been
computed. The histogram shows the number of TNRC6 target sites
within a given nucleotide distance from the binding site of another
RNA binding protein. Approximately 950 (i.e. ca. 50%) of the CCRs
from the TNRC6 PAR-CLIP experiment fall within 25 nt of a CCR
from the AGO-PAR-CLIP. (E) 6-mer enrichment in the full CCRs
and the region ranging from 2 nt upstream to 10 nt downstream of
the predominant crosslinking site. The upper panel shows the frac-
tion of CCRs having a 6-mer hit for the top 100 expressed miRNAs.
The background set consists of dinucleotide shuffled versions of ei-
ther the full CCRs or the region around the crosslinking site. The
lower panel shows the enrichment of 6-mers relative to the back-
ground set in the region indicated in previous panel (full CCRs,
and 13 nt around the predominant crosslinking site).
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Figure 58: Seed complementary sequences from abundant HEK293 miRNAs
are enriched in AGO-PAR-CLIP CCRs. Related to Figure 16. CCRs
from the AGO-PAR-CLIP are enriched for target sites for the most
abundant miRNAs in HEK293 cells. (A) Correlation between occur-
rence of 8-mer (upper panel) and 7-mer (lower panel) seed matches
in the CCRs and the abundance of the corresponding miRNA
seed families. (B) Spearman correlation between the number of 7-
mer (2-8) seed matches in the CCRs from AGO-PAR-CLIP and
the experimentally determined counts of corresponding miRNA
seeds in various miRNA samples from the smiRNAdb database
(www.mirz.unibas.ch/smirnadb) and the HEK293 RNA analyzed
in this study. Triangles indicate different HEK293 miRNA libraries.
(C) Comparison of the U content of CCRs with at least a 7-mer seed
match to the top 100 most abundant miRNAs versus CCRs with at
most a 6-mer seed match to the top 100 most abundant miRNAs.
The mean of the distributions was significantly different (ranksum
test, p = 1.910−45). (D) The number of crosslinking events corre-
lates with the enrichment of the CCRs in the putative binding sites
for the most abundantly expressed miRNAs. The frequency of the
most strongly enriched miRNA seed motif (complementary to posi-
tions 2-8 of the miRNAs) was determined in the 17,319 AGO CCRs,
which were sorted by the number of U-to-C changes and grouped
into bins of 100. The frequency of miRNA seed-complementary mo-
tifs in the CCRs decreases with the number of U-to-C mutations
in the clusters corresponding to these CCRs. (E) Number of pairs of
non-overlapping seed (pos. 2-8) matches for the 20 most abundantly
expressed miRNAs in HEK 293 cells in the crosslinked regions
(red triangle) and in control regions (100 sets of dinucleotide shuf-
fled crosslinked regions). Only the experimental set shows enrich-
ment of miRNA pairs. (F) Number of co-occurring pairs of miRNA
seed matches in the AGO crosslinked regions and the shuffled con-
trol regions for 20 randomly chosen miRNAs. (G) Number of co-
occurring pairs of miRNA seed matches in the AGO crosslinked
regions for 100 sets of 20 randomly chosen miRNAs. (H) Heat map
representation of miRNA seed match co-occurrence. Only miRNA
seed matches were counted that did not overlap and could there-
fore be bound simultaneously by two AGO-proteins. The scale in-
dicates the absolute number of co-occurring pairs. Matches to the
seed of miR-17 co-occur with matches to the seed of miR-19/miR-
130/miR-301/miR-30/miR-15/miR-16. miR-16 seed matches have
the tendency to co-occur with themselves.
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Figure 59: Properties of CCRs containing miRNA seed complementary sites.
Related to Figure 17. (A) Seed complementary sequences in the
3’UTR are more efficiently crosslinked than seed complementary
regions in the CDS. Fraction of crosslinked seed matches (1-7 or 2-
8) for the miR-124 (dark bars) and miR-7 (light bars) transfection
experiments are shown; and in (B) the fraction of crosslinked seed
matches for miR-15, miR-16, miR-19, and let-7 in the ALL_AGO
dataset is shown. (C) Properties of AGO-PAR-CLIP sequence read
clusters obtained after miR-124 and miR-7 transfection. Transcripts
with PAR-CLIP sequence read clusters identified after miR-124
and miR-7 transfection (n indicates number of transcripts consid-
ered) are bound by AGO2 and destabilized. Transcript stability
(dark grey bars) was determined as in Figure 13 by comparison
of mRNA-abundance of mock-transfected and miR-124 and miR-7-
transfected HEK293 cells. miR-7 and miR-124 mediated AGO2 bind-
ing (light grey bars) was determined by comparing transcripts en-
riched by AGO2-IPs of mock transfected and miR-124 and miR-7
transfected HEK293 cells [95]. Transcripts containing PAR-CLIP se-
quence read clusters were categorized according to the transcript re-
gion bound by AGO2 (CDS/3’UTR). (D) Same as in (C). Transcripts
were categorized in more detail according to the number and re-
gion (CDS/3’UTR) of sequence read clusters identified. (E) Same
as in (C). Transcripts containing a miR-124 and miR-7 seed com-
plementary sequence but without PAR-CLIP sequence read clus-
ters (unbound) were compared to transcripts with PAR-CLIP se-
quence read clusters with miR-124 and miR-7 seed complementary
sequences (bound). The unbound and bound transcripts are catego-
rized according to regions within the transcript (5’UTR, CDS, and
3’UTR). (F) In addition to the AGO2 binding and mRNA destabi-
lization following miR-124 transfection shown in (G) for PAR-CLIP
identified transcripts, changes in protein level following miR-124
transfection (as measured by SILAC in HeLa cells by Baek et al.
[8]) are indicated. (G-H) Codon adaptation index (CAI) for regions
upstream and downstream of CCRs (relative to 5’ end of the seed
match) found in the CDS for the (G) miR-7 and (H) miR-124 trans-
fection experiments. The red and the black lines indicate the CAI
for crosslinked and non-crosslinked transcripts, respectively.
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Figure 59: (I) The sequence context defines a functional miRNA binding site in
the UTR as well as in the CDS. Four different criteria (selection pres-
sure, destabilization score, local A/U content, target site openness)
were compared for crosslinked transcripts containing 7-mer seed
matches for a miR-124 and miR-7 and (J) the miR-15, miR-19, miR-
20, and let-7 miRNA families in the AGO PAR-CLIP experiments
compared to non-crosslinked transcripts containing the same 7-mer
seed matches. (K) In 3’UTRs longer than 3,000 nt the crosslinked
sites distribute preferentially near to the boundaries of the UTR.
Distance from the region boundaries (stop codon and polyA signal,
respectively) of CCRs with 7-mer seed complement regions falling
in the 3’UTR to miR-124 and miR-7 in the transfection experiments
(red line) and (L) 7-mer seed matches to the miR-15, miR-16, miR-
19 and let-7 seed families from the AGO PAR-CLIP (red line) com-
pared to non-crosslinked seed-matches (black lines). (M) Distance
from the stop codon of CCRs falling in the CDS containing 7-mer
seed matches of miR-124 and miR-7 (red line) or (N) 7-mer seed
matches of the miR-15, miR-16, miR-19 and let-7 seed families (red
line) compared to non-crosslinked seed-matches (black lines). Only
for the miR-124 and miR-7 transfection experiments the crosslinked
sites in the CDS distribute significantly closer to the stop-codon.
(O) Comparison of PAR-CLIP with ElMMo, TargetScan context, Tar-
getScan Pct, and PicTar miRNA target predictions. We determined
the number of seed matches in the top 1000 CCRs for each of the
indicated miRNAs. For each miRNA we selected an equal indicated
number of target sites (on mRNAs found by DGE and having a sig-
nal intensity above the median on the Affymetrix mRNA microar-
rays) that map to the indicated number of genes, starting from those
with the best score, as given by the indicated prediction method.
The figure shows average log2 fold changes of mRNA targets iden-
tified by the different methods upon miRNA inhibition (of miRNAs
let-7a, miR-103, miR-15a, miR-19a, miR-20). (P) Average log2 fold
changes of mRNA targets identified by various methods upon miR-
7 and miR-124 transfection.
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Plasmids
Plasmids pENTR4 IGF2BP1-3, QKI, AGO1-4, TNRC6A-C and PUM2
were generated by PCR amplification of the respective coding sequences
(CDS) followed by restriction digest with SalI and NotI and ligation
into pENTR4 (Invitrogen). pENTR4 IGF2BP1,-2, and -3 were recom-
bined into pFRT/TO/FLAG/HA-DEST destination vector (Invitrogen)
using GATEWAY LR recombinase (Invitrogen) according to manufac-
turer’s protocol to allow for doxycycline-inducible expression of stably
transfected FLAG/HA-tagged protein in Flp-In T-REx HEK293 cells
(Invitrogen) from the TO/CMV promoter. pENTR4 QKI and pENTR4
PUM2 were recombined into pFRT/FLAG/HA-DEST for constitutive
expression in Flp-In T-REx HEK293 cells.
Plasmids for bacterial expression of N-terminally His6-tagged IGF2BP1,
2, and 3 in E. coli were generated by ligation of CDS into pET16
(Novagen). The plasmid for bacterial expression of N-terminally His6-
tagged QKI was generated by LR recombination of pENTR4 QKI with
pDEST17 (Invitrogen). The plasmids described in this study can be
obtained from Addgene (www.addgene.org).
Antibodies
Polyclonal rabbit antibodies against IGF2BP1, 2, and 3 were generated
by injection of synthetic peptides corresponding to amino acids 561-
573, 264-275, and 567-579, respectively. Rabbit anti-QKI (BL1040) was
purchased from Bethyl Laboratories.
Recombinant protein expression and purification
pET16 IGF2BP1,-2, and -3 and pDEST17-QKI plasmids, encoding an
N-terminal His6-tag, were transformed in E. coli STAR(DE3) (Invitro-
gen). Cells were grown in LB medium supplemented with 50 µg/ml
ampicillin at 37◦C to A600 = 0.6. The cells were cooled to 25◦C, protein
synthesis was induced by addition of IPTG to a final concentration of
1 mM, cells were harvested 3 h later. The cell pellet was resuspended
in 10 ml lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM KCl, 5 mM
MgCl2, 0.1% Triton X-100, and complete EDTA-free protease inhibitor
(Roche)) per gram cell pellet. All the following steps were carried out
at 4◦C. Cells were resuspended in lysis buffer and incubated with 1
mg/ml lysozyme for 30 min and sonicated to reduce viscosity. Insolu-
ble material was removed by centrifugation at 12,000xg for 20 min. For
His-tag affinity selection, the supernatant was incubated with 250 µl
HIS-Select Cobalt Affinity Gel (Sigma) per 10 ml cell supernatant for 1
h. The gel was washed three times with 10 gel volumes of wash buffer
(50 mM Tris-HCl, pH 8.0, 300 mM Kcl, 5 mM MgCl2, 1 mM DTT, 0.1
% Triton X-100, 25 mM imidazol, and complete EDTA-free protease in-
hibitor (Roche)). His-tagged proteins were eluted in 3 gel volumes of
elution buffer (50 mM Tris-HCl pH 8.0, 300 mM KCl, 5 mM MgCl2, 1
mM DTT, 0.1% Triton X-100, 250 mM imidazol, and complete EDTA-
free protease inhibitor (Roche)). The eluted proteins were applied to a
Heparin column equilibrated in 20 mM Tris-HCl pH 7.8, 5 mM MgCl2,
100 mM KCl, 1 mM DTT, 0.1% Triton X-100, 10% glycerol. Proteins
were eluted with a KCl gradient (0.5 - 1.5 M) in 20 mM Tris-HCl, pH
7.8, 5 mM MgCl2, 1 mM DTT, 0.1% Triton X-100, 10% glycerol. His6-
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IGF2BP1, -2, and -3 eluted at 550 to 650 mM KCl and His6-QKI at 1.1
M KCl.
Electrophoretic mobility-shift analysis
Radiolabeled RNA (100 pM) was incubated with recombinant His6-
IGF2BP2 protein at indicated concentrations and 100 ng tRNA in bind-
ing buffer (20 µl of 20 mM Tris-HCl, pH 7.8, 140 mM KCl, 2 mM MgCl2
and 0.1% Triton X-100 at 30◦C) for 1 h. After addition of 6 µl loading
dye (40% glycerol, bromophenol blue in binding buffer), the reaction
mixture was loaded onto a native 6% acrylamide gel containing 0.5x
TBE, running at 200 V for 1 h at room temperature, using 0.5x TBE as
running buffer. Radiolabeled RNA (1 nM) was incubated with recom-
binant His6-QKI protein at various concentrations and 100 ng tRNA in
20 µl of binding buffer (20 mM HEPES-KOH, pH 7.4, 330 mM KCl, 10
mM MgCl2, 0.1 mM EDTA and 0.01% IGEPAL CA630 (Sigma)). After
addition of 6 µl loading dye (40% glycerol, bromophenol blue in bind-
ing buffer), the solution was loaded onto a native 10% acrylamide gel
containing 0.5x TBE, running at 200 V for 2 h at room temperature, us-
ing 0.5x TBE as running buffer. The protein-bound RNA and the free
RNA were quantified using a phosphorimager.
Cell lines and culture conditions
HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high
glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine,
1% (v/v) 10,000 U/ml penicillin/10,000 µg/ml streptomycin, 100 µg/ml
zeocin and 15 µg/ml blasticidin. Cell lines stably expressing FLAG/HA-
tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA
or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were
selected by exchanging zeocin with 100 µg/ml hygromycin. Expres-
sion of FLAG/HA-IGF2BP1, -2, -3 and TNRC6A, B and C was induced
by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.
miRNA profiling
miRNAs were extracted from FLAG/HA-AGO immunoprecipitates as
described in Meister et al. [153]. miRNAs from immunoprecipitates
and the lysate were cloned and Solexa-sequenced [89] using following
bar-coded 5’ adapters:
AGO1-IP: TCTAGTCGTATGCCGTCTTCTGCTTGT
AGO2-IP: TCTCCTCGTATGCCGTCTTCTGCTTGT
AGO2-IP: TCTGATCGTATGCCGTCTTCTGCTTGT
AGO3-IP: TTAAGTCGTATGCCGTCTTCTGCTTGT
Lysate: TCACTTCGTATGCCGTCTTCTGCTTGT
Determination of incorporation levels of 4-thiouridine into total RNA
Flp-In HEK293 were grown in medium supplemented with 100 µM
4SU 16 h prior to harvest. As a control, cells grown without 4SU addi-
tion were also harvested. 3 volumes of Trizol reagent (Sigma) were
added to the washed cell pellets and total RNA was extracted ac-
cording to manufactures instructions. Total RNA was further puri-
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fied using Qiagen RNAeasy according to the manufacturer’s proto-
col. To prevent oxidization of 4SU during RNA isolation and analy-
sis, 0.1 mM dithiothreitol (DTT) was added to the wash buffers and
subsequent enzymatic steps. Total RNA was digested and dephos-
phorylated to single nucleosides for HPLC analysis [5]. Briefly, in a
30 µl volume, 40 µg of purified total RNA were incubated for 16 h
at 37◦C with 0.4 U bacterial alkaline phosphatase (Worthington Bio-
chemical) and 0.09 U snake venom phosphodiesterase (Worthington
Biochemical). As a reference standard, synthetic 4SU-labeled RNA,
CGUACGCGGAAUACUUCGA(4SU)U was used and also subjected
to complete enzymatic digestion. The resulting mixtures of ribonucle-
osides were separated by HPLC on a Supelco Discovery C18 (bonded
phase silica 5 µM particle, 250 x 4.6 mm) reverse phase column (Belle-
fonte PA, USA). HPLC buffers were 0.1 M TEAA in 3% acetonitrile (A)
and 90% acetonitrile in water (B). The gradient was isocratic 0% B for
15 min, 0 to 10 % B for 20 min, 10 to 100% B for 30 min, and a 5 min
100% B wash applied between runs to clean the HPLC column.
UV 254 nm and UV 365 nm crosslinking
For UV crosslinking, cells were washed once with ice-cold PBS while
still attached to the plates. PBS was removed completely and cells were
irradiated on ice with 254 nm UV light (0.15 J/cm2), or 365 nm UV
light for cells treated for 14 h with 100 µM nucleoside analogs (0.15
J/cm2) in a Stratalinker 2400 (Stratagene), equipped with light bulbs
for the appropriate wavelength. Cells were scraped off with a rubber
policeman in 1 ml PBS per plate and collected by centrifugation at
500xg for 5 min.
Cell lysis and first partial RNase T1 digestion
The pellets of cells crosslinked with UV 365 nm were resuspended
in 3 cell pellet volumes of NP40 lysis buffer (50 mM HEPES, pH 7.5,
150 mM KCl, 2 mM EDTA, 1 mM NaF, 0.5% (v/v) NP40, 0.5 mM DTT,
complete EDTA-free protease inhibitor cocktail (Roche)) and incubated
on ice for 10 min. The typical scale of such an experiment was 3 ml of
cell pellet. The cell lysate was cleared by centrifugation at 13,000xg.
RNase T1 (Fermentas) was added to the cleared cell lysates to a final
concentration of 1 U/µl and the reaction mixture was incubated in a
water bath at 22◦C for 15 min and subsequently cooled for 5 min on
ice before addition of antibody-conjugated magnetic beads.
Immunoprecipitation and recovery of crosslinked target RNA fragments
preparation of magnetic beads 10 µl of Dynabeads Protein
G magnetic particles (Invitrogen) per ml cell lysate were washed twice
with 1 ml of citrate-phosphate buffer (4.7 g/l citric acid, 9.2 g/l Na2HPO4,
pH 5.0) and resuspended in twice the volume of citrate-phosphate
buffer relative to the original volume of bead suspension. 0.25 µg of
anti-FLAG M2 monoclonal antibody (Sigma) per ml suspension was
added and incubated at room temperature for 40 min. Beads were
then washed twice with 1 ml of citrate-phosphate buffer to remove un-
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bound antibody and resuspended again in twice the volume of citrate-
phosphate buffer relative to the original volume of bead suspension.
immunoprecipitation (ip), second rnase t1 digestion, and
dephosphorylation 10 µl of freshly prepared antibody-conjugated
magnetic beads per ml of partial RNase T1 treated cell lysate were
added and incubated in 15 ml centrifugation tubes on a rotating wheel
for 1 h at 4◦C. Magnetic beads were collected on a magnetic particle
collector (Invitrogen). Manipulations of the following steps were car-
ried out in 1.5 ml microfuge tubes. The supernatant was removed from
the bead-bound material. Beads were washed 3 times with 1 ml of IP
wash buffer (50 mM HEPES-KOH, pH 7.5, 300 mM KCl, 0.05% (v/v)
NP40, 0.5 mM DTT, complete EDTA-free protease inhibitor cocktail
(Roche)) and resuspended in one volume of IP wash buffer. RNase T1
(Fermentas) was added to obtain a final concentration of 100 U/µl,
and the bead suspension was incubated in a water bath at 22◦C for
15 min, and subsequently cooled for 5 min on ice. Beads were washed
3 times with 1 ml of high-salt wash buffer (50 mM HEPES-KOH, pH
7.5, 500 mM KCl, 0.05% (v/v) NP40, 0.5 mM DTT, complete EDTA-free
protease inhibitor cocktail (Roche)) and resuspended in one volume of
dephosphorylation buffer (50 mM Tris-HCl, pH 7.9, 100 mM NaCl, 10
mM MgCl2, 1 mM DTT). Calf intestinal alkaline phosphatase (NEB)
was added to obtain a final concentration of 0.5 U/µl, and the suspen-
sion was incubated for 10 min at 37◦C. Beads were washed twice with
1 ml of phosphatase wash buffer (50 mM Tris-HCl, pH 7.5, 20 mM
EGTA, 0.5% (v/v) NP40) and twice with 1 ml of polynucleotide kinase
(PNK) Buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2,
5 mM DTT). Beads were resuspended in one original bead volume of
PNK buffer.
radiolabeling of rna segments crosslinked to immuno-
precipitated proteins To the bead suspension described above,
γ-32P-ATP was added to a final concentration of 0.5 µCi/µl and T4
PNK (NEB) to 1 U/µl in one original bead volume. The suspension
was incubated for 30 min at 37◦C. Thereafter, non-radioactive ATP was
added to obtain a final concentration of 100 µM and the incubation was
continued for another 5 min at 37◦C. The magnetic beads were then
washed 5 times with 800 µl of PNK Buffer and resuspended in 70 µl of
SDS-PAGE Loading Buffer (10% glycerol (v/v), 50 mM Tris-HCl, pH
6.8, 2 mM EDTA, 2% SDS (w/v), 100 mM DTT, 0.1% bromophenol
blue).
sds-page and electroelution of crosslinked rna-protein
complexes from gel slices The radiolabeled bead suspension
was incubated for 5 min at 95◦C and vortexed. The magnetic beads
were separated on a magnetic separator and 40 µl of supernatant were
loaded per well of an SDS-PAGE. The gel was analyzed by phospho-
rimaging. The radioactive RNA-protein complex migrating at the ex-
pected molecular weight of the target protein was excised from the gel
and electroeluted in a D-Tube Dialyzer Midi (Novagen) in 800 µl SDS
running buffer according to the instructions of the manufacturer.
proteinase k digestion An equal volume of 2x Proteinase K
Buffer (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 12.5 mM EDTA, 2%
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(w/v) SDS) with respect to the electroeluate was added, followed by
the addition of Proteinase K (Roche) to a final concentration of 1.2
mg/ml, and incubation for 30 min at 55◦C. The RNA was recovered
by acidic phenol/chloroform extraction followed by a chloroform ex-
traction and an ethanol precipitation. The pellet was dissolved in 10.5
µl water.
cDNA library preparation and deep sequencing
The recovered RNA was carried through a cDNA library preparation
protocol originally described for cloning of small regulatory RNAs [89].
The first step, 3’ adapter ligation, was carried out as described on a 20
µl scale using 10.5 µl of the recovered RNA. UV 254 nm crosslinked
RNAs were processed using standard adapter sets, followed by PCR
to introduce primers compatible with 454 sequencing; UV 365 nm
crosslinked sample RNAs were processed using Solexa sequencing
adapter sets. Depending on the amount of RNA recovered, 5’-adapter-
3’-adapter products without inserts may be detected after amplifica-
tion of the cDNA as additional PCR bands. In such case, the longer
PCR product of expected size was excised from a 3% NuSieve low-
melting point agarose gel, eluted from the gel pieces with the Illustra
GFX-PCR purification kit (GE Healthcare) and Solexa sequenced.
Oligonucleotide transfection and mRNA array analysis
siRNA, miRNA and 2’-O-methyl oligonucleotide transfections of HEK293
T-REx Flp-In cells were performed in 6-well format using Lipofec-
tamine RNAiMAX (Invitrogen) as described by the manufacturer. Total
RNA of transfected cells was extracted using TRIZOL following the in-
structions of the manufacturer. The RNA was further purified using
the RNeasy purification kit (Qiagen). 2 µg of purified total RNA was
used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix)
according to manufacturer’s protocol. Biotinylated cRNA targets were
cleaned up, fragmented, and hybridized to Human Genome U133 Plus
2.0 Array (Affymetrix). For details of the analysis, see Bioinformatics
section.
Generation of Digital Gene Expression (DGEX) libraries
1 µg each of total RNA from HEK293 cells inducibly expressing tagged
IGF2BP1 before and after induction was converted into cDNA libraries
for expression profiling by sequencing using the DpnII DGE kit (Illu-
mina) according to instructions of the manufacturer. For details of the
analysis, see Bioinformatics section.
c.4 bioinformatics analyses
Adapter removal and sequence annotation
The basic method for removing adaptors and assigning a functional
annotation to the sequence reads was described in Berninger et al. [16].
Briefly, we used an in-house ends-free local alignment algorithm (score
parameters: 2 for match, -3 for mismatch, -2 for gap opening, -3 for
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gap extension) to align the Solexa adapter to the 3’ end of each se-
quence read, allowing for the possibility that the adapter was not com-
pletely sequenced2. We removed from the reads the fragments that
aligned to the adaptor as long as the number of matches exceeded
that of mismatches by at least 3. Sequences that were either too short
(less than 20 nt) or too repetitive (using a cut-off of 0.7 and 1.5 in
the entropy of the mono- and dinucleotide distributions, respectively,
of individual sequence reads [16]) were discarded because they would
probably map to multiple genomic locations. The remaining sequences
were mapped to the hg18 version of the human genome assembly
that was downloaded from the University of California at Santa Cruz
(http://genome.cse.ucsc.edu) and to a database of sequences whose
function (rRNA, tRNA, sn/snoRNA, miRNA, mRNA, etc.) is already
known. These were obtained from the sources specified in Berninger
et al. [16]. The Oligomap algorithm [16] was used for this purpose, and
all the perfect and 1-error (mismatch or insertion or deletion (indel)
mappings were obtained. Based on the GMAP [232] genome mapping
of human mRNA transcripts from NCBI downloaded on November
4th, 2008, we determined whether the sequence reads mapped to in-
tronic or exonic regions of genes. Based on the coding region anno-
tation of transcripts in GenBank, we determined whether the exonic
sequence reads originated from the 5’UTR, CDS or 3’UTR.
Generation of clusters of mapped sequence reads
For subsequent analyses only sequence reads that were at least 20
nucleotides long and mapped uniquely to the genome with at most
one error were used. A single-linkage clustering of the sequence reads
was performed, with two reads being placed in the same cluster if
they overlapped by at least one nucleotide in their genomic mappings.
Each cluster was then annotated based on the functional annotation of
sequence reads that covered most of the cluster length. We then con-
sidered all the mRNA-annotated clusters containing at least 5 mRNA-
annotated sequence reads, and we defined a scoring scheme to identify
the clusters that had the highest probability of being real crosslinking
sites (see below: Identification of high confidence clusters).
Analysis of the mutational spectra
From the clusters defined above, all sequence reads were used that
mapped uniquely and with one error (mismatch or indel) to the genome
to infer the mutational bias of the method. For each library, we cal-
culated the proportion of mutations involving each of the four nu-
cleotides as well as the proportion of each of the four nucleotides in
the crosslinked sequence reads (see Figure 53B,C).
Identification of high-confidence clusters
We used the crosslinked clusters of PUM2 and QKI, to define criteria
for selecting high-confidence binding sites. The criteria that we tested
reflected the mechanistic aspects of generating the sequence reads. Our
2 Software can be downloaded from http://www.mirz.unibas.ch/restricted/clipdata/
RESULTS/index.html
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preliminary analysis revealed that T to C mutations are by far the
most frequently observed mutations in these data sets, and that they
are most frequent inside or in the immediate vicinity of the binding
motifs as opposed to the rest of the sequence (see Figures 12E, 13E,
and 14E). This suggested that the observed mutational bias is directly
linked to the crosslinking event and should thus be a good criterion
for separating true crosslinked sites from background sequence reads.
The preliminary analysis also indicated a strong bias for having G nu-
cleotides at the last position of a sequence read and also at the genomic
position immediately upstream of a sequence read. This bias reflects
the sequence specificity of the RNase T1, and may again help in the
identification of sequence reads that map to multiple sites or for dis-
criminating random RNA turnover products unrelated to RNase T1
treatment. Finally, we observed that many clusters with abundantly
sequenced reads contained more than one position with a T to C mu-
tation. The results of testing these criteria for their ability to select
clusters that contained the known binding motif for QKI and PUM2
are shown in Figure 54. For QKI, binding motifs were defined as oc-
currences of ACUAA or AUUAA, which we identified from a very
small number of clusters. The first of these motifs was also identified
previously through SELEX experiments [71]. For PUM2, in order to
account for additional motif variants besides the consensus UGUA-
NAUA, binding motifs were identified as matches to the weight ma-
trix (as inferred by MotEvo [218] that resulted from the motif search
(see below). We found that ranking of the clusters by the number of
T to C mutations in all reads in the clusters of sequence reads leads
to the strongest enrichment in clusters with a binding site (Figure 54).
The figures show the fraction of the crosslinked clusters that contain
at least one occurrence of the known binding motif as a function of
the number of clusters that passed a given cut-off in the selection cri-
terion (e.g. total number of sequence reads, total number of T to C
mutations, total number of sequence reads with a G at position -1 rel-
ative to their genomic locus). The cut-off decreases from the left to the
right of the x-axis. It is clear that, particularly for PUM2, the number
of T to C mutations strongly correlates with the presence/absence of
the motif in the cluster. For comparison, we also show the same plots
when using as the ranking criterion not the total number of T to C
mutations in the cluster, but just the total number of sequence reads
per cluster. For QKI, this leads to a significantly lower enrichment of
clusters with recognition elements. We also investigated how the frac-
tion of clusters with the known binding motif depends on the number
of distinct crosslinking positions (i.e. positions with at least one T to C
mutation) inside the cluster (Figure 54). The fraction of clusters with
a binding site increases steadily from 0 to 5 crosslinking positions for
both proteins, with the strongest increase from 0 to 1 for PUM2 and
between 0 and 2 crosslinking positions for QKI. When requiring that at
least two positions with T to C mutations are present in the cluster, the
fraction of clusters with a binding site increases roughly by 20 % for
PUM2, and by more than 40 % for QKI. These considerations led us to
the following procedure for defining high confidence clusters for any
given RBP. We first selected all the clusters with at least two crosslink-
ing positions and, secondly, within this subset, we ranked all clusters
by the total number of T to C mutations in all sequence reads in the
cluster.
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Extraction of peaks and crosslink-centered regions (CCRs) from sequence read
clusters
From each ranked, mRNA-annotated cluster, a peak region, defined
as a 32-nt long region with the highest average sequence read density,
was extracted. Because the T to C mutation was diagnostic for the site
of crosslinking, we focused our motif analysis on regions anchored
at the position in a cluster with the most T to C mutations. We then
investigated the mutational profile around this position and we found
that this profile approaches the background profile after about 20 nt to
the left and right of the main site of T to C mutations. Thus, these 41-nt
long regions centered on the main site of T to C mutations are most
likely to contain the binding sites and we focused our motif search on
these regions.
RNA recognition element search
For the motif search defining the core of a RNA recognition site we
selected, for each RBP, the top 100 high confidence clusters, defined
as described above. We selected the 41-nt region centered on the main
T to C mutation site and searched for over-represented sequence mo-
tifs using PhyloGibbs [197]. We used a first-order Markov model as the
background model and searched each set of sequences for three motifs
of lengths varying between 4 and 8 nt, demanding an expected total
number of 50 motifs. For each parameter setting, we performed five
replicate runs. This generally resulted for each RBP in various shifted
versions of the same motif. Therefore we hierarchically clustered all
the weight matrices that we obtained from these runs, allowing for
partial overlap of at least 4 nucleotides between pairs of weight ma-
trices. In the clustering procedure, two weight matrices were fused if
the posterior probability of their stemming from the same as opposed
to two different probability distribution was larger than 0.2 (for a de-
scription of the Bayesian calculation, see Berninger et al. [16, section
4.1]). Replicating this procedure multiple times yielded very similar
results (not shown). For each protein, we selected the largest cluster of
weight matrices, i.e. the cluster that contained most of the weight ma-
trices that we obtained in replicate runs, and created the final weight
matrix by summing up the counts for each nucleotide of the weight
matrices belonging to this cluster. Since the clustering procedure also
allows the fusion of only partially overlapping weight matrices, the
resulting weight matrices are typically longer (roughly 10 nucleotides)
than the motif length that we imposed in individual runs, and can
contain stretches of low information content. We therefore selected for
each RBP, the window with highest information content. For PUM2
and QKI, the length of this window was 8 and 6 nt, respectively, in
accordance with the known or expected consensus motifs [71, 76], re-
spectively. For the IGF2BPs, we chose a window length of 4 nt, which
is believed to be the size of binding motifs of KH-domains [217]. To
identify binding sites in PUM2 clusters of aligned sequence reads us-
ing the inferred weight matrix, we used the MotEvo algorithm [218],
which is based on a hidden Markov model that models the input se-
quences as contiguous stretches of nucleotides drawn from a back-
ground or a weight matrix model. We chose for the background a
first order Markov model (which makes every nucleotide dependent
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on the preceding nucleotide in the sequence). The background model
parameters (dinucleotide frequencies) were estimated from the set of
input sequences. MotEvo was run in the prior-update mode, meaning
that we attempted to find the prior probabilities for sites and back-
ground that maximize the likelihood of the sequence data. MotEvo
generates as an output a list of sites for the given input weight ma-
trix as well as their corresponding posterior probabilities. Note that
not all matches to the weight matrix are reported, but only the subset
of matches whose corresponding sequence is more likely under the
weight matrix model than the background model. We chose a cut-off
of 0.4 on the posterior probability to define the set of binding sites.
Determination of the location of sequence read clusters within functional
mRNA regions
For each RBP, we investigated whether clusters of mapped sequence
reads preferentially originated in 5’UTR, CDS or 3’UTR (Figure 53A).
As a result of our annotation pipeline, we could assign probabilities
to each cluster to belong to either 5’UTR, CDS and 3’UTR based on
the annotation of individual sequence reads within the cluster (see
above). Taking together these probabilities for all clusters, we obtained
estimates of the numbers of clusters originating in each of these three
regions. We compare these numbers to those that we would expect if
clusters were sampled uniformly from anywhere along the transcripts.
This would for instance result in many more clusters from 3’ compared
to 5’UTR regions simply because 3’UTRs tend to be longer than the
5’UTRs. We determined all the transcripts to which a cluster mapped,
and based on the GenBank annotation of the CDS of these transcripts,
we calculated the fraction of the cluster nucleotides that fell in the
5’UTR (f5), CDS (fCDS), and 3’UTR (f3). In the cases in which the
cluster mapped to several transcripts belonging to the same gene, these
fractions were averaged over all transcripts. The expected proportion
of nucleotides sequenced from each region was calculated by summing
these fractions for all clusters. The variance was determined by noting
that the probability that a nucleotide was sampled from a particular
region, e.g. 5’UTR, is Bernoulli distributed with parameter f5, which
has a variance of f5(1− f5). The total variance was then computed as
the sum of all the variances.
Distance distribution between consecutive CAU-motifs in the IGF2BP RNA
binding sites
Since each of the IGF2BPs has 4 KH domains and we found only one
clear motif, we hypothesized that all KH domains have the same or a
very similar binding specificity. In analogy to what has been observed
for the neuronal RBP involved in splicing, Nova [215], we propose that
the binding specificity of the IGF2BPs arises from the concerted action
of several KH-domains that each recognize the same 4 letter sequence
(CAUH), which should be apparent by a preferred spacing between
subsequent occurrences of the motif as determined by the distance of
corresponding KH-domains in the structure of the IGF2BPs. We calcu-
lated, for each IGF2BP separately, the distribution of distances between
subsequent occurrences of the CAU-motif in clusters unambiguously
derived from the 3’UTR of protein coding genes. We restricted our-
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selves to these clusters since 3’UTR regions are overrepresented in clus-
ters of the IGF2BPs and each region, 5’UTR, CDS and 3’UTR, has differ-
ent sequence biases that need to be taken into account when modeling
background distributions. In order to reduce boundary effects due to
the finite length of the clusters, we extended each cluster region 32 nt
to the right and left3. We then compared this distance distribution to
the distance distribution of consecutive occurrences of the CAU motif
in randomly chosen 3’UTR regions of the same length distribution as
the clusters of mapped sequence reads. To estimate the mean and stan-
dard deviation of the relative frequency of each inter-motif distance in
the background dataset, we repeated the random selection of 3’UTR
regions 1000 times.
Enrichment of identified binding motifs in all clusters
We defined the binding motifs for PUM2, QKI and IGF2BPs using a
subset of high-confidence clusters for each protein. To determine to
what extent these motifs were indeed representing the binding sites
of the proteins in the complete data sets, we collected, for each pro-
tein and for each cluster, all the respective crosslink-centered regions
(CCRs) and ranked them by the number of T to C mutations. We then
calculated for varying cut-offs on the number of T to C mutations the
fraction of clusters above the given cut-off that contain at least one
binding site (Figure 55, blue traces). The binding site was defined to
be UGUANAUA for PUM2, ACUAA or AUUAA for QKI and CAU or
two CAUs separated by no more than 10 nucleotides for the IGF2BPs.
To estimate the number of sites expected by chance, we generated 1000
sets of random sequences with the same nucleotide frequencies as the
CCRs (dinucleotide shuffling for PUM2 as well as QKI and mononu-
cleotide shuffling for the IGF2BPs, due to the small length of the bind-
ing motif). For all proteins, the CCRs are clearly enriched in the respec-
tive binding motifs. The enrichment is strongest for PUM2, which has
the longest recognition motif. For the IGF2BPs, the enrichment for the
CAU-spacer-CAU motif is much stronger than for the CAU motif due
to the clustering of the CAU motif (see previous section). For PUM2,
we additionally determined the enrichment only for the first half of
motif UGUA. This short motif is clearly enriched and is contained in
more than 72 percent of all CCRs, suggesting the presence of other
variants of the PUM2 motif besides the consensus UGUANAUA.
Analysis of siRNA knockdown experiments
We imported the CEL files into the R software (http://www.R-project.
org) using the BioConductor affy package [74]. The transcript probe set
intensities were background-corrected, adjusted for non-specific bind-
ing and quantile normalized with the GCRMA algorithm [233]. Probe
sets with more than 6 of the 11 probes mapping ambiguously to the
genome were discarded, as were probe sets that mapped to multiple
genes. We then collected all probe sets matching a given gene, and
we selected for further analysis the RefSeq transcript with median
3’UTR length corresponding to that gene. In total 16,063 transcripts
were identified. The log-intensity of probe sets mapping to the gene
3 The genomic regions are shown on the website http://www.mirz.unibas.ch/
restricted/clipdata/RESULTS/index.html
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were then averaged to obtain the expression level per RefSeq transcript.
The changes of transcript abundances were computed as the logarithm
of the ratio of transcript expression in the cocktails of siRNA treated
samples and mock-transfected cells.
To study the effect of individual proteins on the mRNA stability of
their targets, we performed the following analysis. We first made the
links between clusters of mapped Solexa sequence reads and expres-
sion data based on the NCBI Gene ID. That is, both the transcripts that
were crosslinked and those whose expression was measured on mi-
croarrays have associated Gene IDs in the Gene database of NCBI. We
mapped both the mapped sequence read clusters as well as the tran-
scripts on microarrays to their corresponding genes, and thus iden-
tified which genes that were represented on microarrays have been
crosslinked. From this set of genes we removed those that are likely off-
targets of the transfected siRNAs. As previous studies showed, comple-
mentarity to the first 8 nucleotides of the miRNA is a good indicator
that the transcript will be downregulated by a miRNA or siRNA, so we
defined as putative off-targets those genes whose representative Ref-
Seq transcripts carried such complementary sites in their 3’UTR. We
divided the list of genes sorted by the maximum score of any cluster
associated with a given gene. In order to improve the target identifica-
tion and the assessment of the target response, we used some specific
information that was available for individual data sets. For instance,
for the IGF2BPs we only considered clusters with at least 2 positions
of T to C changes, because we previously observed that this criterion
improves the accuracy of target identification for the PUM2 and QKI.
Thus, for the IGF2BPs we divided the bound transcripts into the fol-
lowing bins, top 100 genes, 101th - 300th genes, 301th -500th genes
and 501th -1000th genes, 1001th-2000th, 2001th-3497th, and calculated
the log2fold change of transcript abundance. To determine whether
the siRNA knockdown has an effect on mRNA stability, we compared
these distributions with the distribution of log-fold changes of genes
that did not have any associated clusters from CLIP analysis. For QKI,
we performed the same analysis starting from clusters with a single T
to C mutation site, but that additionally contained the QKI motif.
Generation and ranking of clusters of mapped sequence reads for AGO and
TNRC6 family PAR-CLIP
To generate sequence read clusters for the cDNA libraries from the
AGO and TNRC6 PAR-CLIP we used sequence reads of at least 20 nt
in length and with unique, perfect or 1-error mapping to the genome.
We clustered the reads with single-linkage criterion, meaning that we
placed two reads in the same cluster if they overlapped by at least one
nucleotide in their genomic mappings. We then selected the clusters
that contained at least 5 mRNA-annotated reads and at least 2 posi-
tions at which T to C mutations occurred in the sequence reads relative
to the genomic sequence, and we ranked them by the total number of
T to C mutations which, as we described above, is indicative of the
number of crosslinks.
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Definition of CCRs for sequence read clusters of AGO and TNRC6 PAR-CLIP
In each ranked, mRNA-annotated cluster we identified the position
with the largest number of T to C mutations, and we constructed the
mutation frequency profile around this position. We found that this
profile approaches the background after about 20 nucleotides to the
left and right of the position with the maximum number of T to C
changes, and we therefore extracted a genomic region of 41 nucleotides
centered on this position for further analyses.
Filtering to remove unspecific “background” clusters for AGO and TNRC6
Because it is still possible that a substantial number of the clusters we
obtained contain degradation products of abundantly expressed mR-
NAs and because a number of proteins that associate with the RISC
complex have a molecular weight that is similar to that of AGO pro-
teins and may be responsible for some of the sequence reads/clus-
ters that we obtained in the experiment with FLAG-tagged AGO we
have collected PAR-CLIP data for a number of proteins and identified
the AGO-specific clusters as follows. We built similar clusters for all
the proteins that we investigated (PUM2, QKI, IGF2BP1-3, AGO1-4,
TNRC6A-C), we compared the clusters, and when two clusters bound
by two different proteins overlapped by more than 75% of their total
length we considered that the two proteins shared a cluster. Finally, we
discarded the following AGO clusters: clusters in which no position
had a T to C mutation rate greater than 0.2, the experimentally deter-
mined T to C mutation rate at non-crosslinked sites; clusters that were
shared between AGO libraries and libraries of other RBPs, with the
number of sequence reads in the AGO libraries being less than 1/10
of the number of sequence reads in the other library. After applying
these filters we obtained 17,319 AGO1-4 binding regions. We applied
the same procedure to the clusters that we obtained from miR-124 and
miR-7 transfection experiments.
Analysis of crosslinked position with respect to miRNA seed-complementary
sequence
We identified all the target regions (T to C anchored regions of 41
nucleotides) that have an 8-mer (A opposite miRNA position 1 and
perfect match at miRNA positions 2-8) seed match and we extended
symmetrically the seed-complementary region by 20 nt to the left and
right. We then computed the positional T to C mutation frequency in
these regions and normalized it over the length of the target region.
Identification of pairing regions of miRNAs within CCRs
To determine whether positions other than the seed region may be in-
volved in base-pairing interaction with targets, we first took the T to C
anchored target regions and identified those that had at least a 6-mer
(2-6 and A opposite miRNA position 1, 2-7 or 3-8) seed complementar-
ity to at least one of the top 100 most expressed miRNAs in HEK293
cells. For each of these T to C anchored regions and each miRNA that
matched to it, we identified all the occurrences of complementarities
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of at least 4 nucleotides between the miRNA and the putative target
region. Each of these was counted with a weight 1/n towards the posi-
tional profile of miRNA-target site matches, with n being the number
of miRNAs that matched the putative target region.
Analysis of transcript stabilization as a function of the type of miRNA bind-
ing sites
We constructed the distribution of log-fold-changes of transcripts with
various types of PAR-CLIP clusters, and we compared them with the
distribution of log-fold-changes of transcripts that did not yield PAR-
CLIP clusters, although they were expressed, as determined by the
microarray measurements. The categories of transcripts were the fol-
lowing:
1. Transcripts with various types of miRNA seed matches
• At most 6-mer match: 1-6 (with A opposite miRNA position
1), 2-7, 3-8, 4-9 match to at least one of the top 100 most
abundant miRNAs.
• At most 7-mer match: 1-7 (with A opposite miRNA posi-
tion 1), 2-8, 3-9 match to at least one of the top 100 most
abundant miRNAs.
• At most 8-mer match: 1-8 (with A opposite miRNA position
1), 2-9 match to at least one of the top 100 most abundant
miRNAs.
• At most 9-mer match: 1-9 (with A opposite miRNA posi-
tion 1) match to at least one of the top 100 most abundant
miRNAs.
2. Transcripts with PAR-CLIP clusters originating exclusively in a
particular transcript region (5’UTR, CDS, 3’UTR).
3. Transcripts with 1, 2, 3, 4 or more non-overlapping PAR-CLIP
clusters.
Digital Gene Expression (DGE)
The sequence reads from the DGE (Illumina) experiments have been
analyzed in a manner similar to that described above in the section
"Adapter removal and sequence annotation". We only considered ge-
nomic and transcript matches containing the GATC recognition se-
quence of the DpnII restriction enzyme directly upstream of the mapped
sequence read. For our analyses we further used sequence reads that
had a perfect match in the genome. The probability that a sequence
read originates in a given locus was then computed as 1/n of loci to
which the sequence read can be mapped. The sequence reads were also
mapped to the mRNA sequences and then we computed an expression
level per gene. This was defined as the sum of the weighted copies of
all sequence reads that can be mapped to transcripts that originate in
that gene. Finally, to assess the accuracy of the expression level mea-
surements, we correlated the logarithm of the expression level mea-
sured Affymetrix GeneChip microarray with the logarithm expression
level measured using the DGE technology. The Spearman correlation
coefficient was 0.68. We found a considerable number of transcripts
160 supplementary material to the chapter on par-clip
that could be detected by sequencing (22,465) and that were unde-
tectable on the microarrays (on which we measured 16,063 transcripts).
Correlation between biological replicates of HEK293 cells was higher
than 0.99.
Analysis of miRNA-induced destabilization of crosslinked and non-crosslinked
miR-124 and miR-7 targets
We intersected the transcripts with the background-noise-filtered PAR-
CLIP clusters obtained after miR-124 and miR-7 transfection (see âFil-
tering to remove unspecific âbackgroundâ clusters for AGO and TNRC6â
section above) with those for which we had destabilization and AGO-
IP Affymetrix microarray measurements. We then constructed, for each
miRNA, three non-overlapping sets of transcripts: those with PAR-
CLIP clusters exclusively in the 3’UTR, with PAR-CLIP clusters ex-
clusively in the CDS, and transcripts that did not yield any PAR-CLIP
clusters. For each set, we computed the average log2 fold change upon
miRNA transfection, and the average log2 fold enrichment in the AGO-
IP. We compared these values between transcripts with and transcripts
without PAR-CLIP clusters (Figure 59). The error bars on the bar plot
represent 95% confidence intervals on the mean log2 fold changes. Fi-
nally, we performed Wilcoxon’s rank sum test to assess the significance
of the difference in the log2 fold changes of pairs of transcript sets.
We also looked at various combinations of CLIP cluster locations (Fig-
ure 59) that occurred more than 25 times in a given data set. Finally,
we compared the destabilization and AGO-binding of crosslinked and
non-crosslinked single miR-124 and miR-7 seed matches (Figure 59).
A seed match was defined as a match to nucleotides 1-7, 2-8 or 1-8 of
the miRNA (both miRNAs start with U, so a 1-7 or 1-8 seed match
also means having an A opposite nucleotide 1 of the miRNA). A seed
match was considered "crosslinked" if it overlapped with a CLIP clus-
ter from the corresponding transfection library.
Estimation of miRNA expression based on SOLEXA sequencing
The miRNA profile was generated from Solexa sequencing runs con-
taining small RNAs from the following libraries: AGO1- IP and lysates
of AGO1-4 IP, which were combined and denoted lysate in Figure 15C.
The miRNA annotation was preformed as described in Berninger et al.
[16], Landgraf et al. [129].
Plots of motif frequency versus enrichment
We performed a 7-mer word enrichment analysis based on the T to C
anchored target regions from the miRNA transfection experiments. We
enumerated all words of length 7 and we determined their frequency
in the real set as well as in a background set of shuffled sequences
with the same dinucleotide content. For each 7-mer, we then calculated
its enrichment as the ratio of the two frequencies. Additionally, we
calculated for each 7-mer the posterior probability that the frequency
of the 7-mer is different in foreground and background allowing for
sampling noise [16]. To determine whether the enriched motifs may
correspond to miRNAs, all significantly enriched motifs (with a poste-
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rior > 0.99) were aligned with Needleman-Wunsch algorithm (penal-
ties: gapopening -4, gapextension -4) to the reverse complement of the
transfected and to the top 20 most expressed in HEK293 miRNAs. We
only reported cases in which the enriched word mapped with 0 or 1
errors to the first 9 positions of one of these miRNAs.
Identification of significantly enriched types of miRNA binding sites
In order to identify individual miRNA binding sites in the sequence
data we first defined a set of putative “binding models”. These were
either contiguous matches to at least 6 nucleotides of a miRNA, or
matches that had a single structural defect. This was defined as either
an internal loop or a bulge either in the miRNA or in the mRNA.
For each of the 553 miRNAs we enumerated all these binding models,
and we determined the enrichment of the T to C anchored regions
in each of these models, relative to the average over 10 dinucleotide
randomized sequence sets. Using a cutoff of 10−20 in the probability
that the real set had a lower frequency of occurrence compared to the
randomized sets, which we used as a measure of the significance of the
enrichment, we found all the T to C anchored regions that contained at
least one significantly enriched binding model from one of the top 100
most expressed miRNAs within 10 nucleotides of the T to C mutation
site. To obtain a comprehensive list of target sites we added to these the
7-mer nucleotide matches (within the same 10 nucleotides of the T to C
mutation) to positions 1-7 or 2-8 of one of the top 100 most expressed
miRNAs, irrespective of whether the T to C anchored regions were
enriched in these 7-mers.
Correlation of miRNA seed family expression with frequencies of occurrence
of seed-complementary motif
From all samples of smirnadb [129], all miRNAs that had at least 50
counts in total from all samples were used to build seed groups (de-
fined by the motif found at positions 2-8). We added an additional
sample, which was generated by pooling together the miRNA reads
from deep sequencing of HEK293 small RNA as well as AGO1-4 IPs
without crosslinking. For each sample, we computed the expression
of a seed group as the sum of the sequence reads of all miRNAs that
were part of the seed group. We correlated the seed expression with
the frequency of the seed-complementary motif in the T to C anchored
regions.
Co-occurrence of miRNA seed pairs within CCRs
To determine if the crosslinked regions are enriched in pairs of bind-
ing sites for highly expressed miRNAs. Assuming that not all of these
sites may have been captured in our experiment, we used for this pur-
pose the 17,319 cluster regions that we extended by 32 nucleotides on
either side. We scanned these regions for non-overlapping 7-mers cor-
responding to the positions 2-8 of the top 20 most expressed miRNAs
in HEK293 cells. We performed a similar procedure using 100 random-
ized variants of the extended clusters that preserved the dinucleotide
composition. As additional controls we performed, first, the same pro-
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cedure using 20 randomly selected miRNAs (Figure 58F) and secondly
counting of the number of seed match pair occurrence in the extended
clusters for 100 sets of 20 randomly selected miRNAs (Figure 58H). A
visualization of seed match pair occurrence is shown in Figure 58G.
Properties of crosslinked and non-crosslinked miRNA seed matches
For the analyses whose results are presented in Figure 59, we needed
to intersect the CLIP transcript sets with the transcript set measured by
the Affymetrix microrray. In order to study the properties of crosslinked
and predicted but non-crosslinked seed complementary matches we
do not need to make this intersection, and we therefore considered the
entire set of miRNA seed matches that are present in the representative
RefSeq transcripts. We chose as the representative RefSeq transcript
for a given gene that transcript that had the median 3’UTR length
from all RefSeq transcripts corresponding to a gene. RefSeq transcripts
that could not be detected in the DGE transcriptome profiling were
discarded. For the analysis of the miR-124 and miR-7 transfection li-
braries, we scanned the 5’UTR, CDS and 3’UTRs of representative ex-
pressed RefSeq transcripts for 7-mer or 8-mer seed matches to miR-
124 or miR-7, and intersected these with the background-noise-filtered
miR-124 and miR-7 PAR-CLIP clusters to identify the crosslinked and
non-crosslinked seed matches. In parallel, we scanned the 5’UTR, CDS
and 3’UTRs of representative expressed RefSeq transcripts for 7-mer
and 8-mer seed matches to miR-15, miR-20, miR-103, miR-19, let-7 rep-
resenting the top expressed miRNA families in HEK293 cells. These
seed matches were then separated into crosslinked and non-crosslinked
based on the intersection with the background-noise-filtered AGO1-4,
PAR-CLIP clusters. Furthermore, because we wanted to analyze prop-
erties of the environment of the putative miRNA target sites, we only
considered seed matches located at least 100 nucleotides away from
either of the boundaries of the transcript. For each individual seed
match, we computed the following quantities:
selection pressure is the posterior probability that a seed com-
plementary region is under evolutionary selection pressure, as
computed by the ElMMo algorithm described in Gaidatzis et al.
[70].
predicted destabilization score is a score that characterizes
the extent to which the environment of a seed match is favorable
for its functionality in mRNA destabilization, as computed by
the TargetScanS method [83]. For the analysis, we downloaded
the TargetScan 5.1 from the www.TargetScan.org website.
local au content is the proportion of A + U nucleotides within
50 nucleotides upstream and 50 nucleotides downstream of the
miRNA binding site, defined as a 20 nt-long region, anchored at
the 3âend by the seed-matching region.
target site eopen is similarly defined in terms of the energy re-
quired to open the secondary structure of the target in a region of
20 nucleotides anchored at the 3’ end by the seed-complementary
region (opposite positions 1-8 of the miRNA). This was com-
puted using the program RNAup of the Vienna package [102]
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with the following parameters: u=20 (length of the window re-
quired to be single-stranded), w=50 (maximal length of the in-
teracting region). The rest of the parameters were left with their
default values. The negative value of this energy can be viewed
as a measure of accessibility.
We tested whether the four properties introduced above took signifi-
cantly different values when comparing crosslinked to non-crosslinked
seed matches using Wilcoxon’s rank sum test.
Codon adaptation index around crosslinked and non-crosslinked seed matches
We compared the Codon Adaptation Index (CAI) [193] around crosslinked
and non-crosslinked seed matches as follows. We estimated an optimal
human codon usage by analyzing all the CDS from the 25% highest ex-
pressed genes among all the genes expressed in at least one of the two
“whole brain” samples of the SymAtlas project [205]. This set of genes
was determined by reanalyzing the two Affymetrix CEL files using the
pipeline described above in the ’Analysis of miRNA knockdown and
overexpression experiments’ section. We then anchored all sequences
at the codon covering the 5’ end of seed match (1-7, 2-8, or 1-8 of miR-
15, miR-20, miR-103, miR-19, let-7 miRNAs) and computed the CAI
for the 70 codons upstream and downstream of the anchor, i.e. a total
of 141 codons. The 7-mer or 8-mer seed match is entirely covered by
codons 0, 1 and 2, which highly constrains the codon usage at these
positions, making it uninformative. The figure therefore does not show
the CAI at these positions. For crosslinked seed matches, we smoothed
the profile using a moving average of 5.
Analysis of positional bias of crosslinked and non-crosslinked regions
We set to determine whether crosslinked seed matches (1-7, 2-8, or 1-8
of miR-15, miR-20, miR-103, miR-19, let-7 miRNAs) have a positional
bias relative to the STOP codon. Noting that at least in the 4 AGO PAR-
CLIP libraries, crosslinked seed matches tended to be located in CDS of
shorter lengths than their non-crosslinked counterparts, we performed
local polynomial regression [40], fitting the distance between the seed
matches and the STOP codon to the CDS length (Figure 59M,N). The
loess fit and 95% confidence interval on the distance to the STOP codon
given the CDS length were obtained using R’s loess and predict loess
functions with default parameters. The miRNA transfection and AGO
PAR-CLIP libraries were separately analyzed, and loess fits were com-
puted separately for crosslinked and non-crosslinked seed matches
(Figure 59K-N, shown in red and black, respectively). Finally, we rep-
resented the expected distance to the STOP codon as a function of the
CDS length assuming that seed matches are distributed uniformly over
the CDS (dashed blue curve). We used the same methodology to de-
termine whether crosslinked sites are located preferentially towards a
3’UTR boundary (stop-codon or polyA-tail) instead of the stop-codon.
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Comparison of the set of targets determined by the experimental assay (PAR-
CLIP) and computational methods (ElMMo, TargetScan 5.1)
We computed the number of seed matches to each of the top 5 ex-
pressed miRNA families in the top 1000 CCRs from the AGO-PAR-
CLIP. For each of these 5 miRNA families, we selected an equal num-
ber of target sites predicted by the ElMMo method, located on the mR-
NAs that could be detected in the DGE expression profiling (i.e. with
at least one tag count), and starting from targets predicted with highest
confidence. In addition, only genes that are expressed above the me-
dian on the arrays (i.e., the arrays in which the miRNAs are inhibited
or not present) were considered in the analysis. We repeated the pro-
cedure using the TargetScan context scores, TargetScan PCT and Pictar.
The ElMMo and TargetScan miRNA prediction methods only scan the
mRNA 3’UTRs for target sites. Therefore, we determined a fourth set
of miRNA target sites through keeping only the CCRs harboring a
seed match to at least one of the top 5 miRNA families, and located
in the 3’UTR region of an mRNA. Finally, for each of these 6 sets of
miRNA targets and each of the top 5 miRNA families, we determined
the average log2 fold change in gene expression upon transfecting the
antisense 2’-O-methyl oligonucleotide cocktail as well as the 95% confi-
dence interval on the mean log2 fold change. We performed the same
analysis on the miR-7 and miR-124 transfection data sets, this time
analyzing only CCRs containing seed matches to miR-7 or miR-124.
Stability of transcripts containing CCRs with 6-mer seed complementary
matches
For all mRNAs representative of genes detected through DGE profil-
ing, we computed the number of 3’UTR-located 6-mer and 7-mer (or
longer) seed matches to the top 5 expressed miRNA families. We then
plotted the mean log2 fold change in gene expression following the
transfection of the antisense 2’-O-methyl oligonucleotide cocktail as a
function of the number of 6-mer and 7-mer (or better) seed matches,
as well as the 95% confidence interval on the mean log2 fold change.
Finally, we performed the same analysis on the miR-7 and miR-124
transfection data sets, this time analyzing only seed matches to miR-7
and miR-124.
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